Gastric Cancer (DBCOND0028483)

Identifiers

Synonyms
Gastric Cancers / Gastric (Stomach) Cancer / Cancer, Gastric / Malignant Neoplasm of Stomach / Gastric Malignancies / Cancer of the Stomach / Gastric Cancer (GC) / Stomach (Gastric) Cancer / Stomach Cancer / Cancer of Stomach / Gastrointestinal Cancers - Stomach / Gastric cancer / Gastric malignancy / Malignant neoplasm of stomach, unspecified / Malignant tumor of stomach (disorder) / Gastric cancer NOS

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Fluorouracil
A pyrimidine analog used to treat basal cell carcinomas, and as an injection in palliative cancer treatment.
Irinotecan
A topoisomerase inhibitor used to treat metastatic carcinoma of the colon or rectum and pancreatic adenocarcinoma.
Paclitaxel
A taxoid chemotherapeutic agent used as first-line and subsequent therapy for the treatment of advanced carcinoma of the ovary, and other various cancers including breast and lung cancer.
Uracil
An antineoplastic agent used in combination with tegafur to treat various cancers, including breast, prostate, and liver cancer.
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT00582257
Early Onset and Familial Gastric Cancer RegistryNo drug interventionsNot AvailableNot Availablecompleted
NCT01514045
The Gastric Cancer Foundation: A Gastric Cancer RegistryNo drug interventionsNot AvailableNot Availablerecruiting
NCT02794428
Chemoprevention of Gastric Carcinogenesisprevention2completed
NCT02838836
Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid CancersNo drug interventionsNot AvailableNot Availablerecruiting
NCT03190941
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patientstreatment1 / 2recruiting
NCT03551951
Tumor Cell and DNA Detection in the Blood, Urine, and Bone MarrowNo drug interventionsNot AvailableNot Availablerecruiting
NCT03745326
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patientstreatment1 / 2recruiting
NCT04557969
Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic AnalysisNo drug interventionsNot AvailableNot Availablerecruiting
NCT04683939
Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumorstreatment1 / 2terminated
NCT04882241
Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)-China Extensiontreatment3active_not_recruiting
NCT04913337
Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignanciestreatment1 / 2active_not_recruiting
NCT04931654
A Study to Assess the Safety and Efficacy of AZD7789 in Participants With Advanced or Metastatic Solid Cancertreatment1 / 2recruiting
NCT05104567
A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203)treatment2terminated
NCT05878964
Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors.No drug interventionsNot AvailableNot Availablerecruiting
NCT06005493
Study of AZD5863 in Adult Participants with Advanced or Metastatic Solid TumorsNo drug interventionstreatment1 / 2recruiting
NCT06219941
AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2treatment2recruiting
NCT06346392
AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2treatment3recruiting
NCT06503146
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer DetectionNo drug interventionsdiagnostic2not_yet_recruiting
NCT04535414
Phase II Randomized Trial of Bethesda Protocol Compared to Cambridge Method for Detection of Early Stage Gastric Cancer in CDH1 Mutation CarriersNo drug interventionsdiagnostic2active_not_recruiting
NCT04566393
Expanded Access to Ulixertinib (BVD-523) in Patients with Advanced MAPK Pathway-Altered MalignanciesNot AvailableNot Availableavailable
NCT04644068
Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignanciestreatment1 / 2recruiting
NCT04713891
A Study of KF-0210 in Advanced Solid Tumors Patientstreatment1completed
NCT04725994
Study to Assess the Safety, Tolerability, and Efficacy of IDX-1197 in Combination with XELOX or Irinotecan in Patients with Advanced Gastric Cancertreatment1 / 2recruiting
NCT04768686
FLX475 Combined with Pembrolizumab in Patients with Advanced or Metastatic Gastric Cancertreatment2completed
NCT04772989
A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignanciestreatment1active_not_recruiting
NCT04871412
The Thoracic Peri-Operative Integrative Surgical Care Evaluation Trial - Stage IIINo drug interventionstreatment3recruiting
NCT04999761
AB122 Platform Studytreatment1recruiting
NCT05002127
A Study of Evorpacept (ALX148) in Patients with Advanced HER2+ Gastric Cancer (ASPEN-06)treatment2 / 3recruiting
NCT05111626
Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer.treatment3recruiting
NCT05208762
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumorstreatment1recruiting
NCT05239143
P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumorstreatment1recruiting
NCT05277766
Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis from Gastrointestinal Cancertreatment1recruiting
NCT05322577
A Study Evaluating Bemarituzumab in Combination With Other Anti-cancer Therapies in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer.basic_science1 / 2recruiting
NCT05349227
Comprehensive Outcomes for After Cancer HealthNo drug interventionssupportive_careNot Availablerecruiting
NCT05427214
Imaging Study on Halcyon 4.0 System for Patients Receiving Radiation TherapyNo drug interventionsdevice_feasibilityNot Availableactive_not_recruiting
NCT05500508
Oral AMXT 1501 Dicaprate in Combination with IV DFMOtreatment1 / 2active_not_recruiting
NCT05581004
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumorstreatment1recruiting
NCT06608381
Comparison Partial Versus Total Omentectomy in Minimal Invasive Distal Gastrectomy for cT3/4a Gastric Cancer (KLASS-10)No drug interventionstreatment3recruiting
NCT05714553
NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumourstreatment1 / 2recruiting
NCT05854368
Circulating Biomarker Signatures for the Detection of Gastric Preneoplasia and CancerNo drug interventionsotherNot Availablerecruiting
NCT05864144
A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumorstreatment1 / 2recruiting
NCT05867121
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-Care Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumorstreatment1recruiting
NCT06008054
A Study of SI-B003, BL-B01D1+SI-B003 and BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Esophageal Cancer, Gastric Cancer, Colorectal Cancer and Other Gastrointestinal TumorsNo drug interventionstreatment2recruiting
NCT06055439
A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell TherapyNo drug interventionstreatment1 / 2recruiting
NCT06109467
Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Gastroesophageal Cancertreatment2recruiting
NCT06264921
A Study with NKT3447 for Adults with Advanced/Metastatic Solid TumorsNo drug interventionstreatment1recruiting
NCT06296706
A Clinical Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancertreatment3enrolling_by_invitation
NCT06337084
Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients with Solid TumorsNo drug interventionsdiagnostic1recruiting
NCT06452329
A Study to Evaluate Nivolumab in Patients With Unresectable Advanced/Metastatic Gastric Cancer and Gastroesophageal Junction CancerNot AvailableNot Availableactive_not_recruiting
NCT06487221
Avutometinib and Defactinib in Diffuse Gastric Cancertreatment2recruiting
NCT06586957
A Study with NKT3964 for Adults with Advanced/Metastatic Solid TumorsNo drug interventionstreatment1not_yet_recruiting
NCT06614751
A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR PathwayNo drug interventionstreatment1not_yet_recruiting
NCT06617169
Dose-Escalation of MNPR-101-PCTA-177Lu in Solid Tumorstreatment1not_yet_recruiting
NCT06597526
The Role of 18F-FDG&68Ga-FAPI PET/CT in the Assessment of Conversion Therapy Efficacy in Gastric Cancer with Peritoneal Metastasis.No drug interventionsNot AvailableNot Availablerecruiting
NCT06603974
The Efficacy and Safety of Benmelstobart for GC/EGCtreatmentNot Availablenot_yet_recruiting
NCT03144843
Apatinib Combined With Paclitaxol as Second Line Therapy for Advanced Gastric Cancer.treatment2unknown_status
NCT04251403
Novel Approach to Surveillance of Gastric LesionsNo drug interventionsscreening0unknown_status
NCT02064803
Gastric Partitioning Procedure for the Treatment of Unresectable and Obstructive Distal Gastric CancerNo drug interventionstreatmentNot Availablecompleted
NCT01889303
Phase II Study of DC Versus 5-FU/CF as Chemotherapy and Concurrent Chemoradiotherapy for Locally Advanced Gastric Cancertreatment2unknown_status
NCT01633203
Observational Study of Perioperative Chemotherapy in Gastric CancerNot AvailableNot Availablecompleted
NCT01803503
Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid Tumorstreatment2unknown_status
NCT01388790
Cetuximab in Combination With S-1 and Cisplatin in Gastric Cancertreatment2completed
NCT06006390
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid TumorsNo drug interventionstreatment1 / 2recruiting
NCT05750290
CKD-702 Plus Irinotecan in Gastric Cancertreatment2recruiting
NCT04714190
A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer With the HER2-Overexpressiontreatment3recruiting
NCT01070290
A Study of ARQ 197 Versus Investigator's Choice of Second-Line Chemotherapy in Patients With Locally Advanced or Metastatic Gastric Cancer Who Have Progressive Neoplastic Disease Following Treatment With One Prior Chemotherapy Regimentreatment2withdrawn
NCT03130790
Varlitinib in Combination With mFOLFOX6 for Advanced or Metastatic Gastric Cancer (First Line)treatment2 / 3completed
NCT04214990
Aspirin Use for Gastric Cancer Prevention in the Early Gastric Cancer Patientsprevention3recruiting
NCT05646290
Validation of a Model for Predicting Anastomotic LeakageNo drug interventionsNot AvailableNot Availablerecruiting
NCT05165264
A Study of Nivolumab Plus Chemotherapy in First Line Treatment of Adult Participants With Advanced or Metastatic Gastric CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT00165464
Taxotere, Cisplatin and Irinotecan (CPT-11) for Esophagogastric Cancertreatment2completed
NCT00209664
Phase II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancertreatment2suspended
NCT06278064
Exosome-based Liquid Biopsies for Upper Gastrointestinal Cancers DiagnosisNo drug interventionsNot AvailableNot Availablerecruiting
NCT03957564
Liquid Biopsy in Monitoring the Neoadjuvant Chemotherapy and Operation in Gastric CancerNo drug interventionstreatment2unknown_status
NCT01683864
Randomized Controlled Trial to Prevent Peritoneal Seeding in Gastric Cancertreatment2 / 3terminated
NCT06301464
Pepsinogen II and Helicobacter Pylori Test in Gastric CancerNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT04734821
Fluorescence Image Guided Foregut SurgeryNo drug interventionsotherNot Availablerecruiting
NCT06023121
Use of a Liquid Biopsy Signature to Detect Early-onset Gastric CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT05075421
Prognostic Values of Inflammation-based Indices in Gastric CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT02780921
Effect of Prehabilitation in Gastroesophageal Adenocarcinoma: Study Protocol of a Multicentric, Randomised Control TrialNo drug interventionstreatment3unknown_status
NCT00503321
Phase II Study of TS-1 Therapy and TS-1+PSK Therapy Against Advanced Gastric Carcinomatreatment2 / 3terminated
NCT00502502
Assessment of Symptom-Related Cytokines in Lung and Gastrointestinal (GI) Cancer PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT04656002
As a Second-line Treatment for Metastatic Gastric Adenocarcinoma Patients, the Safety and Effective of Vactosertib Administration in Combination With Paclitaxel+Ramucirumab is Evaluated, and a Phase 2a Clinical Trial to Biomarkerstreatment2not_yet_recruiting
NCT04250402
The Incidence of Gallstones After Gastric Cancer SurgeryNo drug interventionsNot AvailableNot Availablerecruiting
NCT00433602
Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid TumorsNo drug interventionsNot AvailableNot Availablecompleted
NCT05536102
The Effectiveness and Safety of XELOX and Tislelizumab + PLD for Resectable Gastric Cancer (LidingStudy)treatment2recruiting
NCT05029102
TAS-102 and Anlotinib in ≥3 Lines mGCtreatment2recruiting
NCT04260802
A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancerstreatment1 / 2recruiting
NCT05035602
Google Location History Following Oesophagectomy and/or GastrectomyNo drug interventionsNot AvailableNot Availablecompleted
NCT03272984
ERAS for Patients Received Neoadjuvant ChemotherapyNo drug interventionstreatmentNot Availablecompleted
NCT04286984
Implementation of a Patient Blood Management Program in Gastric Cancer SurgeryNo drug interventionsNot AvailableNot Availablecompleted
NCT02689284
Combination Margetuximab and Pembrolizumab for Advanced, Metastatic HER2(+) Gastric or Gastroesophageal Junction Cancertreatment1 / 2completed
NCT04943484
ICG (Indocyanine Green) Imaging Fluorescence Technology in Surgical Treatment of Advanced Gastric CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT05390684
Predictive Model to Early Diagnosis of Anastomotic Leak After Esophagectomy and Gastrectomy.No drug interventionsNot AvailableNot Availableunknown_status
NCT05788484
A Study of CDX-585 in Patients With Advanced MalignanciesNo drug interventionstreatment1recruiting
NCT04294784
Nab-paclitaxel Plus PD-1 Inhibitor Versus Nab-paclitaxel as Second-line Treatment in Advanced Gastric Cancertreatment2active_not_recruiting
NCT03813784
A Study to Evaluate SHR-1210 in Combination With Capecitabine + Oxaliplatin Sequenced by SHR-1210 + Apatinib as First-line Therapy in Treatment of Advanced Gastric Cancertreatment3unknown_status
NCT00917384
Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Participants With Gastric Cancer and Adenocarcinomatreatment3completed
NCT04202484
Tripletrumab Combined With Oxaliplatin and Teggio (SOX) in First-line Treatment of Gastric and Gastroesophageal Junction Adenocarcinomatreatment2unknown_status
NCT02446379
Use of the EnLightTM and LightPathTM Imaging Systems in Gastrointestinal Tumour SurgeryNo drug interventionsNot AvailableNot Availablewithdrawn
NCT05901779
Effect of Probiotic Supplements on Gastric Cancer Patients Receiving Neoadjuvant ChemotherapypreventionNot Availablerecruiting
NCT06337279
Systemic Oxidative Stress Score as a Predictor of Gastric Cancer Survival and Recurrence RiskNo drug interventionsNot AvailableNot Availablecompleted
NCT00400179
A Safety and Efficacy Study in Patients With Gastric Cancertreatment3completed
NCT05076279
Safety and Efficacy of Single or Reduced Ports Laparoscopic Gastrectomy for Advanced Gastric Cancer (SPACE-01)No drug interventionstreatmentNot Availablerecruiting
NCT03620643
Crizotinib in Lobular Breast, Diffuse Gastric and Triple Negative Lobular Breast Cancer or CDH1-mutated Solid Tumoursother2active_not_recruiting
NCT06370143
A Study Collecting Health Information to Understand and Prevent Gastric CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT00816543
Docetaxel + Oxaliplatin + S-1 in Potentially Operable Gastric or Gastroesophageal Adenocarcinomatreatment2completed
NCT02137343
A Phase 3 Study of Rilotumumab (AMG 102) With Cisplatin and Capecitabine (CX) as First-line Therapy in Gastric Cancertreatment3terminated
NCT01059643
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Necktreatment2completed
NCT03478943
The Real World Study of Apatinib for Gastric Cancer Treatment in Henan ProvinceNo drug interventionsNot AvailableNot Availableunknown_status
NCT01158287
Sorafenib. ICORG 06-41, V4treatment2completed
NCT03391687
Incidence of Pancreatic Fistula After Radical GastrectomyNo drug interventionsNot AvailableNot Availableunknown_status
NCT00020787
Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal Cancertreatment3completed
NCT01764087
A Study of KX2-391 With Paclitaxel in Patients With Solid Tumorstreatment1 / 2unknown_status
NCT04929587
Analysis of Influencing Factors of Preoperative Frailty in Elderly Patients With Gastric Cancer Based on the Health Ecology TheoryNo drug interventionsNot AvailableNot Availablecompleted
NCT00683787
Docetaxel With or Without Vandetanib in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancertreatment2terminated
NCT05842187
In Vitro Organoid Drug Sensitivity-Guided Treatment for Metastatic Pancreatic and Gastric CancerNo drug interventionstreatmentNot Availablerecruiting
NCT02711033
Laparoscopic-assisted Total Gastrectomy Versus Open Total Gastrectomy With Splenic Hilum Lymph Nodes DissectionNo drug interventionstreatment2unknown_status
NCT05025033
Chemotherapy Combined With Apatinib and PD-1 Antibodytreatment2completed
NCT03332433
High-flow Nasal Cannula Oxygenation Decrease Hypoxia in Gastroscopy Sedated by PropofolNo drug interventionspreventionNot Availablecompleted
NCT05039333
Clinical Study to Prove Safety and Effectiveness When Applying RUS™ Surgical NavigationNo drug interventionsNot AvailableNot Availableunknown_status
NCT00352833
Safety and Efficacy Study With Catumaxomab in Patients After Curative Resection of a Gastric Adenocarcinomatreatment2completed
NCT00004233
S9915 Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or Stomachtreatment2completed
NCT05411133
Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer PatientsNo drug interventionstreatment1recruiting
NCT05720533
Disitamab Vedotin Combined With Sintilimab as First-line Treatment of Elderly Patients With Gastric Cancertreatment2not_yet_recruiting
NCT02563054
A Study of Capecitabine (Xeloda) in Participants With Advanced or Metastatic Gastric Cancertreatment3completed
NCT00423254
Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.No drug interventionstreatment1completed
NCT05000554
The Safety and Efficacy of PD-1 Monoantrapical Chemotherapy in the Treatment of Local Advanced Stomach CancerNo drug interventionstreatment2recruiting
NCT05013554
Dose Escalation and Expansion Study of SAR443216 in Participants With Relapsed/Refractory HER2 Expressing Solid TumorsNo drug interventionstreatment1terminated
NCT00342654
Nutrition Intervention Trials in Linxian Follow-up StudyNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT06426654
Sintilimab Combined With LDRT for Neoadjuvant Treatment of Locally Advanced dMMR/MSI-H Gastric Cancertreatment1 / 2not_yet_recruiting
NCT06079554
Microbiota and Metabolomics of Intestinal Type of Gastric CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT02197351
Narrow Band Imaging for Gastric NeoplasiaNo drug interventionsdiagnosticNot Availablerecruiting
NCT05721651
Efficacy and Safety of Fruquintinib in Combination With PD-1 Inhibitors as First-line Maintenance Therapy for Advanced HER-2 Negative Gastric Cancer: a Single-arm, Prospective, Exploratory Clinical Studytreatment2recruiting
NCT03236051
Multimodal Analgesia in Laparoscopic Radical Gastrectomy With Gastric Cancer: a Multi-center StudyNo drug interventionstreatmentNot Availableunknown_status
NCT01798251
XELOX With Capecitabine Maintenance or XELOX in Elderly Metastatic Adenocarcinoma of Stomachtreatment2unknown_status
NCT00275951
Cetuximab Plus P-HDFL for the First-line Treatment of Advanced Gastric Cancertreatment2completed
NCT02908451
A Study of AbGn-107 in Patients With Gastric, Colorectal, Pancreatic or Biliary CancerNo drug interventionstreatment1terminated
NCT01783951
Study of S-1 Plus DC-CIK for Patients With Advanced Gastric Cancertreatment1 / 2completed
NCT04547153
Infusional Fluorouracil and Weekly Docetaxel for Gastric Cancer With Bone Marrow Involvement and DICtreatment2completed
NCT03399253
Chemotherapy Alone Versus Surgery Plus Chemotherapy for Distal Gastric Cancer With One Non-curable FactorNo drug interventionstreatment2 / 3recruiting
NCT01815853
Neoadjuvant Chemoradiotherapy vs. Chemotherapy With Radical Gastrectomy and Adjuvant Chemotherapy for Advanced Gastric CancerNo drug interventionstreatment3recruiting
NCT02623153
Comparison Between XELOX and S1, Oxaliplatin and Docetaxel as Neoadjuvant Chemotherapy for Gastric Cancertreatment2unknown_status
NCT04762953
Study of Sequential Systemic Therapy + Intraperitoneal Paclitaxel in Gastric/GEJ Peritoneal Carcinomatosistreatment2recruiting
NCT01813253
Phase 3 Study of Nimotuzumab and Irinotecan as Second Line With Advanced or Recurrect Gastric and Gastroesophageal Junction Cancertreatment3terminated
NCT02404753
A Comparison of Laparoscopic With Open Distal Gastrectomy in Advanced Gastric Cancer After Neoadjuvant ChemotherapyNo drug interventionstreatment2unknown_status
NCT03652077
A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignanciestreatment1completed
NCT03704077
An Investigational Immuno-therapy Study of Relatlimab Plus Nivolumab Compared to Various Standard-of-Care Therapies in Previously Treated Participants With Recurrent, Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinomatreatment2withdrawn
NCT03156777
Application Value of CTCs Detection for Advanced Gastric Cancer PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT05643677
Fruquintinib Plus Irinotecan in the Treatment of Advanced Gastric Cancertreatment2not_yet_recruiting
NCT00961077
Attenuated SOX as First-line Treatment in Elderly Patients With Relapsed or Metastatic Gastric Cancertreatment2unknown_status
NCT04868877
Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combinationtreatment1 / 2recruiting
NCT04107077
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancertreatment2recruiting
NCT00681577
Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Gastric CancerNo drug interventionstreatment1 / 2completed
NCT03694977
Biomarker Study of PDR001 in Combination With MCS110 in Gastric Cancertreatment2unknown_status
NCT00767377
Continuous Infusion of FU Combined With Epirubicin and Oxaliplatin in Patients With A/MGCNo drug interventionstreatment2completed
NCT05861947
A Phase 1 Clinical Trial of AUR106 in Patients With Relapsed Advanced MalignanciesNo drug interventionstreatment1recruiting
NCT05070247
A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumorstreatment1 / 2recruiting
NCT00021047
Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumortreatment1 / 2completed
NCT02454647
Induction Chemotherapy, Chemoradiotherapy and Surgery in Locally Advanced Gastric Cancer PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT05410847
Nab-paclitaxel Plus Camrelizumab and S-1 Conversion Therapy for Gastric Cancer With Positive Exfoliative Cancer Cellstreatment2not_yet_recruiting
NCT05991947
Preliminary Experimental Study on Key Technologies for Early Screening of Gastric CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT03872947
A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumorstreatment1recruiting
NCT04868747
The Effect of Perioperative Lidocaine Infusion on Neutrophil Extracellular Trappingsupportive_careNot Availablewithdrawn
NCT05027347
Detection of Plasma Circulating Tumor DNA in Gastric CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT02983045
A Dose Escalation and Cohort Expansion Study of NKTR-214 in Combination With Nivolumab and Other Anti-Cancer Therapies in Patients With Select Advanced Solid Tumorstreatment1 / 2completed
NCT01814345
Her 2 Testing in Indian Patients With Gastric CancerNo drug interventionsNot AvailableNot Availableterminated
NCT03730545
Effect of Enteral Immunonutrition on Immune, Inflammatory Markers and Nutritional Status in Patients Undergoing Gastrectomy for Gastric CancerNo drug interventionssupportive_careNot Availablecompleted
NCT01228045
A Study of Trastuzumab in Combination With TS-ONE & Cisplatin in First-line Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancertreatment2unknown_status
NCT04778345
Preoperative Abdominal Enhanced CT, 18F-FDG PET/CT and 68Ga-FAPI PET/CT in Peritoneal Carcinomatosis of Gastric CancerNo drug interventionsdiagnosticNot Availableunknown_status
NCT03766945
Fatigue and QoL Among Gastric Cancer Patients Undergoing Abdominal SurgeryNo drug interventionsNot AvailableNot Availableunknown_status
NCT05540145
Neo-Sequence 1: Neoadjuvant Chemotherapy With or Without Antiangiogenesis and Sequential Immunotherapy for HER2-negative MMR-proficient Locally Advanced Gastric or Gastroesophageal AdenocarcinomaNo drug interventionsNot AvailableNot Availablecompleted
NCT05300945
HIPEC Combined Gastrectomy in Patients With Advanced Gastric Cancer Received Neoadjuvant ChemotherapyNo drug interventionstreatment2 / 3not_yet_recruiting
NCT02752698
Domestic Surgical Robot Clinical StudyNo drug interventionsotherNot Availableunknown_status
NCT00178698
Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic Tumorstreatment2unknown_status
NCT01456598
Efficacy of Laparoscopic Subtotal Gastrectomy With D2 Lymph Node Dissection for Locally Advanced Gastric CancerNo drug interventionstreatmentNot Availablecompleted
NCT05720598
Staging LaParoscopy to Assess Lymph NOde InvoLvement in Advanced GAstric CancerNo drug interventionsdiagnosticNot Availablerecruiting
NCT03418298
Prehabilitation in Patients With Esophageal or Gastric CancersNo drug interventionstreatmentNot Availablecompleted
NCT03890198
A Phase 1 Study of LCAR-C182A Cells in the Treatment of Advanced Gastric Cancer and Pancreatic Ductal AdenocarcinomaNo drug interventionstreatment0terminated
NCT02903498
The Maintenance Treatment of UFT in Advanced Gastric Cancertreatment2completed
NCT01090505
Study of S-1 and Oxaliplatin as Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancertreatment2unknown_status
NCT06109805
Plasma Metabolic Biomarkers for Gastric Cancer DiagnosisNo drug interventionsNot AvailableNot Availablerecruiting
NCT03006705
Study of Adjuvant ONO-4538 With Resected Gastric Cancertreatment3completed
NCT04440605
A Study to Confirm the Accuracy of Locally Advanced Gastric Cancer DiagnosisNo drug interventionsNot AvailableNot Availableunknown_status
NCT02800005
Effect of Obesity on Surgical Outcomes and Survival for Gastric CancerNo drug interventionsscreeningNot Availableunknown_status
NCT00660205
Venous Thromboembolism and Haemostatic Disturbances in Patients With Upper Gastrointestinal CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT01130805
A Study of Pazopanib With CAPEOX in AGC Patientstreatment2completed
NCT03485105
Prediction of Benefit From Adjuvant Chemotherapy for pT1N1 Gastric CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT03802097
Study About no Antimicrobial Prophylaxis in Totally Laparoscopic Distal GastrectomyNo drug interventionstreatmentNot Availablecompleted
NCT04843397
Diagnostic Performance Indicators in Upper GI Endoscopy:PROSPERO StudyNo drug interventionsNot AvailableNot Availableunknown_status
NCT04611997
IGG Using in Laparoscopic Gastrectomy for Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapytreatment3active_not_recruiting
NCT01191697
CAPOX, Bevacizumab and Trastuzumab for Patients With HER2-Positive Metastatic Esophagogastric Cancertreatment2active_not_recruiting
NCT03909997
Severe Complications After Gastrectomy for Esophagogastric Junction and Gastric CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT05012397
Milademetan in Advanced/Metastatic Solid Tumorstreatment2terminated
NCT02375997
Early Palliative Care in Metastatic Esophageal Squamous Carcinoma (ESCC) and Gastric CancerNo drug interventionstreatment3unknown_status
NCT02444897
The Comparison Between Epidural and Intravenous Patient-controlled Analgesia for Laparoscopic Gastrectomysupportive_care3completed
NCT01341197
Fecal Screening Assay for Taiwanese PopulationNo drug interventionsNot AvailableNot Availablecompleted
NCT06229197
Billroth II With Braun Anastomosis After Radical Distal Gastrectomy for Gastric CancerNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT05928897
Efficacy and Safety of Disitamab Vedotin Combined With Sintilimabtreatment2not_yet_recruiting
NCT06155383
Perioperative Disitamab Vedotin Plus Toripalimab and XELOX in Gastric or Gastroesophageal Junction Adenocarcinoma.treatment2recruiting
NCT05541783
Laparoscopic-assisted Distal Gastrectomy and Totally Laparoscopic Distal Gastrectomy for Gastric CancerNo drug interventionstreatmentNot Availablerecruiting
NCT00002883
Surgery With or Without Combination Chemotherapy in Treating Patients With Cancer of the Esophagustreatment3completed
NCT04345783
Efficacy and Safety of Camrelizumab for Injection, Apatinib Mesylate and Tegio for First-line Refractory Patients With Advanced Gastric Cancertreatment2unknown_status
NCT05238883
A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumorstreatment1recruiting
NCT00746161
Evaluation of Double Tract Reconstruction After Total Gastrectomy in Patients With Gastric CancerNo drug interventionstreatment3completed
NCT00172861
Cyclooxygenase-2-Associated Factors and Gastric Carcinogenesis Mechanisms-Clinical Association and Genomic InvestigationNo drug interventionsNot AvailableNot Availableunknown_status
NCT02191761
Safety and Pharmacokinetics of SM04755 in Subjects With Advanced Colorectal, Gastric, Hepatic, or Pancreatic CancerNo drug interventionstreatment1completed
NCT02806661
Comparison of Vagus Nerve-preserving RADG and Conventional RADG for AGCNo drug interventionstreatmentNot Availableunknown_status
NCT04834661
Performing Laparoscopic Surgery for Colorectal and Gastric Cancer Outside the Primary Registered Medical InstitutionNo drug interventionsNot AvailableNot Availablecompleted
NCT02541461
Body Composition After Laparoscopic Gastrectomy for Gastric CancerNo drug interventionssupportive_careNot Availablecompleted
NCT05361161
Transarterial Chemoembolization With Lipiodol in the Treatment of Initial Unresectable Gastric Cancer (GC)treatment2not_yet_recruiting
NCT02030561
NK Cell Infusions With Trastuzumab for Patients With HER2+ Breast and Gastric Cancertreatment1 / 2unknown_status
NCT01433861
Laparoscopy-assisted Proximal Gastrectomy Versus and Laparoscopy-assisted Total GastrectomyNo drug interventionstreatment3terminated
NCT02980861
Laparoscopic Versus Open Gastrectomy With Splenic Hilum Lymph Nodes DissectionNo drug interventionstreatment3unknown_status
NCT06521528
A Pilot Clinical Study to Evaluate the Feasibility of Using the SPC TestNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00722228
Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic TumorsNo drug interventionsprevention1 / 2unknown_status
NCT03150628
Cytoreductive Surgery and Intraperitoneal Chemotherapy for Stomach CAncer: a Feasibility StudyNo drug interventionstreatment2terminated
NCT06256328
A Study to Investigate the Efficacy and Safety of ONO-4578 in Combination With Nivolumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer)treatment2active_not_recruiting
NCT01331928
Sequential Chemotherapy With Xelox Follows by TX to Treat Gastric Cancertreatment2unknown_status
NCT06560528
Disitamab Vedotin Combined With Tislelizumab and Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Cancer With HER2 Overexpressiontreatment2recruiting
NCT06440811
Preoperative Adjuvant SOX Plus PL-1 Antibody and FLOT Plus PD-1 Antibody for Locally Advanced dMMR Gastric CancerNo drug interventionstreatment1recruiting
NCT06451211
Neoadjuvant Immunotherapy Plus Chemotherapy in Borrmann Type 4 and Large Type 3 Gastric Cancertreatment2recruiting
NCT03817411
Telatinib in Combination With Capecitabine/ Oxaliplatin in 1st Line Gastric or GEJ Cancertreatment2unknown_status
NCT06134011
A Multi-omics-based Metabolic Typing Study of Gastric CancerNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00845611
Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Gastric CancerNo drug interventionstreatment1completed
NCT00183911
Study of 5-Fluorouracil and Leucovorin and Intra-abdominal Floxuridine Chemoradiation in Patients With Fully Resected Locally Advanced Gastric Adenocarcinomatreatment2completed
NCT00004911
Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel ObstructionNo drug interventionssupportive_care1 / 2completed
NCT01257711
A Study Comparing Billroth II With Roux-en-Y Reconstruction for Gastric CancerNo drug interventionstreatmentNot Availablecompleted
NCT03219593
Apatinib as the First-Line Therapy in Elderly Locally Advanced or Metastatic Gastric Cancertreatment2unknown_status
NCT03959293
Clinical Trial Evaluating FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab and Tremelimumab in Second-line Treatment of Patients With Advanced Gastric or Gastro-oesophageal Junction Adenocarcinomatreatment2active_not_recruiting
NCT04791293
The Model for End-Stage Liver Disease Sodium (MELD-Na) Score in Non-cirrhotic Patients With Gastric CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT01364493
A Study to Evaluate the Efficacy and Safety of Trastuzumab in Combination With Capecitabine and Oxaliplatin as First-line Chemotherapy for Inoperable, Locally Advanced or Recurrent and/or Metastatic Gastric Cancertreatment2completed
NCT06383793
Comparative Analysis of Short-Term Therapeutic Effects Between the π-Shaped and Overlap Methods for Esophagogastrostomy in Totally Laparoscopic Total GastrectomyNo drug interventionsNot AvailableNot Availablerecruiting
NCT01305993
Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Metastatic Gastric CancerNo drug interventionstreatment2unknown_status
NCT02915393
System Biology of Spleen Deficiency SyndromeNo drug interventionsNot AvailableNot Availableunknown_status
NCT05465993
the Optimal Surveillance Frequency for Stage II/III Gastric CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT06260293
The Effect of Post-operative Exercise in Gastric Cancer Patients: A Randomized Controlled Trial (RCT) StudyNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT03935893
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancerstreatment2recruiting
NCT06451393
Predicting Gastric Cancer Response to Chemo With Multimodal AI ModelNo drug interventionsNot AvailableNot Availablerecruiting
NCT04276493
Anti-HER2 Bispecific Antibody ZW25 Activity in Combination With Chemotherapy With/Without Tislelizumabtreatment1 / 2active_not_recruiting
NCT05075993
Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumorstreatment1recruiting
NCT02322593
Phase III Study of TAS-118 Plus Oxaliplatin Versus S-1 Plus Cisplatin in Patients With Advanced Gastric Cancertreatment3completed
NCT02624271
Diagnosis of Gastric Precancerous Lesions by a Blood Test GastroPanel in Patients With Increased Gastric Cancer RiskNo drug interventionsdiagnosticNot Availablecompleted
NCT06266871
SOX Combined With Tislelizumab and LDRT for Neoadjuvant Treatment of Locally Advanced Gastric CancerNo drug interventionstreatment1 / 2not_yet_recruiting
NCT04511871
A Phase I Trial of CCT303-406 in Patients With Relapsed or Refractory HER2 Positive Solid TumorsNo drug interventionstreatment1recruiting
NCT02946671
Study of Pre-operative Combination Therapy With Mogamulizumab and Nivolumab Against Solid Cancer Patientstreatment1completed
NCT05844371
Efficacy and Safety of Tirelizumab Plus Chemotherapy Versus Chemotherapy Alone in Patients With Lymph Node Positive Gastric Cancer After Surgerytreatment2recruiting
NCT04155671
POF Versus FOLFOX Plus IP Paclitaxel in AGCNo drug interventionstreatment2unknown_status
NCT00666978
Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smokingtreatment4completed
NCT00429078
Trial of 2nd Generation Anti-CEA Designer T Cells in Gastric CancerNo drug interventionstreatment1withdrawn
NCT02423278
The Long-term Effect of D4 Lymphadenectomy for Gastric Cancertreatment2 / 3unknown_status
NCT05977478
Characterization of Tissue Biochemical Composition in Gastric Precancerous/Cancerous LesionsNo drug interventionsdiagnosticNot Availablerecruiting
NCT02529878
Study of Convernsion Therapy Using S1/Paclitaxel Chemotherapy Plus Apatinib in Unresectable Gastric Cancertreatment2unknown_status
NCT05227378
Safety and Efficacy of Personalized Neoantigen Vaccine in Advanced Gastric CancerNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT01983878
A Study of Ramucirumab in Treating Japanese Participants With Metastatic Gastric or Gastroesophageal Junction Cancertreatment2completed
NCT06172478
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid TumorsNo drug interventionstreatment2recruiting
NCT06206278
Evaluation of Infigratinib in Patients With Locally Advanced or Metastatic Gastric Cancer or GEJ Adenocarcinomatreatment2terminated
NCT00738478
Quality of Life After Routine Nasogastric Decompression After Distal Gastrectomy for Gastric Cancer PatientsNo drug interventionstreatment3completed
NCT01299688
HER2 Circulating Tumor Cells in Gastric CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT05259488
Preoperative Immunonutrition in Laparoscopic Total D2 GastrectomyNo drug interventionsNot AvailableNot Availablecompleted
NCT06489288
ERAS in Totally Laparoscopic Total Gastrectomy for Gastric CancerNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT06510088
Effects of Multimodal Prehabilitation on Frail Elderly Patients Undergoing Elective Gastric Cancer SurgeryNo drug interventionssupportive_careNot Availablecompleted
NCT05510388
HFNO Reduces Hypoxia During Sedated Gastroscopy or Colonoscopy in High Risk PatientsNo drug interventionspreventionNot Availableunknown_status
NCT03601988
Phase III Trial of Adjuvant Chemo-radiotherapy After D2 Surgery of Gastric CancerNo drug interventionstreatment3unknown_status
NCT05831488
Assessing the Accuracy of Seismofit® as an Estimate of VO2 Peak in Patients With Hepato-pancreato-biliary, Colorectal, and Gastro-oesophageal CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT05223088
Tislelizumab Combined With Apatinib and Oxaliplatin Plus S1 as Neoadjuvant Therapy for Borrmann IV、Large Borrmann III Type and Bulky N Positive Advanced Gastric Cancertreatment2recruiting
NCT04027088
Effect of Preoperative Immunonutrition in Upper Digestive TractNo drug interventionssupportive_careNot Availableunknown_status
NCT04086888
Real World Study of Immune Checkpoint Inhibitors for Advanced Gastric CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT04963088
TISLELIZUMAB Combined With Anlotinib and Chemotherapy(XELOX) in the Treatment of Advanced Gastric Carcinomatreatment1 / 2unknown_status
NCT01830907
Efficacy of Preoperative Nutritional Support on Postoperative Outcome in Gastric Cancer Patients at Nutritional Risk by NRS-2002No drug interventionstreatment0completed
NCT04957407
The Research of Constructing a Risk Assessment Model for Gastric Cancer Based on Machine LearningNo drug interventionsNot AvailableNot Availableunknown_status
NCT00096707
Dose Escalation Trial of 2-Deoxy-D-Glucose (2DG) in Subjects With Advanced Solid Tumorstreatment1completed
NCT01980407
Feasibility Study of SOL (S-1,Oral Leucovorin,and Oxaliplatin) in Patients With Advanced Gastric Cancertreatment2unknown_status
NCT01747707
Cisplatin,Docetaxel and S-1 for Advanced Gastric and Gastroesophageal Junction Cancertreatment2unknown_status
NCT04805307
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy, Phase 1 Study of CMG901treatment1recruiting
NCT03766607
Trastuzumab Beyond Progression in HER2 Positive Metastatic Gastric Cancertreatment2withdrawn
NCT06508307
A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumorstreatment1recruiting
NCT06161207
3D-4K-ICG Laparoscopic Gastrectomy for Gastric CancerNo drug interventionstreatment3recruiting
NCT04826107
Study of DP303c Injection in Patients With Advanced or Metastatic Gastric Cancertreatment2not_yet_recruiting
NCT01291407
A Phase I Study of S-1 in Combination With Radiotherapy in Locally Advanced or Recurrent Gastric CancerNo drug interventionstreatment1completed
NCT06339307
A Prospective Clinical Study to Validate a Preoperative Risk Scoring Model for LNM in GC PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT00005607
Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagustreatment2unknown_status
NCT04033107
High Dose Vitamin C Combined With Metformin in the Treatment of Malignant Tumorstreatment2recruiting
NCT02745509
Extensive Intraoperative Peritoneal Lavage After Curative Gastrectomy for Locally Advanced Gastric Cancer (SEIPLUS)No drug interventionstreatmentNot Availablecompleted
NCT01838109
Postoperative Oral Nutritional Supplementation After Major Gastrointestinal SurgeryNo drug interventionstreatmentNot Availablecompleted
NCT04022109
Screening of Gastric Cancer Via Breath Volatile Organic Compounds by Hybrid Sensing ApproachNo drug interventionsNot AvailableNot Availablerecruiting
NCT02250209
T- XELOX in HER2-positive Stage III Gastric Cancer After D2 Gastrectomytreatment2unknown_status
NCT02966509
Engagement of Patients With Advanced CancerNo drug interventionshealth_services_researchNot Availablecompleted
NCT01415609
Endoscopic Submucosal Dissection RegistryNo drug interventionsNot AvailableNot Availablecompleted
NCT03787056
Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer PatientsNo drug interventionsdiagnosticNot Availablerecruiting
NCT01309256
Multi-institutional Study on the Assessment of Robotic Surgery for Gastric CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT03276156
Apatinib in Combination With S-1 as Second-Line Treatment in Patients With Advanced Gastric Cancertreatment1unknown_status
NCT03515356
Exercise to Reduce Chemotherapy-Induced Peripheral NeuropathyNo drug interventionssupportive_careNot Availablecompleted
NCT03972956
Samples Procurement for Colorectal Cancer, Gastric Cancer, and Non-malignant DiseaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT00014456
Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumorstreatment1completed
NCT02178956
A Study of BBI608 Plus Weekly Paclitaxel to Treat Gastric and Gastro-Esophageal Junction Cancertreatment3completed
NCT01444456
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced AnaemiaNo drug interventionsNot AvailableNot Availablecompleted
NCT04062656
Perioperative Immunotherapy vs. Chemo-immunotherapy in Patients With Advanced GC and AEGtreatment2active_not_recruiting
NCT05356156
The Safe Study of Routine Closure of Mesenteric Defects Versus Non-closure After Radical GastrectomyNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT05354856
The Effect of Chemoradiotherapy on Gastric Perfusion in Patients With Gastric Cancer.diagnostic4terminated
NCT06102785
Fruquintinib Combined With TAS102 for Advanced Gastric CancerNot AvailableNot Availablerecruiting
NCT04510285
A Single-Arm Pilot Study of Adjuvant Pembrolizumab Plus Trastuzumab in HER2+ Esophagogastric Tumors With Persistent Circulating Tumor DNA Following Curative Resectiontreatment2terminated
NCT00595985
Sorafenib as a Second Line Treatment in Patients With Advanced or Metastatic Gastric Cancertreatment2terminated
NCT04901585
Enterotomy Closure and Minimally Invasive GastrectomyNo drug interventionsNot AvailableNot Availablecompleted
NCT04157985
Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumorstreatment3recruiting
NCT05631015
Artificial Intelligence for Determination of Gastroscopy Surveillance IntervalsNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00002615
Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancertreatment3completed
NCT03475615
A Study of Intraperitoneal Paclitaxel in Combination With SOX Compared With SOX Alone in Gastric Cancer With Malignant Ascitestreatment3unknown_status
NCT04593615
Indocyanine Green Tracer Using in Laparoscopic Radical Gastrectomy for Locally Advanced Gastric CancerNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT02525237
Apatinib in Combination With S-1 as First-Line Treatment in Patients With Advanced Gastric Cancertreatment2unknown_status
NCT01130337
A Study of Capecitabine [Xeloda] in Combination With Trastuzumab [Herceptin] and Oxaliplatine in Patients With Resectable Gastric Cancertreatment2completed
NCT05585437
Effect of Gastric Cancer Specialist Training Program in Laparoscopic Gastric Cancer Surgery(STP-LRG-1)No drug interventionsNot AvailableNot Availablecompleted
NCT05216237
A Study to Evaluate the Efficacy and Safety of Sintilimab Plus Apatinib and Chemotherapy in Patients With HER-2 Negative Microsatellite Stability (MSS) Advanced or Metastatic Gastric (GC) or Gastroesophageal Junction (GEJ) Cancertreatment2recruiting
NCT00003237
Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomachtreatment2completed
NCT05098132
Phase 1a/1b Study of STK-012 Monotherapy and in Combination With Pembrolizumab in Patients With Solid Tumorstreatment1recruiting
NCT05472532
Evaluation of an Automated System to Culture Metastatic Patient Circulating Tumor Cells in Embryonated Chicken Eggs (in Ovo Culture)No drug interventionsotherNot Availablerecruiting
NCT05768932
BAL0891 in Patients With Advanced Solid Tumorstreatment1recruiting
NCT00025532
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal CancerNo drug interventionstreatment1withdrawn
NCT05235932
the Clinical Efficacy of Robotic and Laparoscopic Radical Total Gastrectomy in Locally Advanced Middle and Upper Gastric CancerNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT01471132
Sequential HIPEC of Oxaliplatin and Paclitaxel for Gastric Cancer Patients With Peritoneum Metastasistreatment2unknown_status
NCT03123432
Immunomodulating Nutrients in Perioperative Patients With Gastric CancerNo drug interventionstreatmentNot Availablecompleted
NCT03517332
Circulating Tumor DNA Exposure in Peripheral BloodNo drug interventionsNot AvailableNot Availableunknown_status
NCT03410732
Dendritic Cell-based Immunotherapy in Treatment Gastric CancerNo drug interventionstreatment2unknown_status
NCT00923052
The Natural History of Solid Organ Cancer Stem Cells (SOCSC)No drug interventionsNot AvailableNot Availableterminated
NCT02020252
Effect of Multi-Media Tool on Enrollment in Oncology Clinical TrialsNo drug interventionsNot AvailableNot Availablecompleted
NCT02810652
Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical ResectionNo drug interventionssupportive_careNot Availablecompleted
NCT02130752
Ultrasonic Scalpel vs. Monopolar Electrocautery for D2 Distal Gastric Carcinoma SurgeryNo drug interventionspreventionNot Availableunknown_status
NCT04447352
HIPEC + FLOT vs. FLOT Alone in Patients With Gastric Cancer and GEJ (PREVENT)treatment3recruiting
NCT05687552
Role of 18F-FDG PET/CT in Gastric CancerNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT02852252
Solid Tumor Cancer Surgery With or Without Intraoperative Imaging: A RegistryNot AvailableNot Availablecompleted
NCT04891900
TQB2450 Plus Anlotinib Combined With Chemotherapy in the Treatment of Gastric or Gastroesophageal Junction AdenocarcinomatreatmentNot Availableactive_not_recruiting
NCT06254300
Online Exercise Program During Perioperative Treatment in Adults With Gastric CancerNo drug interventionssupportive_careNot Availablerecruiting
NCT01839500
A Non-Interventional Study of Treatment Pattern and Clinical Outcomes in Chinese Participants With Gastric CancerNot AvailableNot Availablecompleted
NCT04440800
Feasibility of Wearable Activity Trackers for Detection of TOXicity in People Receiving Systemic Anticancer TreatmentNo drug interventionsNot AvailableNot Availableunknown_status
NCT03021200
Laser Fluorescence in Cancer Surgical TreatmentNo drug interventionstreatmentNot Availableunknown_status
NCT06212700
PRIORITY-CONNECT 2 Pilot TrialNo drug interventionssupportive_careNot Availablerecruiting
NCT02114359
Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancertreatment3completed
NCT06490159
Predicting Peripheral Neuropathy of Paclitaxel for Gastric CancerNot AvailableNot Availablerecruiting
NCT02207959
Gastric In Vivo Studydiagnostic1terminated
NCT04742959
Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumorstreatment1 / 2completed
NCT01674959
Postoperative IMRT Combined With Capecitabine for Advanced Gastric Cancer PatientsNo drug interventionstreatment2unknown_status
NCT03662659
An Investigational Study of Immunotherapy Combinations With Chemotherapy in Patients With Gastric or Gastroesophageal Junction (GEJ) Cancerstreatment2completed
NCT01996059
Functional Jejunal Interposition Improve Nutritional Status After Total GastrectomyNo drug interventionstreatment3unknown_status
NCT02583659
The First-line Combined Chemotherapy for Advanced Gastric Cancer: A Prospective Observational Clinical StudyNo drug interventionsNot AvailableNot Availableunknown_status
NCT00040859
Oxaliplatin and Capecitabine in Treating Patients With Advanced Esophageal Cancer or Stomach Cancertreatment2completed
NCT00183859
Clinical and Pharmacokinetic Trial of Intra-Abdominal Irinotecantreatment1completed
NCT03960775
The Influence of Perioperative Administration of Dexmedetomidine on Inflammation Response and Postoperative Recovery in Patients Undergoing Robot or Laparoscopic Assisted Gastrectomysupportive_careNot Availablecompleted
NCT05013775
The Diagnostic Value of Staging Laparoscopy and Computed Tomography Response Assessment in Patients With Gastric AdenocarcinomaNo drug interventionsNot AvailableNot Availablecompleted
NCT05952375
Exploratory Clinical Trial on the Safety, Efficacy, and Pharmacokinetics of XKDCT086 (iPD-1-Claudin18.2-CAR-T) in Claudin 18.2 Positive Advanced Solid Malignant Tumors: a Single Center, Single Arm, Dose-increasing TrialNo drug interventionstreatmentNot Availablerecruiting
NCT04384575
Study on the Effectiveness of Gastroscope Operation Quality Control Based on Artificial Intelligence TechnologyNo drug interventionsNot AvailableNot Availablecompleted
NCT01657175
Quality of Life After Oesophageal or Gastric Cancer SurgeryNo drug interventionspreventionNot Availablecompleted
NCT01401075
RCT With Adjuvant Mistletoe Treatment in Gastric Cancer Patientssupportive_care4completed
NCT05051670
da Vinci SP Robotic GastrectomyNo drug interventionstreatmentNot Availablecompleted
NCT04139070
Electrochemotherapy for Non-curable Gastric Cancertreatment1unknown_status
NCT06242470
A Study of MGC026 in Participants With Advanced Solid TumorsNo drug interventionstreatment1recruiting
NCT00197470
Cytokine Gene Polymorphisms in Gastric DiseasesNo drug interventionsdiagnosticNot Availableunknown_status
NCT06475170
Preliminary Efficacy Analysis of 'λ+α' Double-Tract Reconstruction After Laparoscopic Proximal GastrectomyNo drug interventionstreatmentNot Availablerecruiting
NCT00938470
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junctiontreatment2completed
NCT02040142
Single Arm Study Treating Patients of Peritoneal Surface Malignancy (Colorectal, Appendical, Pseudomyxoma, Gastric) With Cytoreductive Surgery and Hyperthermic Intraperitoneal Mitomycin-Ctreatment2completed
NCT01711242
Trial of Adjuvant XELOX Chemotherapy and Concurrent Capecitabine and Radiotherapy for Resected Gastric Carcinomatreatment2completed
NCT03613142
Comparison Between Double Tract Anastomosis and Esophagogastrostomy After Radical Proximal GastrectomyNo drug interventionstreatmentNot Availableunknown_status
NCT04430842
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072SNo drug interventionstreatment1completed
NCT04107142
Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid TumourNo drug interventionsother1unknown_status
NCT06027242
Oral Supplementation of Glutamine on Gastric Cancer Patients After GastrectomyNo drug interventionstreatmentNot Availablerecruiting
NCT04408599
A Safety and Tolerability Study of NC410 in Subjects With Advanced or Metastatic Solid TumorsNo drug interventionstreatment1 / 2terminated
NCT05566899
Pilot Study of Stomach Cancer Early Detection and Prevention With EndoscopyNo drug interventionspreventionNot Availablerecruiting
NCT02500199
Phase I Study of Pyrotinib in Patients With HER2-positive Solid Tumorstreatment1unknown_status
NCT00313599
Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumorstreatment1completed
NCT00005599
Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach Cancertreatment2completed
NCT02509806
Apatinib as Maintenance Therapy After First-line Chemotherapy(DC for 4 Cycles) in Postoperative Recurrence/Metastasis Progressive Gastric Cancertreatment2 / 3unknown_status
NCT01742806
Clinical Study for the Impact of Bio-absorbable Felt (NEOVEIL®) With Fibrin Sealant on Removal of Drainage Tube After Minimally Invasive Gastrectomy for Gastric CancerNo drug interventionstreatmentNot Availableunknown_status
NCT06532006
A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancertreatment3not_yet_recruiting
NCT04114006
Novel Screening Modality for Early Gastric CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT03638206
Autologous CAR-T/TCR-T Cell Immunotherapy for MalignanciesNo drug interventionstreatment1 / 2unknown_status
NCT05728606
Robot-assisted D2 Distal Gastrectomy Following Neoadjuvant Chemotherapy for Locally Advanced Gastric CancersNo drug interventionstreatmentNot Availablerecruiting
NCT06054906
Neoadjuvant of Sintilimab Combined Weekly Metronomic Chemotherapy (PLOF) for Resectable Locally Advanced Gastric Cancertreatment2recruiting
NCT05181306
Long-term Oncologic Outcomes of Robotic Versus Laparoscopic Total Gastrectomy for Advanced Gastric CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT01611506
Combination Chemotherapy, Cetuximab and Radiation for Patients With Localized Gastric Cancertreatment1 / 2terminated
NCT02602249
Clinical Safety and Preliminary Efficacy of MUC1-DC-CTL Treatment in Stage IV Gastric Cancer.No drug interventionstreatment1unknown_status
NCT00005049
Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancertreatment2completed
NCT03484949
Web-Mediated Risk Assessment for Endoscopic Screening of Gastric CancerNo drug interventionsdiagnosticNot Availableunknown_status
NCT05948449
To Evaluate the Efficacy and Safety of Cadonilimab With SOX as Neoadjuvant Therapy for Resectable Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.treatment2not_yet_recruiting
NCT05644249
PIPAC and FOLFOX for Gastric Cancer Peritoneal CancertreatmentNot Availablerecruiting
NCT00960349
Study of Cediranib Plus Cisplatin Plus Capecitabine/S-1 in Japanese Gastric Cancer Patientstreatment1completed
NCT00054249
T900607 in Treating Patients With Gastroesophageal Junction Cancertreatment2completed
NCT00978549
Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach Cancertreatment3completed
NCT01148849
Safety Study of MGAH22 in HER2-positive Carcinomastreatment1completed
NCT01406249
XParTS II: Capecitabine/CDDP(XP) and S-1/CDDP(SP) as the First-line Treatment for Advanced Gastric Cancertreatment2unknown_status
NCT05858736
Safety, PK and Efficacy of AI-061 in Advanced Solid TumorsNo drug interventionstreatment1recruiting
NCT00130936
Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlatestreatment1 / 2terminated
NCT01584336
Laparoscopy-assisted Total Gastrectomy for Clinical Stage I Gastric Cancer (KLASS-03)No drug interventionstreatment2unknown_status
NCT05095636
Apatinib Monotherapy Versus Apatinib Combined With Camrelizumab for Third-line Treatment of Metastatic Gastric Cancertreatment2unknown_status
NCT06354036
Transhiatal Tunnel Valvuloplasty for Reconstruction Following the Laparoscopic Proximal GastrectomyNo drug interventionstreatmentNot Availablerecruiting
NCT00834236
Proteiomic Fingerprints of Gastric JuiceNo drug interventionsdiagnosticNot Availablecompleted
NCT00004236
Liposomal Doxorubicin in Treating Patients With Advanced Stomach Cancertreatment2unknown_status
NCT02330913
Novel Esophago-Jejunal Anastomosis Method During Totally Laparoscopic Total GastrectomyNo drug interventionstreatmentNot Availablecompleted
NCT00718913
Postoperative Chemotherapy and Chemo-radiotherapy for Resected Gastric Cancertreatment2completed
NCT02332213
Volatile Markers in Digestive CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00815113
Screening for Gastric Cancer in High-risk PopulationNo drug interventionsNot AvailableNot Availablecompleted
NCT06242613
National Multicenter Cohort Study of Robot-Assisted Gastrectomy Versus Laparoscopy in Gastric CancerNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT01381913
Feasibility Trial of Neoadjuvant Chemoradiotherapy for Locally Advanced Gastric CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT01216813
Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT03083613
Raltitrexed and Paclitaxel for Gastric or Gastroesophageal Junction Adenocarcinomatreatment2completed
NCT05057013
HMBD-001 in Advanced HER3 Positive Solid TumoursNo drug interventionstreatment1 / 2recruiting
NCT04900818
Study of TJ033721 in Subjects With Advanced or Metastatic Solid Tumorstreatment1recruiting
NCT04152018
Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors.No drug interventionstreatment1active_not_recruiting
NCT06440018
INSPIRE: A Multi-Cancer Early Detection StudyNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT04869618
Validation of an Artificial Intelligence System Based on Raman Spectroscopy for Diagnosis of Gastric Premalignant Lesions and Early Gastric CancerNo drug interventionsdiagnosticNot Availableunknown_status
NCT03385018
Trial for Application of Laparoscopic Total Gastrectomy With Lymph Node Dissection for Gastric Cancer (KLASS-06)No drug interventionstreatmentNot Availablerecruiting
NCT05800418
Clinical Study to Compare the Pharmacokinetics and Safety of Ramucirumab Injection With Cyramza ® in Healthy Male Volunteerstreatment1completed
NCT00123318
A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric Cancertreatment3completed
NCT04934618
A Phase II Study of Carelizumab Combined With Irinotecan and Apatinib of Second-line Treatment for Advanced Gastric Cancertreatment2recruiting
NCT01197118
Postoperative Sequence Chemoradiotherapy Compared With Chemotherapy Alone for Advanced Gastric CancerNo drug interventionstreatment2unknown_status
NCT04830618
Aberrant DNA Methylation to Predict Metachronous Gastric NeoplasmsNo drug interventionsNot AvailableNot Availablecompleted
NCT06496919
A Real-world Research on the Prevention and Treatment of Peritoneal Metastasis and Malignant Ascites by Intraperitoneal Infusion of rmhTNF in Gastric and Colorectal Malignant TumorsNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT03958019
Rehabilitation Strategies Following Oesophagogastric and Hepatopancreaticobiliary CancerNo drug interventionstreatmentNot Availablerecruiting
NCT01953419
Phase II Study of Pemetrexed in Advanced or Recurrent Gastric Cancer After Chemotherapytreatment2completed
NCT05999019
Intraoperative Adverse Events in Robotic Radical Gastrectomy for Gastric CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT01160419
Multicenter Study to Perioperative Chemotherapy for Resectable Adenocarcinoma in Gastric Cancertreatment2unknown_status
NCT04214119
EsophaCap for the Detection of Early Esophageal CarcinomaNo drug interventionsNot AvailableNot Availablerecruiting
NCT05540119
Swedish Oesophago-Gastric StudyNo drug interventionsNot AvailableNot Availableunknown_status
NCT05430841
Evaluating the Potential Usefulness of 18F-AlF-FAPI PET/CT in Patients With Gastrointestinal Tumors and Compared With 18F-FDG PET/CTNo drug interventionsdiagnosticNot Availableunknown_status
NCT00663741
Sorafenib Gastric Cancer Asian Phase I Studytreatment1completed
NCT03263741
Exploratory Study on the Paclitaxel + S-1 + Oxaliplatin (PSOX) for Locally Advanced or Advanced Gastric Cancertreatment2unknown_status
NCT04358341
Pegliposomal Doxorubicin and 5-fluorouracil as Second Line Therapy for Metastatic Gastric Cancertreatment2unknown_status
NCT02024841
Intraperitoneal Docetaxel With Cisplatin and TS-ONE for Gastric Cancer With Peritoneal Carcinomatosistreatment1completed
NCT01428141
A Phase I Study of E7050 in Subjects With Solid Tumorstreatment1completed
NCT01857141
Comparative Study on the Effects of Epidural Dexmedetomidine on Heart Rate Variability During General Anesthesia in Patients Undergoing Gastrectomysupportive_careNot Availablecompleted
NCT00436241
A Study of Xeloda (Capecitabine) as First-Line Chemotherapy in Patients With Advanced or Metastatic Gastric Cancer.treatment2completed
NCT04429841
D2 Versus D1 Gastrectomy of Operable Gastric CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT01655641
Study of Tranexamic Acid for Reducing Blood Requirement in Patients Undergoing Major Gastro-intestinal Surgerytreatment2 / 3unknown_status
NCT00003617
Chlorambucil Compared With No Further Therapy Following Anti-Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the Stomachtreatment3unknown_status
NCT01063517
Efficacy Study of Olaparib With Paclitaxel Versus Paclitaxel in Gastric Cancer Patientstreatment2completed
NCT00152217
Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC)No drug interventionstreatment3completed
NCT06475417
Neoadjuvant Adebrelimab + DOS in Locally Advanced Resectable Gastric Cancertreatment2recruiting
NCT03342417
Combination of Nivolumab and Ipilimumab in Breast, Ovarian and Gastric Cancer Patientstreatment2terminated
NCT00216034
Randomized Controlled Study of Postoperative Adjuvant Therapy for Gastric Cancer Using TS-1 or TS-1+PSKtreatment3completed
NCT00027534
Vaccine Therapy in Treating Patients With Advanced or Metastatic CancerNo drug interventionstreatment1completed
NCT01132534
A Randomized Study Comparing Autofluorescence Imaging(AFI) Followed by Narrow Band Imaging(NBI) With Videoendoscopy for the Detection of High Risk Lesions of StomachNo drug interventionsNot AvailableNot Availablecompleted
NCT03258034
A Feasibility Study for Convernsion Therapy Using S1/Paclitaxel Chemotherapy Plus Apatinib in ELM Gastric CancerNo drug interventionstreatment2unknown_status
NCT04727034
Efficacy and Safety of Remimazolam Tosylate for Sedation in GastroscopytreatmentNot Availablerecruiting
NCT05447234
TCRx_T Cells for Advanced or Recurrent Gastric/Gastroesophageal Junction Cancer After Failure of First ChemotherapyNo drug interventionstreatment0not_yet_recruiting
NCT01220934
An Observational Study of Herceptin (Trastuzumab) in Patients With HER2-positive Advanced Gastric CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT05566834
Minnelide™ Capsules Alone and in Combination With Paclitaxel in Advanced Gastric Cancertreatment1recruiting
NCT02349724
A Clinical Research of CAR T Cells Targeting CEA Positive CancerNo drug interventionstreatment1unknown_status
NCT01171924
A Phase Ib Expansion Study Investigating the Safety, Efficacy, and Pharmacokinetics of Intravenous CUDC-101 in Subjects With Advanced Head and Neck, Gastric, Breast, Liver and Non-small Cell Lung Cancer Tumorstreatment1completed
NCT00957424
Acceptability of Less Harmful Alternatives to CigarettesNot AvailableNot Availablecompleted
NCT02725424
Optimizing the Strategy for Preoperative Chemotherapy in Locally Advanced Gastric/Gastroesophageal Cancertreatment2completed
NCT02457624
Gastric Cancer Screening Quality Improvement System EstablishmentNo drug interventionsNot AvailableNot Availableunknown_status
NCT06298916
64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract CancerNo drug interventionsdiagnostic1 / 2not_yet_recruiting
NCT02080416
Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumorstreatment0terminated
NCT02002416
Prognostic Value and Clinical Pathology of c-MET Expression and Amplification in Gastric CarcinomaNo drug interventionsNot AvailableNot Availableunknown_status
NCT05551416
The EpiGASTRIC/EDGAR Project: New Strategies for the Early Detection and Prevention of Gastric CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT06339216
A Clinical Study of Adebrelimab Combined With Apatinib and Paclitaxel in Patients With Advanced Gastric Cancer.treatment2not_yet_recruiting
NCT00088816
S-1 and Cisplatin Before Surgery in Treating Patients With Stage IV Gastric Cancertreatment2unknown_status
NCT02926716
NBI for Identifying Resection Margin Status in Gastric CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT05101616
A Pilot Study of Neoadjuvant Chemotherapy With or Without Camrelizumab for Locally Advanced Gastric Cancertreatment1 / 2suspended
NCT04850716
Relationship Between Standard Treatment Efficacy and The Tumor Microenvironment in Advanced Gastric CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT04504916
A Study of Zilovertamab Vedotin (MK-2140/VLS-101) in Participants With Solid Tumors (MK-2140-002)treatment2terminated
NCT02872116
Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancertreatment3completed
NCT02746796
Study of ONO-4538 in Gastric Cancertreatment2 / 3completed
NCT05515796
Multi-omics Sequencing in Neoadjuvant Immunotherapy of Gastrointestinal Tumorstreatment2recruiting
NCT05259696
Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01)treatment1 / 2active_not_recruiting
NCT02961296
Helicobacter Pylori Antibiotic Susceptibility Testing of KoreaNo drug interventionsNot AvailableNot Availableunknown_status
NCT01450696
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancertreatment3terminated
NCT03229096
Apatinib Plus XELOX as Neoadjuvant Therapy in Locally Advanced Gastric Cancertreatment2unknown_status
NCT01955096
Fast Track Surgery With Laparoscopic-assisted Gastrectomy for Advanced Gastric Cancer: a Randomized Controlled TrialNo drug interventionssupportive_careNot Availablecompleted
NCT05641896
Study of [18F]FAPI-74 PET in Patients With Gastrointestinal CancersNo drug interventionsdiagnostic2recruiting
NCT04913896
CT and MRI in Prediction of Response in Patients With Gastric Cancer Following Neoadjuvant Chemotherapy and/or ImmunotherapyNot AvailableNot Availableunknown_status
NCT04068896
Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination TherapyNo drug interventionstreatment1 / 2completed
NCT01702558
A Combination Study of Kadcyla (Trastuzumab Emtansine) and Capecitabine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (mBC) or HER2-Positive Locally Advanced/Metastatic Gastric Cancer (LA/mGC)treatment2terminated
NCT02229058
Albumin Bound Paclitaxel Plus S-1 as the First Line Chemotherapy in Advanced or Recurrent Gastric Cancertreatment2completed
NCT01675258
Identifying Saliva Markers of Patients With Stomach, Colorectal (Including Pre-cancer Polyp) and Pancreatic CancersNo drug interventionsNot AvailableNot Availableunknown_status
NCT05493358
Long-term Outcomes of Open Versus Laparoscopic Distal Gastrectomy for T4a Gastric CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT02555358
Three Drugs in Advanced Gastric Cancer Neoadjuvant Chemotherapy for Stage Ⅲ Clinical Studytreatment2completed
NCT06048458
Cancer Treatment Related Cardiovascular Toxicity: Comprehensive Myocardial and Vascular PhenotypingNo drug interventionsNot AvailableNot Availablerecruiting
NCT04062058
A Phase II Study of Total Neoadjuvant Therapy for Locally Advanced Gastric CancerNo drug interventionstreatment2unknown_status
NCT02949258
Neoadjuvant Chemotherapy With SEEOX Regimen for Borrmann Type 4 Gastric Cancertreatment2unknown_status
NCT05412758
Augmented Response of Volatile Biomarkers in Assessment of Oesophagogastric Cancer (AROMA 1 / BIORESOURCE)No drug interventionsdiagnosticNot Availablerecruiting
NCT00019435
LMB-9 Immunotoxin in Treating Patients With Advanced Solid TumorsNo drug interventionstreatment1completed
NCT03793335
Individually Tailored Strategies for the Precision Prevention of Gastric Cancer and Colorectal Cancer in the CommunityNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT05450835
Safety of OGT-assisted Overlap Esophagojejunostomy Versus Traditional Overlap MethodNo drug interventionstreatmentNot Availablerecruiting
NCT04066335
Study to Evaluate the Safety of Nanoxel M Inj.No drug interventionsNot AvailableNot Availableunknown_status
NCT03526835
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumorstreatment1 / 2recruiting
NCT06103435
Multivisceral Resections for Locally Advanced Gastric CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT05410535
To Evaluate Efficacy of Ursodeoxycholic Acid (UDCA) for the Prevention of Gallstone Formation After Gasterectomyother4completed
NCT06036563
Prospective Screening and Differentiating Common Cancers Using Peripheral Blood Cell-Free DNA SequencingNo drug interventionsNot AvailableNot Availablerecruiting
NCT01170663
A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinomatreatment3completed
NCT05010863
Gastric Cancer Marker Detection and Its Kit DevelopmentNo drug interventionsNot AvailableNot Availablerecruiting
NCT04795063
Total Robotic Versus Robotic Assisted Distal Gastrectomy for Gastric CancerNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT03419663
Systematic Review and Meta-analysis of Cereal or Grain Consumption and Gastric CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT05816863
Clinical Study of Pabolizumab for Neoadjuvant Immunotherapy of Locally Advanced Microsatellite-unstable Gastric AdenocarcinomaNo drug interventionsNot AvailableNot Availablerecruiting
NCT00024063
SU006668 in Treating Patients With Advanced Solid Tumorstreatment1unknown_status
NCT02179463
Compare Different Response Evaluations to Neoadjuvant Chemotherapy for Gastric CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT00588263
Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individuals Who Have CancerNo drug interventionsNot AvailableNot Availablewithdrawn
NCT02833363
Difference of Gastric Microbiota in the Process of Correa's Model.No drug interventionsNot AvailableNot Availableunknown_status
NCT00278863
Capecitabine Versus S-1 in Elderly Advanced Gastric Cancer (AGC): Randomized Trialtreatment2completed
NCT02574663
TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumorstreatment1completed
NCT00012363
S0101 Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the Esophagustreatment2completed
NCT01048463
Effect of Enteral Nutrition Rich in Eicosapentaenoic Acid (EPA) on Patients Receiving Chemotherapy for GI Tumortreatment3unknown_status
NCT02358863
Molecularly Tailored Therapy for Patients With Metastatic Cancer of the Esophagus and StomachtreatmentNot Availableterminated
NCT02562963
Clinical Efficacy and Safety of NKT Cell Infusion in Patients With Advanced Solid TumorNo drug interventionstreatment1 / 2recruiting
NCT05002686
Safety and Efficacy of Sintilimab in Combination With Chemoradiothrapy Followed by D2 Surgical Resection in Patients With Advanced Gastric Cancer With Retroperitoneal Lymph Node Metastasistreatment2 / 3unknown_status
NCT00407186
Randomized Phase III Trial of Adjuvant Chemotherapy or Chemoradiotherapy in Resectable Gastric Cancer (CRITICS)treatment3active_not_recruiting
NCT04697186
Helicobacter Pylori Eradication With Berberine Plus Amoxicillin Triple Therapy Versus Bismuth-containing Quadruple Therapytreatment4completed
NCT06371586
Neo-Sequence 2:NCT Plus Anti-angiogenesis Therapy and Immunotherapy for LADGCtreatment2recruiting
NCT00524186
Sunitinib, Irinotecan, Fluorouracil, and Leucovorin In Treating Patients With Advanced Stomach Cancer or Gastroesophageal Cancertreatment1terminated
NCT02751086
Robotic, Laparoscopic and Open Gastrectomy Compared on Short and Long Term OutcomesNo drug interventionsNot AvailableNot Availablerecruiting
NCT01360086
Fluorouracil, Cisplatin, Leucovorin Calcium, and Cetuximab in Treating Patients With Adenocarcinoma of the Stomach or Gastroesophageal Junctiontreatment2completed
NCT02595086
Comparison of Laparoscopic Pylorus Preserving Gastrectomy Versus Laparoscopic Distal GastrectomyNo drug interventionstreatmentNot Availableunknown_status
NCT03957486
Effect of Arterial Cannulation on the Continuous and Non-invasive Hemoglobin MonitoringNo drug interventionspreventionNot Availablecompleted
NCT01662739
Cremona Population-Based Gastric Tumors RegistryNo drug interventionsNot AvailableNot Availableunknown_status
NCT02970539
Ph1b Study of Oraxol in Comb. w. Ramucirumab in Patients w. Gastric, Gastro-esophageal, or Esophageal Cancerstreatment1unknown_status
NCT05497739
Intraperitoneal Chemotherapy Guided by the Detection of DNA in Peritoneal Lavage Fluid in Patients With Gastric CancerNo drug interventionstreatment2unknown_status
NCT03129139
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumorstreatment1recruiting
NCT01641939
A Study of Trastuzumab Emtansine Versus Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancertreatment2 / 3terminated
NCT00022139
Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junctiontreatment2completed
NCT02867839
Adjuvant Chemotherapy With S-1 Plus Oxaliplatin Versus S-1 Alone in Locally Advanced Gastric Cancertreatment3unknown_status
NCT03780439
Procalcitonin to Predict Infection After Gastrectomy for Gastric CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT05526339
HFNO Combined With NPA Reduces Hypoxia During Sedated Gastrointestinal Endoscopy In Obese PatientsNo drug interventionspreventionNot Availableunknown_status
NCT03253939
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinomatosis From Gastric CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT04278222
Anlotinib Plus Toripalimab as First-line Treatment for Advanced Gastric Cancer With ECOG 2 (APICAL-GC)treatment2recruiting
NCT02178722
Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancerstreatment1 / 2completed
NCT06414122
Modulated Mid-frequency Whole-body Electromyostimulation and Nutritional Therapy in Gastrointestinal Cancer PatientsNo drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT00887822
A Study of Bevacizumab (Avastin) Versus Placebo in Combination With Capecitabine (Xeloda) and Cisplatin as First-Line Therapy for Advanced Gastric Cancertreatment3completed
NCT03760822
Second-Line Chemotherapy With Ramucirumab +/- Paclitaxel in Elderly Advanced Gastric or Gastroesophageal Junction Cancer Patientstreatment2active_not_recruiting
NCT00003125
Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumorstreatment2completed
NCT02641925
Omentectomy for Metabolic Syndrome in Gastric Cancer PatientsNo drug interventionstreatmentNot Availableunknown_status
NCT04547725
Complete Cytoreduction Followed by IP and Systemic Chemotherapies for Gastric Cancer With Peritoneal CarcinomatosisNo drug interventionstreatmentNot Availablerecruiting
NCT03775525
Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancertreatment1active_not_recruiting
NCT02817425
A Efficacy and Tolerability Study of TEGAFOX Sequential S-1 in the Treatment of Adjuvant Chemotherapy for Gastric CancerNo drug interventionstreatment2 / 3unknown_status
NCT05405530
Nasal Mask Kit in Gastrointestinal EndoscopyNo drug interventionspreventionNot Availableunknown_status
NCT04863430
Apatinib With Oxaliplatin and S-1 Treatment for Advanced Hepatoid Adenocarcinoma Of The Stomachtreatment2recruiting
NCT05539430
Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic AdenocarcinomaNo drug interventionstreatment1recruiting
NCT01365130
Chemotherapy for Patients With Gastroesophageal Cancers Who Have Progressed After One Prior Chemo Regimentreatment2terminated
NCT03321630
A Phase II a Study of Lenvatinib, a Multi-targeted Tyrosine Kinase Inhibitor, Combined With Pembrolizumab (PD-1 Inhibitor) for the Treatment of Metastatic Gastroesophageal Cancer Patients Who Have Progressed on First or Subsequent Line Therapiestreatment2completed
NCT00387530
Phenylbutyrate and Valganciclovir in Treating Patients With Relapsed or Refractory Epstein-Barr Virus-Positive Cancertreatment2withdrawn
NCT03251430
Bone Microstructure by Using HR-pQCT in Long Courses After GastrectomyNo drug interventionsNot AvailableNot Availableunknown_status
NCT06078930
Development of Novel Gastric Cancer Screening and Diagnosis Technologies Using Tongue Imaging and Study of Tongue Image Changes MechanismsNo drug interventionsNot AvailableNot Availablerecruiting
NCT04681248
Expanded Access Use of DKN-01 for the Treatment of Advanced Solid TumorsNot AvailableNot Availableavailable
NCT04250948
Efficacy of Perioperative Chemotherapy Plus PD-1 Antibody in the Locally Advanced Gastric Cancertreatment2active_not_recruiting
NCT01338948
Image-guided Minimally Invasive Robotic Surgery Using Preoperative CT Scan for Gastric Cancer PatientsNo drug interventionstreatment1 / 2completed
NCT02662348
T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive Systemtreatment1unknown_status
NCT00003748
Irinotecan in Treating Patients With Esophageal or Stomach Cancertreatment2completed
NCT06243757
A Study of Minimally Invasive Proximal Gastrectomy Versus Minimally Invasive Total Gastrectomy for Gastric and Gastroesophageal Junction CancersNo drug interventionsNot AvailableNot Availablerecruiting
NCT00033657
Radiation Therapy and Chemotherapy Before and After Surgery in Treating Patients With Esophageal Cancertreatment2completed
NCT04631757
Conversion Therapy of Camrelizumab Plus Chemoradiotherapy in Participants With Initial Unresectable Gastric or Gastroesophageal Junction (GEJ) Adenocarcinomatreatment2unknown_status
NCT01461057
A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Patients With HER2-Positive Advanced Gastric Cancertreatment2completed
NCT04384757
Comparison of Open and Laparoscopic Distal Gastrectomy for T4a Gastric CancerNo drug interventionstreatmentNot Availablerecruiting
NCT00003157
Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomachtreatment1completed
NCT04579757
Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumorstreatment1 / 2active_not_recruiting
NCT04607057
Supplemental Parenteral Nutrition During Postgastrectomy in Nutritionally at Risk PatientNo drug interventionstreatment4unknown_status
NCT04258657
Neoadjuvant Chomotherapy With Paclitaxel-albumin and S-1 for Advanced Gastric Cancertreatment2unknown_status
NCT00062257
Irofulven in Treating Patients With Recurrent or Metastatic Gastric Cancertreatment2completed
NCT05472857
Clinical Study of CLDN18.2-targeting CAR T Cells in Advanced Solid Tumors With Positive CLDN18.2 ExpressionNo drug interventionstreatment1recruiting
NCT02720926
Study of TKI 258 in Combination With Xeloda and Oxaliplatin in Advanced Colorectal and Gastric Cancertreatment1terminated
NCT03797326
Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)treatment2active_not_recruiting
NCT02130726
Surgical Technique, Open Versus Minimally-invasive Gastrectomy After CHemotherapyNo drug interventionstreatmentNot Availablecompleted
NCT03001726
To Observe the Efficacy and Safety by Comparing Chemotherapy(Docetaxel, Oxaliplatin Plus S1 ) Followed With Radical Resection Versus Chemotherapy Alone in Advanced Gastric Cancer With Single Non-curable Factor.Not AvailableNot Availableunknown_status
NCT03734926
A Phase 1 Study of ZSP1241 in Participants With Advanced Solid TumorsNo drug interventionstreatment1unknown_status
NCT05959226
Effect of Exercise and Enteral Nutrition on SurvivalNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT03221426
Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)treatment3active_not_recruiting
NCT02789826
Laparoscopic Versus Open Resection of Cancer StomachNo drug interventionstreatmentNot Availablecompleted
NCT00899626
Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT03941626
Autologous CAR-T/TCR-T Cell Immunotherapy for Solid MalignanciesNo drug interventionstreatment1 / 2unknown_status
NCT04140526
Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLCtreatment1 / 2recruiting
NCT00020826
Assessing Quality of Life of Patients With Stomach CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT06023966
A Clinical Prospective Study to Validate a Risk Scoring Model for the HMGC After Curative SurgeryNo drug interventionsNot AvailableNot Availablerecruiting
NCT06043466
A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid TumorsNo drug interventionstreatment1recruiting
NCT02848066
Glycans Bound to Serum Haptoglobin: a Novel Gastric Cancer Tumor BiomarkerNo drug interventionsNot AvailableNot Availablecompleted
NCT04015466
Advanced GC Multi-omic Characterization in EU and CELAC PopulationsNo drug interventionsNot AvailableNot Availablecompleted
NCT04808466
Comparative Study of Lobaplatin and Paclitaxel in Advanced Gastric Cancer Patients With D2 Surgery Combined With Hyperthermic Intraperitoneal Chemotherapytreatment2recruiting
NCT05156866
First in Human Study of TORL-2-307-ADC in Participants With Advanced CancerNo drug interventionstreatment1recruiting
NCT01576666
Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumorsother1completed
NCT00004065
Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancertreatment1completed
NCT02672865
Adjuvant Hyperthermic Intraperitoneal Chemotherapy for Locally Advanced Gastric CancerNo drug interventionstreatment1completed
NCT02796365
Prevention Using Exercise Rehabilitation to Offset Cardiac Toxicities Induced Via ChemotherapyNo drug interventionspreventionNot Availablecompleted
NCT00613665
Safety and Immunogenicity of Chiron's Investigational H. Pylori Vaccine in Healthy AdultsNo drug interventionsprevention1completed
NCT01766765
Early Jejunostomy Nutrition Minimizes Time to ChemotherapyNo drug interventionssupportive_care4unknown_status
NCT06464965
Clinical Study of Cord Blood-Derived CAR-NK Cells in Gastric Cancer and Pancreatic CancerNo drug interventionstreatment1recruiting
NCT01743365
Clinical Trial of Chemotherapy Combination Cisplatin-Fluorouracil-Afatinib in Patients With Inoperable Gastric Cancertreatment2completed
NCT06580574
Immune Checkpoint Inhibitors for Organ Preservation in Non-metastatic dMMR/MSI-H Gastric or Colon CancersNo drug interventionstreatment2recruiting
NCT02560974
A Study of Capecitabine (Xeloda) in Combination Chemotherapy Versus Surgery Alone in Participants With Gastric Cancertreatment3completed
NCT05550974
Articulated Laparoscopic Instruments Clinical StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT01665274
Efficiency of XELOX Neoadjuvant Chemotherapy in Gastric Cancertreatment2terminated
NCT02672774
Novel Endoscopic Imaging Methods for the Evaluation of Blood Vessels in Gastrointestinal CancersNo drug interventionsdiagnosticNot Availableunknown_status
NCT05107674
A Study of NX-1607 in Adults With Advanced Malignanciestreatment1recruiting
NCT00911820
Cisplatin, Irinotecan and Bevacizumab (PCA) Versus Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancertreatment2completed
NCT03977220
Nab-paclitaxel Combined With S-1 Treating Diffuse Type of Stage Ⅲ Gastric Cancertreatment1unknown_status
NCT03273920
Robotic Versus Laparoscopic Distal Gastrectomy With D2 Lymphadenectomy for Locally Advanced Gastric CancerNo drug interventionstreatmentNot Availableunknown_status
NCT04116320
Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumorstreatment1active_not_recruiting
NCT03505320
A Study of Zolbetuximab (IMAB362) in Adults With Gastric Cancertreatment2recruiting
NCT01271582
Investigation of Association Between UGT1A1 Polymorphisms and Irinotecan Toxicity in Korean Patientstreatment4unknown_status
NCT04476082
Nutrition in Gastrointestinal TumorsNo drug interventionsNot AvailableNot Availablecompleted
NCT03621982
Study of ADCT-301 in Patients With Selected Advanced Solid Tumorstreatment1terminated
NCT00865982
Study to Evaluate Safety and Efficacy of Perioperative Chemotherapy With Docetaxel, Cisplatin and Capecitabine (DCX) in Patients With Gastro-esophageal Cancertreatment2unknown_status
NCT06078982
Posterior-line Treatment With Disitamab Vedotin Plus PD-1 in Advanced HER2-low Expressing Gastric Cancertreatment1recruiting
NCT01379482
Neo-adjuvant Chemo + Peritonectomy + Hyperthermic Intraperitoneal Chemo in Peritoneal Carcinomatosis From Gastric Cancertreatment2completed
NCT04065282
The Purpose of This Study is to Evaluate the Efficacy and Safety of Sintilimab in Combination With Xelox as Neoadjuvant Therapy for Patients With Resectable Locally Advanced Gastric or Gastroesophageal Adenocarcinoma.treatment2unknown_status
NCT05187182
CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancertreatment1recruiting
NCT04624282
Metabonomics Study of Chronic Gastritis and Gastric CarcinomaNo drug interventionsNot AvailableNot Availableunknown_status
NCT01896531
A Study of Ipatasertib (GDC-0068) in Combination With Fluoropyrimidine Plus Oxaliplatin in Participants With Advanced or Metastatic Gastric or Gastroesophageal Junction Cancertreatment2completed
NCT05327231
IN10018 Monotherapy or in Combination With Docetaxel in Gastric or GEJ Adenocarcinomatreatment1completed
NCT06506331
Impact of Preoperative VFA on Intraoperative Adverse Events in Patients Undergoing Laparoscopic Radical GastrectomyNo drug interventionsNot AvailableNot Availablecompleted
NCT00673673
FOLFOX With Bevacizumab in Metastatic or Unresectable Gastroesophageal and Gastric Cancertreatment2completed
NCT02454673
Therapeutic Individualization for Patients With Locally Advanced Gastric and Gastroesophageal CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT01345773
Incidence of Venous Thromboembolism Following Surgery in Patients With Gastric CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT02955173
Significance of Circulating Tumor Cells in the Treatment of Gastric and Rectal CancerNo drug interventionsscreeningNot Availablecompleted
NCT03271073
A Study of Apatinib Combined With S1 in Patients With Advanced Gastric Cancertreatment2unknown_status
NCT04933227
A Study to Explore the Efficacy and Safety of Atezolizumab Plus Tiragolumab and Chemotherapy in 1st Line HER2 Negative Unresectable, Recurrent or Metastatic Gastric Cancer or Adenocarcinoma of Gastroesophageal Junction (GEJ)treatment2terminated
NCT00004127
Oxaliplatin Combined With Fluorouracil and Leucovorin in Treating Patients With Recurrent or Metastatic Cancer of the Esophagus or Stomachtreatment2completed
NCT00511576
Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer Tumorstreatment1terminated
NCT02413476
Comparison of Surgical,Clinical and Oncological Outcomes Between Robotic-assisted and Laparoscopic-assisted GastrectomyNo drug interventionstreatment2 / 3unknown_status
NCT05901376
MicroRNAs From Blood Samples as Biomarkers for Gastric Cancer DetectionNo drug interventionsNot AvailableNot Availablerecruiting
NCT01123876
Evaluating the Safety and Tolerability of the Poly-ADP Ribose (PARP) Inhibitor With FOLFIRI in Subjects With Solid Tumortreatment1completed
NCT06335576
Establishment of Serum Proteomics Subtypes of Gastric Cancer and Its Clinical ApplicationNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT04454476
Reversal of Preneoplastic Metaplasia in the Stomach With MEK Inhibitortreatment1active_not_recruiting
NCT04483076
Oxaliplatin Combined With S-1(SOX) Neoadjuvant Chemotherapy for Different Cycles in Patients With Gastric CancerNo drug interventionstreatment3recruiting
NCT01962376
Preoperative Chemotherapy With Bevacizumab For Potentially Resectable Gastric Cancer With Liver Metastasistreatment4unknown_status
NCT00005876
Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During Surgerytreatment2unknown_status
NCT04609176
Study of Camrelizumab (SHR-1210) and Apatinb Based Therapies for Alpha-fetoprotein (AFP)-Producing Gastric Cancer or Gastroesophageal Junction Adenocarcinomatreatment2recruiting
NCT05311176
A Study of IMU-131 (HER-Vaxx) in Combination With Chemotherapy or Pembrolizumab in Patients With Metastatic HER2/Neu Over-Expressing Gastric Cancer (nextHERIZON)treatment2active_not_recruiting
NCT04281576
Effect of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Chemotherapy as First Line Treatment of Unresectable Gastroesophageal Junction or Gastric AdenocarcinomatreatmentNot Availableunknown_status
NCT01411176
Phase III Study of NPO-11 in Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopytreatment3completed
NCT00654160
Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancertreatment1completed
NCT06134960
NKG2D/CLDN18.21 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid TumorNo drug interventionstreatment1not_yet_recruiting
NCT03170960
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumorstreatment1 / 2active_not_recruiting
NCT05494060
XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinomatreatment2recruiting
NCT00005060
Combination Chemotherapy and Surgery in Treating Patients With Locally Advanced Stomach Cancertreatment3completed
NCT05930860
Efficacy and Safety of ESD for the Treatment of Superficial Gastric NeoplasmsNo drug interventionsNot AvailableNot Availablerecruiting
NCT01401894
Perception Prognosis, Goals of Treatment, and CommunicationNo drug interventionsNot AvailableNot Availablecompleted
NCT03471494
GlobalSurg 3: Quality and Outcomes in Global Cancer SurgeryNo drug interventionsNot AvailableNot Availablecompleted
NCT02960594
hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapseprevention1completed
NCT06295094
The Efficacy of PIPAC and Minimally Invasive Radical Resection in High-risk Gastric Cancer Patients.prevention2not_yet_recruiting
NCT01739894
Feasibility Study of Intraperitoneal Paclitaxeltreatment2unknown_status
NCT01412294
XParTS: Capecitabine/Cisplatin(XP) for Recurrent Gastric Cancertreatment2unknown_status
NCT04352894
Intraoperative ICG Fluorescence Imaging for Peritoneal Carcinomatosis DetectionNo drug interventionsdiagnosticNot Availableunknown_status
NCT02047994
Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer MortalityNo drug interventionsprevention4recruiting
NCT00165594
A Study of E7070 in Patients With Gastric Cancertreatment1 / 2terminated
NCT04108494
A Trial of Total Versus Partial Omentectomy for Advanced Gastric Cancer in GastrectomyNo drug interventionstreatmentNot Availablerecruiting
NCT04597294
Prophylactic Preoperative HIPEC in Advanced Gastric Cancer at High Risk of Peritoneal RecurrenceNo drug interventionsprevention3recruiting
NCT05918094
Comparing Modified XELOX Plus Sintilimab With Standard XELOX Plus Sintilimab in First-line Treatment for HER2-negative Gastric/Gastroesophageal Junction Adenocarcinomatreatment3recruiting
NCT02272894
A Trial to Evaluate the Superior Mesenteric Vein (14V) Lymphadenectomy for Distal Advanced Gastric CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT05019794
Infigratinib in Subjects With GC or GEJ With FGFR2 Amplification or Other Solid Tumors With Other FGFR Alterationstreatment2unknown_status
NCT01542294
SOX as Adjuvant Chemotherapy for Resectable Gastric Cancertreatment1 / 2unknown_status
NCT05122091
Fruquintinib Plus SOX as Neoadjuvant Therapy for Locally Advanced Gastric Adenocarcinomatreatment2recruiting
NCT01836991
D2 and D2+ Radical Surgery for the Treatment of Advanced Distal Gastric CancerNo drug interventionstreatment2unknown_status
NCT04907591
Postoperative Prognosis Management Service Based mHealth for Gastric Cancer PatientsNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT04149691
Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid MalignanciesNo drug interventionstreatment1recruiting
NCT02951091
Biomarker-Integrated Umbrella, Advanced Gastric CancerNo drug interventionstreatment2unknown_status
NCT04354662
Toripalimab Combined With FLOT Neoadjuvant Chemotherapy in Patients With Resectable Gastric Cancertreatment2unknown_status
NCT05419362
GEN-001 in Combination With Avelumab for Patients With PD-L1 Positive Gastric Cancertreatment2active_not_recruiting
NCT06010862
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid TumorsNo drug interventionstreatment1recruiting
NCT00003862
Chemotherapy and Radiation Therapy in Treating Patients With Stomach Cancertreatment2completed
NCT04777162
Tislelizumab Plus Anlotinib for Immunotherapy Resistant Gastrointestinal Cancertreatment2unknown_status
NCT02426762
Quick Skin Sealant in Closure of Surgical Wound After Laparoscopic SurgeryNo drug interventionsprevention2unknown_status
NCT02538562
Human Epidermal Growth Factor Receptor 2 (HER2) Advanced Gastric Epidemiology Study in KoreaNo drug interventionsNot AvailableNot Availablecompleted
NCT02226380
FOLFOX6 as Neoadjuvant Chemotherapy in Local Advanced Gastric CancerNo drug interventionstreatment2unknown_status
NCT03493880
The Analysis of Immuno-Nutrition Index in Advanced Gastric Cancer Receiving Preoperative TreatmentsNo drug interventionsNot AvailableNot Availablerecruiting
NCT05395780
A Phase 2 Study to Evaluate the Safety and Efficacy of Max-40279-01 in Patients With Advanced Gastric Cancer or Gastroesophageal Junction Cancertreatment2unknown_status
NCT00009880
Combination Chemotherapy Plus Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Esophagus or Stomachtreatment2completed
NCT06346080
Molecular Analysis for Gastro-Esophageal Cancer: Multicenter Discrete Choice ExperimentNo drug interventionsotherNot Availablerecruiting
NCT00927680
Familial Colorectal Cancer Registry in HispanicsNo drug interventionsNot AvailableNot Availablerecruiting
NCT06468280
Synergistic Effects of PD-1 Antibody and Chemotherapy Followed by Surgery in Limited-metastatic G/GEJ AdenocarcinomaNo drug interventionstreatment2not_yet_recruiting
NCT00477880
Cetuximab in Treating Patients With Ménétrier Disease at High Risk of Developing Stomach Cancertreatment1completed
NCT02942329
Exploratory Clinical Study of Apatinib and SHR-1210 in Treating Advanced Hepatocellular Carcinoma or Gastric Cancertreatment1 / 2unknown_status
NCT02504229
DC-CIK In Combination With Chemotherapy ( Gio / Oxaliplatin or Cisplatin ) Versus First-line Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma Randomized Controlled Phase II Clinical Study of Treatmenttreatment2unknown_status
NCT05537129
Laparoscopic vs Open Total Gastrectomy for Gastric CancerNo drug interventionstreatmentNot Availablerecruiting
NCT04595929
Oncological Benefits of Pressured Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients With T3-4 Gastric Cancer Cyt-treatmentNot Availablerecruiting
NCT00048529
Study of T900607-Sodium in Subjects With Previously Treated Gastric Cancer or Adenocarcinoma of the Esophagustreatment2suspended
NCT00209729
Phase I/II Study of Oral S-1 Plus Docetaxel in Elderly Patients With Advanced Gastric Cancer.treatment1 / 2suspended
NCT02805829
Combination Trastuzumab With Expanded Natural Killer Cells for Treating HER2-positive Gastric Cancertreatment1 / 2unknown_status
NCT04294589
Evaluation of NETs in Patients With Solid Cancers Associated With a High Risk of Venous Thromboembolic EventsNo drug interventionsNot AvailableNot Availableunknown_status
NCT03716089
Comparison of Tumor Efficacy Safety in Laparoscopic Resection of Gastrointestinal Stromal Tumors Between Favorable and Unfavorable SiteNo drug interventionsNot AvailableNot Availablerecruiting
NCT06186089
Effect of Gastrectomy on Gut Microbiome and Cognitive FunctionNo drug interventionsNot AvailableNot Availablerecruiting
NCT05924789
Epidemiological Characteristics of Gastric and Pancreatic Cancers in Latin AmericaNo drug interventionsNot AvailableNot Availablerecruiting
NCT01411189
Phase III Open-labeled Study of NPO-11 in Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopytreatment3completed
NCT03525392
Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.treatment1terminated
NCT06417892
Fruquintinib and Albumin-paclitaxel Combined With or Without PD-1 Antibody in 2nd-line Treatment of G/GEJ AdenocarcinomaNot AvailableNot Availablenot_yet_recruiting
NCT00836992
Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00003192
Aminocamptothecin in Treating Patients With Stomach Cancer or Cancer of the Esophagustreatment2completed
NCT05086692
A Beta-only IL-2 ImmunoTherapY Studytreatment1 / 2recruiting
NCT00985192
Everolimus in Treating Patients With Previously Treated Unresectable or Metastatic Esophageal Cancer or Stomach Cancertreatment2completed
NCT01198392
Trial of S-1 Plus Cisplatin in Gastric Cancertreatment3unknown_status
NCT00963092
Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT03639792
Escorting Octogenarian for Gastric Cancer SurgeryNo drug interventionsNot AvailableNot Availablecompleted
NCT05513144
Potential Clinical Utilities of Circulating Tumor DNA in Advanced HER2 Negative Gastric CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT01978444
Study on Laparoscopic D2 Lymphadenectomy Plus Complete Mesogastrium Excision(D2+CME)for Advanced Gastric CancerNo drug interventionspreventionNot Availableunknown_status
NCT01216644
5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancertreatment2 / 3completed
NCT04282044
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignanciestreatment1recruiting
NCT06419244
Myosteatosis in Oeso-gastric Cancer: Clinical ImpactsNo drug interventionsbasic_scienceNot Availablerecruiting
NCT03931044
Fluorescence Image-Guided Lymphadenectomy in Robotic GastrectomyNo drug interventionstreatmentNot Availableunknown_status
NCT06182644
Head-to-head Comparison of Positron Nuclide Radio-labeled FAPI and 18F-FDG PET/CT in Patients With Malignant TumorsNo drug interventionsdiagnosticNot Availablerecruiting
NCT05397444
Handgrip Strength (HGS) With HGS Asymmetry Are Associated With All-cause Mortality and Hospital ReadmissionsNo drug interventionsNot AvailableNot Availablecompleted
NCT04258644
Camrelizumab in Combination With Apatinib Mesylate, Paclitaxel-albumin and S-1 for Translational Treatment of Gastric Cancertreatment2unknown_status
NCT06222944
Anlotinib, TQB2450 (PD-L1 Inhibitor), and Albumin-bound Paclitaxel Regimens in the Treatment of GC/GEJAtreatment2not_yet_recruiting
NCT04340440
Curative D2 vs D1 Lymphadenectomy in Operable Gastric CarcinomaNo drug interventionstreatmentNot Availablecompleted
NCT00757640
Gastrectomy Plus Prophylactic Cholecystectomy in Gastric Cancer SurgeryNo drug interventionstreatmentNot Availablecompleted
NCT04508140
Study of BO-112 With Pembrolizumab for Colorectal or Gastric/GEJ Cancer With Liver Metastasistreatment2terminated
NCT01679340
A PhaseⅡ Study: SOX vs SP in Adjuvant Chemotherapy After D2 Surgeryprevention2unknown_status
NCT06419140
Multimodal Rehabilitation on Gastric Adenocarcinoma Patients Following Radical D2 GastrectomyNo drug interventionstreatment2not_yet_recruiting
NCT00576940
Standard and Immunostimulating Enteral Nutrition in Surgical PatientsNo drug interventionstreatment4completed
NCT02519140
Assessing How the Viscosity of Submucosal Gel Injections Helps With Endoscopic Mucosal ResectionsNo drug interventionstreatment3withdrawn
NCT03777540
Gastric Cancer Surgery in Elderly PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT02395640
The Comparison of XELOX and EOX in the First-line Treatment of Advanced Gastric Cancertreatment3completed
NCT05159440
First in Human Study of TORL-2-307-MAB in Participants With Advanced CancerNo drug interventionstreatment1active_not_recruiting
NCT03333967
The Real World Study of Apatinib for Gastric Cancer Treatment in Anhui ProvinceNo drug interventionsNot AvailableNot Availableunknown_status
NCT00447967
Combination of CPT-11 and LoHP vs Combination of 5-FU, Leucovorin and LoHP as 1st Line Treatment in Gastric Patientstreatment2completed
NCT00674167
The Effect of Preoperative Docetaxel, Cisplatin and Capecitabine on Serum RUNX3 Hypermethylation Status in Patients With Gastric and Lower Oesophagus Adenocarcinomatreatment2unknown_status
NCT06238167
Tislelizumab Plus Chemotherapy as Postoperative Adjuvant Therapy in Elderly Patients With LA GC/GEJCtreatment2not_yet_recruiting
NCT03840967
A Study Evaluating Safety and Efficacy of Niraparib in Patients With Previously Treated Metastatic Esophageal/Gastroesophageal Junction/Proximal Gastric Adenocarcinomatreatment2terminated
NCT00661167
Phase II Study of ABI-007 for Gastric Cancertreatment2completed
NCT03961867
Docetaxel Versus Oxaliplatin as Addition to S-1 for Stage II / III Gastric Adenocarcinomatreatment3recruiting
NCT03259867
Combination of TATE and PD-1 Inhibitor in Liver Cancertreatment2recruiting
NCT03228667
QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitorstreatment2active_not_recruiting
NCT05583201
NKG2D/CLDN18.2 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid TumorsNo drug interventionstreatment0recruiting
NCT03343301
A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 in Gastric/Gastroesophageal Cancertreatment1completed
NCT03829501
Safety and Efficacy of KY1044 and Atezolizumab in Advanced Cancertreatment1 / 2active_not_recruiting
NCT06374901
Tislelizumab Combined With Neoadjuvant Chemotherapy Used in the Perioperative Treatment.treatment2not_yet_recruiting
NCT06585501
A Study of Treatment Patterns in HER2-positive Unresectable and Advanced Gastric/ Gastroesophageal Junction Cancer in ChinaNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT05561504
Helicobacter Pylori Local Prevalence and Antibiotic ResistanceNo drug interventionsNot AvailableNot Availablerecruiting
NCT01088204
Feasibility Study of Laparoscopy-assisted D2 Distal Gastrectomy to Treat Advanced Gastric CancerNo drug interventionstreatment2unknown_status
NCT01470404
Pharmacogenomic Study (Adjuvant Chemotherapy)No drug interventionsNot AvailableNot Availablecompleted
NCT01138904
FOLFOX Followed by FOLFIRI or Reverse Sequence Treatment in Advanced Gastric Cancer (AGC)treatment2completed
NCT03238404
Neoadjuvant Chemotherapy for Patients With Advanced Gastric Cancer in ERAS Programs for Radical GastrectomyNo drug interventionstreatmentNot Availablecompleted
NCT05124704
Propofol EC50 for Inducing Loss of Consciousness in General Combined Epidural AnesthesiatreatmentNot Availablecompleted
NCT01697072
First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinomatreatment3terminated
NCT05853172
Surgical Conversion of Candonilimab (AK104) Plus Paclitaxel, S-1 and Apatinib for Unresectable Advanced G/GEJ Cancertreatment2recruiting
NCT04187872
LITT and Pembrolizumab in Recurrent Brain Metastasistreatment1terminated
NCT05379972
Study of SBRT/Olaparib Followed by Pembrolizumab/Olaparib in Gastric Cancerstreatment2recruiting
NCT03985072
Study With Andes-1537 in Patients With Specific Types of Advanced Solid TumorNo drug interventionstreatment1completed
NCT01962272
The Effect of Nutritional Counseling for Cancer PatientsNo drug interventionssupportive_care4completed
NCT00003172
Comparison of Combination Chemotherapy Regimens in Treating Patients With Advanced Stomach Cancertreatment2completed
NCT03801668
Albumin-bound Paclitaxel Plus S-1 Versus SOX as First-line Treatment in Advanced or Recurrent Gastric Adenocarcinomatreatment3unknown_status
NCT00287768
Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric Cancertreatment3completed
NCT03471468
Kinetics of Microparticles Under Chemotherapy in Patients With Gastric or Pancreatic CancerNo drug interventionsbasic_scienceNot Availableterminated
NCT03817268
Capecitabine or Observation for Patients With pT1N+M0 or pT2-3N0M0 Gastric Adenocarcinoma Undergoing R0 Resectiontreatment3recruiting
NCT00546468
Clinical Study on Laparoscopic Gastrectomy for Early Gastric Cancer (COACT_0301)No drug interventionstreatment3completed
NCT01522768
Afatinib and Paclitaxel in Patients With Advanced HER2-Positive Trastuzumab-Refractory Advanced Esophagogastric Cancertreatment2completed
NCT01795768
Proof-of-Concept Study of AZD4547 in Patients With FGFR1 or FGFR2 Amplified Tumourstreatment2unknown_status
NCT00539968
A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED)treatment1 / 2terminated
NCT02287168
Effect of Peritoneal Lavage on Surgery-induced Positive Peritoneal Cytology in Gastric Cancer PatientsNo drug interventionstreatment0completed
NCT05177068
Conversion Therapy of Fruquintinib in Combination With Sintilimab and SOX in Unresectable Gastric Cancertreatment2recruiting
NCT06241469
Efficacy and Safety of Sintilimab Combined With Nab-paclitaxel and Tegio (aTS) as First-line Treatment of Unresectable Locally Advanced, Recurrent or Metastatic Adenocarcinoma of Gastric and Gastroesophageal Junction,a Phase II Clinical Studytreatment2not_yet_recruiting
NCT00202969
Study of S-1, S-1/CDDP, and 5-FU/CDDP for Advanced Gastric CancerNo drug interventionstreatment3completed
NCT05617469
DLCS for Predicting Neoadjuvant Chemotherapy ResponseNo drug interventionsNot AvailableNot Availablerecruiting
NCT06468969
Enhanced vs. Routine Follow-Up After Total Gastrectomy for Advanced Gastric Cancer: A Randomized Controlled TrialNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT05514769
Proximal Gastrectomy Anterior Anastomosis With Pyloroplasty Versus Esophagogastric Anastomosis for Gastric CancerNo drug interventionstreatmentNot Availablerecruiting
NCT00012246
Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tracttreatment2terminated
NCT04168346
Preoperative Intravenous Iron Therapy in Patients With Gastric Cancerprevention4not_yet_recruiting
NCT01716546
Trial of Panitumumab Cisplatin, Fluourouracil and Docetaxel in Locally Advanced or Metastatic Gastric Cancertreatment1 / 2terminated
NCT05966246
The Effect of Prucalopride Succinate on Gastrointestinal Motility After Laparoscopic Gastrectomy : Prospective Double Blind Case-control StudytreatmentNot Availablecompleted
NCT01373346
Safety and Efficacy of Long Limb Roux-en Y ReconstructionNo drug interventionstreatmentNot Availablecompleted
NCT01073046
Gastric Decompression After Sub-total GastrectomyNo drug interventionsNot AvailableNot Availablecompleted
NCT05140746
Prediction of Neoadjuvant Chemotherapy Efficacy in Locally Advanced Gastric CancerNo drug interventionsdiagnosticNot Availablerecruiting
NCT00183846
Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal Cancerstreatment1completed
NCT06208046
Predict 5-Year Survival in Elderly Gastric CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT05100446
Comparison Between High-dose Amoxicillin Dual Therapy and Pylera Quadruple Therapy in the Treatment of Helicobacter Pylori Infectiontreatment0unknown_status
NCT01426646
S-1 Versus S-1 Plus Cisplatin as an Adjuvant Chemotherapy to Treat Gastric Cancertreatment2unknown_status
NCT00857246
Pre-operation Chemo and Antibody Therapy Followed by Surgical Resection and Adjuvant Chemoradiation for Gastric Cancertreatment2completed
NCT01927146
Lauren Classifications and HER2 Status in Gastric Cancer PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT04365946
Microbiome Analysis in Gastric Intestinal Metaplasia and in Gastric Cancer and Subtypes CorrelationNo drug interventionsNot AvailableNot Availableunknown_status
NCT02307812
Ramucirumab Use in Combination With Paclitaxel in Gastric or Gastroesophageal Junction Adenocarcinoma; Temporary Authorization for Use (ATU) in FranceNot AvailableNot Availableno_longer_available
NCT06413212
Exploratory Study of Precise Therapy for Advanced Tumor Patients With Malignant Hydrothorax or Ascites by Using PTC Drug Sensitivity TestingNo drug interventionsNot AvailableNot Availablerecruiting
NCT02349412
Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family CaregiversNo drug interventionssupportive_care3completed
NCT03013712
A Clinical Research of CAR T Cells Targeting EpCAM Positive CancerNo drug interventionstreatment1 / 2unknown_status
NCT03067012
Nutritional Safety and Metabolic Benefits of Oncometabolic Surgery for Obese Gastric Cancer PatientsNo drug interventionstreatmentNot Availablecompleted
NCT01163812
Clinical Trial for Laparoscopic D2 GastrectomyNo drug interventionstreatment2completed
NCT00209612
Phase I/II Study of Paclitaxel Plus CPT-11 in Pts. With 2nd Line Chemotherapy of Inoperable or Recurrent GC.treatment1 / 2withdrawn
NCT00529412
Bioresorbable Membrane to Reduce Postoperative Small Bowel ObstructionNo drug interventionstreatment3completed
NCT02063412
Nursing and Pharmacy Care Between Capecitabine and 5-Fluoruracil RegimensNo drug interventionsNot AvailableNot Availablewithdrawn
NCT00004910
Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal ObstructionNo drug interventionssupportive_care1 / 2completed
NCT01441310
Laparoscopic Sentinel Node Navigation Surgery for Gastric CancerNo drug interventionstreatment2completed
NCT05130710
The Impact of COVID-19 Pandemic on Clinical Presentation and Staging of Gastric CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT01896310
New Classification of Stomach Using Probe-based Confocal Laser EndomicroscopyNo drug interventionsNot AvailableNot Availablecompleted
NCT06308510
Detection of Aneuploidy in Cell Free DNA to Improve the Sensitivity of Diagnostic Peritoneal Lavage in Gastric CancerNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT04342910
Study to Evaluate the Efficacy and Safety of Camrelizumab and Apatinib in Patients With GC/GEJCtreatment3unknown_status
NCT06499610
Clinical Study of Irinotecan Liposome Combination Therapy for Advanced Gastric Cancertreatment4not_yet_recruiting
NCT01514110
Gastric Cancer RAD001 Studytreatment1 / 2completed
NCT00601510
Imatinib, Capecitabine, and Cisplatin in Treating Patients With Unresectable or Metastatic Stomach Cancertreatment1completed
NCT05974410
Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer PatientsNot AvailableNot Availableavailable
NCT00052910
Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancertreatment3completed
NCT06461910
Efficacy and Safety of Anti-PD-1, Thymosin, and SOX in Neoadjuvant Treatment of cStage III Gastric/GEJ AdenocarcinomaNo drug interventionstreatment2not_yet_recruiting
NCT03568110
Frailty and Postoperative Outcomes After Gastric Cancer SurgeryNo drug interventionsNot AvailableNot Availablecompleted
NCT04161781
A Study of PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00166881
Weekly Docetaxel/Irinotecan for Non-resectable Gastric Cancers After Cisplatin Plus 5-FU/Leucovorintreatment2completed
NCT00217581
Bevacizumab, Oxaliplatin, and Docetaxel in Treating Patients With Locally Advanced Unresectable or Metastatic Stomach or Gastroesophageal Junction Cancertreatment2completed
NCT02694081
The Advantages and Disadvantages Between Uncut Roux-en-Y Reconstruction and Billroth II Reconstruction After Laparoscopy-assisted Distal Gastrectomy for GastricNo drug interventionstreatment2unknown_status
NCT06202781
Tumor Microenvironment in Gastric Cancer Patients Treated With Combined Immunotherapy and ChemotherapyNo drug interventionsNot AvailableNot Availablerecruiting
NCT00699881
Study of Cetuximab to Treat Gastric Cancertreatment2completed
NCT06194981
Duration of Adjuvant Chemotherapy for Gastric Cancer Patients at Pathological N3 StageNot AvailableNot Availablerecruiting
NCT03597581
A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal Cancertreatment1recruiting
NCT00113581
Safety Study of EMD 72000 in Combination With ECX (Epirubicin, Cisplatin and Capecitabine) in Oesophagogastric Cancertreatment1completed
NCT05594381
A Biomarker Study for Predicting the Efficacy of Neoadjuvant Sintilimab Plus SOX for Gastric Adenocarcinoma.prevention2not_yet_recruiting
NCT03619681
Trial of KN026 in Patients With HER2-positive Advanced Malignant Breast Cancer and Gastric Cancertreatment1completed
NCT03372681
Comparative Study of Antiperistaltic vs Isoperistaltic Billroth II + Braun Anastomosis for Postoperative RefluxNo drug interventionstreatmentNot Availableunknown_status
NCT04660695
Nasobiliary Drain Assisted EUS-guided Gastroenterostomies in Unresectable Malignant Gastric Outlet ObstructionNo drug interventionsNot AvailableNot Availablecompleted
NCT00004895
Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgerysupportive_care2completed
NCT02311595
A Phase II Clinical Trial of Reduced Port Totally Laparoscopic Distal Gastrectomy With D2 Lymph Node DissectionNo drug interventionstreatment2unknown_status
NCT03228095
Volatiles in Breath and Headspace Analysis - Diagnostic MarkersNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT00215995
Cisplatin and Irinotecan Chemotherapy, Followed by ZD 1839 (Iressa) in Patients With Esophageal or Gastric Carcinomastreatment2completed
NCT03413514
Real World Evidence for the Cycle of Neoadjuvant Chemotherapy in Gastric Cancer With Shared Decision MakingNo drug interventionstreatmentNot Availableunknown_status
NCT05827614
Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), in Subjects With Tumors With Oncogene Amplificationstreatment1recruiting
NCT02489214
Donafenib Monotherapy for Previously Treated Metastatic Gastric Cancertreatment1 / 2terminated
NCT05627414
Conversion Therapy of Disitamab Vedotin Combined With Sintilimab and S-1 in HER2 Overexpression Gastric Cancertreatment2not_yet_recruiting
NCT00215514
Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction Adenocarcinomaprevention0completed
NCT05125614
Gastric Cancer Survival Without ChemotherapyNo drug interventionsNot AvailableNot Availablecompleted
NCT02903914
Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumorstreatment1 / 2completed
NCT02346955
Study of CM-24 (MK-6018) Alone and In Combination With Pembrolizumab (MK-3475) in Participants With Selected Advanced or Recurrent Malignancies (MK-6018-001)treatment1terminated
NCT02756455
Procalcitonin Reveals Early Dehiscence in Gastric Surgery: the PREDIGS StudyNo drug interventionsNot AvailableNot Availableunknown_status
NCT02216955
Nutrition and Lifestyle Study Cohort of Gastric Cancer in ChinaNo drug interventionsNot AvailableNot Availableunknown_status
NCT06306755
Effectiveness of Risk-based Sequential Screening for Esophageal and Gastric CancerNo drug interventionsscreeningNot Availablerecruiting
NCT05071755
Gastrectomy Outcomes in Elderly PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT01132755
Rapid Gastric and Pancreas Cancer Staging Utilizing Peritoneal LavageNo drug interventionsdiagnostic2completed
NCT00003055
Cisplatin and Irinotecan in Treating Patients With Locally Advanced or Metastatic Esophageal or Gastric Cancertreatment2completed
NCT01456455
Gastric Cancer Metastasized to the Central Nervous System (CNS)No drug interventionsNot AvailableNot Availableunknown_status
NCT04641455
Use of Mucolytic Solution Before Upper EndoscopydiagnosticNot Availableunknown_status
NCT06123455
Clinical Study of Taurine Combined With Sintilimab and Chemotherapy for Treatment of Advanced Gastric Cancertreatment2recruiting
NCT06253650
Adjuvant TRastuzumab Deruxtecan for HER2-positive Gastroesophageal Cancer With Persistence of miNImal Residual DiseaseNo drug interventionstreatment2recruiting
NCT04661150
A Study of Atezolizumab and Trastuzumab in Combination With Capecitabine and Oxaliplatin in Patients With HER2 Positive Locally Advanced Resectable Gastric Cancer of Adenocarcinoma of Gastroesophageal Junctiontreatment2active_not_recruiting
NCT02815150
Safety of 250ml Preoperative Carbohydrate Drink in Gastric Cancer PatientsNo drug interventionsotherNot Availablecompleted
NCT01637350
Digestive Tract Reconstruction After Gastrectomy of Gastric Cancer With Type 2 DiabetesNo drug interventionsNot AvailableNot Availableunknown_status
NCT06035250
AI Prediction of Gastric Cancer Response to Neoadjuvant ChemotherapyNo drug interventionsNot AvailableNot Availablerecruiting
NCT06392750
PWP1's Expression in Gastric Cancer.No drug interventionsNot AvailableNot Availablecompleted
NCT04980950
"The Impact of Immunonutrition on Gut Microbiota-related Aspects in Colorectal Cancer and Gastric Cancer Patients"No drug interventionssupportive_careNot Availableunknown_status
NCT05708950
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)treatment1 / 2recruiting
NCT00032123
Erlotinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer or Gastroesophageal Junction Cancertreatment2completed
NCT05051423
"Mechanisms and Biomarkers of Response and Resistance to Current Targeted Therapies in Gastric Cancer" (THERRES)No drug interventionsNot AvailableNot Availableunknown_status
NCT02415023
A Phase Ib/2 Clinical Study of Fruquintinib Combined With Paclitaxel in the Treatment of Advanced Gastric Cancertreatment1 / 2completed
NCT06363123
Plasma Metabolic Biomarkers for Multi-Cancer DiagnosisNo drug interventionsNot AvailableNot Availablerecruiting
NCT03117023
The Addition of Dexmedetomidine on Postoperative Sleep for Middle-aged and Elderly Patients With Gastric Cancertreatment3unknown_status
NCT01518023
Long Term Diabetes Improvement After Cancer Gastrectomy and ColectomyNo drug interventionsNot AvailableNot Availablecompleted
NCT06149923
Association Between ABO Polymorphism and Gastric/Colorectal CancersNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT05517408
Dose Exploration of Ciprofol for Sedation in Gastrointestinal Endoscopic Diagnosis and Treatment of Obese Patients.No drug interventionstreatmentNot Availablerecruiting
NCT04584008
Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular CharacteristicsNo drug interventionstreatmentNot Availablerecruiting
NCT04517708
Effectiveness of Nutritional Interventions for Cancer Patients Undergoing ChemotherapyNo drug interventionspreventionNot Availablecompleted
NCT03895008
Comparing the Prognosis of Patients With Cardia and Non-cardia Gastric Cancer.No drug interventionsNot AvailableNot Availablerecruiting
NCT00365508
Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smokingtreatment4completed
NCT04019808
Gastric Cancer Risk Factors Knowledge in European and Latinamerican PopulationNo drug interventionsNot AvailableNot Availablecompleted
NCT02585908
Safety and Efficacy of γδ T Cell Against Gastric CancerNo drug interventionstreatment1 / 2unknown_status
NCT06543108
Preliminary Study on the Diagnostic Value Comparison of 18F-FAPI-04 PET/CT and PET/MR in Gastric CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT00439608
Cetuximab, Paclitaxel, Carboplatin & Radiation for Esoph, Gastroesoph & Gastric Cancertreatment2completed
NCT04937738
Perioperative Chemotherapy in Gastric Cancertreatment2active_not_recruiting
NCT00858338
Adjuvant Intraperitoneal Floxuridine Added to Chemoradiation for Fully Resected Advanced Stomach Cancertreatment2completed
NCT01874938
A Study of LY2875358 in Participants With MET Positive, Advanced Gastric Cancertreatment2completed
NCT05468138
PD-1 Antibody Adjuvant Therapy for GC Patients With MSI-H After D2 Radical SurgeryNo drug interventionstreatment2not_yet_recruiting
NCT01045538
Study of Vorinostat Plus Capecitabine (X) and Cisplatin (P) for 1st Line Treatment of Metastatic or Recurrent Gastric Cancer: Zolinza+XPtreatment1 / 2completed
NCT04338438
Efficacy and Safety of Apatinib Combined With S-1 for Patients With Advance Gastric Cancertreatment2completed
NCT02024438
Monosialotetrahexosylganglioside Sodium Injection for Prevention Neurotoxicity of mFOLFOX 6 in Advanced Gastric Cancerprevention3unknown_status
NCT00209638
Phase I/II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancertreatment1 / 2completed
NCT00711243
Docetaxel, Oxaliplatin, and Fluorouracil in Treating Patients With Metastatic or Unresectable Stomach Cancer, Gastroesophageal Junction Cancer, or Other Solid Tumortreatment1 / 2completed
NCT02267343
Study of ONO-4538 in Unresectable Advanced or Recurrent Gastric Cancertreatment3completed
NCT01926743
Identification of Complete Lymph Node Removal by Application of Near Infrared Fluorescence Imaging in Laparoscopic and Robotic GastrectomyNo drug interventionstreatmentNot Availablecompleted
NCT02892643
Comparison of Laparoscopic Proximal Gastrectomy and Laparoscopic Total GastrectomyNo drug interventionstreatmentNot Availablecompleted
NCT04440943
A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced MalignanciesNo drug interventionstreatment1completed
NCT04348643
Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ CancerNo drug interventionstreatment1 / 2unknown_status
NCT00152243
A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-GC)treatment3completed
NCT00017043
BMS-247550 in Treating Patients With Metastatic Stomach Cancer Previously Treated With Chemotherapytreatment2completed
NCT04284943
Surgical TreAtment for Obesity Related Disease and Onco-Metabolic SurgeryNo drug interventionstreatmentNot Availablerecruiting
NCT00687843
Study of TS-1 or TS-1 + PSK for Gastric Cancer Patientstreatment3unknown_status
NCT01219543
A Phase I Study of AZD1480 in Patients With Advanced Solid Malignancies and Advanced Hepatocellular Carcinoma in the Escalation Phase,Non-Small Cell Lung Cancer(NSCLC) and Non-smokers With Lung Metastasis and Gastric Cancer and Solid Tumour in the Expansion Phase.treatment1terminated
NCT00952003
Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patientstreatment2completed
NCT02501603
Afatinib, Paclitaxel, 2nd Line, Advanced Gastric Cancertreatment2completed
NCT03392103
Adjuvant IMRT With Concommitant Raltitrexed Chemotherapy for Locally Advanced Gastric Cancer After D0/D1 Radical Resectiontreatment2unknown_status
NCT00004103
Combination Chemotherapy Followed by Surgery in Treating Patients With Stomach Cancertreatment2completed
NCT06100003
A Clinical Study Aims to Assess the Consistency of Clinical Efficacy in Gastric Cancer Treatment and Drug Susceptibility Outcomes Using a Novel Drug Susceptibility Testing MethodNo drug interventionsNot AvailableNot Availablerecruiting
NCT03393403
Comparison of the Effect of Intravenous and Perineural Dexmedetomidine in Gastric Cancer SurgerytreatmentNot Availableunknown_status
NCT00980603
Docetaxel Versus Docetaxel Plus Cisplatin Versus Docetaxel Plus S-1 as Second-line Chemotherapy in Metastatic Gastric Cancertreatment2unknown_status
NCT00103103
Bortezomib, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Stomach Cancertreatment2terminated
NCT02931890
Multicentric Randomised Trial for Resectable Gastric Cancertreatment2active_not_recruiting
NCT05379790
Concomitant Intraperitoneal and Systemic Chemotherapy in Patients With Extensive Peritoneal Carcinomatosis of Gastric Origintreatment1recruiting
NCT04188990
Cost Effectiveness of an Intervention in Hospitalized Patients With Disease-related MalnutritionNo drug interventionstreatmentNot Availablecompleted
NCT05126290
CTNNA1 Familial Expansion StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT02172690
Laparoscopic Staging for Locally Advanced Gastric Cancer in Chinese PatientsNo drug interventionsdiagnosticNot Availableunknown_status
NCT04907864
Effect of Multi-modal Intervention Care on Cachexia in Patients With Advanced Cancer Compared to Conventional Management (MIRACLE)supportive_care2unknown_status
NCT04082364
Combination Margetuximab, Retifanlimab, Tebotelimab, and Chemotherapy Phase 2/3 Trial in HER2+ Gastric/GEJ Cancertreatment2 / 3active_not_recruiting
NCT01704664
Perioperative Immunonutrition, Phagocytic and Bactericidal Activity of Blood Platelets in Gastric Cancer Patientssupportive_careNot Availableunknown_status
NCT03623464
RCT of Mobile Apps & FitBit v. Usual CareNo drug interventionsotherNot Availableactive_not_recruiting
NCT06257264
A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumorstreatment1recruiting
NCT01497964
Cabazitaxel in Asian Patients With Advanced Gastric Cancer Who Failed Prior Chemotherapytreatment1 / 2completed
NCT05919264
FOG-001 in Locally Advanced or Metastatic Solid TumorsNo drug interventionstreatment1 / 2recruiting
NCT03453164
Checkpoint Inhibitor and Radiotherapy for Recurrent Gastric Cancer (CIRCUIT)treatment1 / 2unknown_status
NCT05274464
A Recurrence Nomogram for Hepatoid Adenocarcinoma of the StomachNo drug interventionsNot AvailableNot Availablecompleted
NCT00511264
Laparoscopic Ultrasound Guided Tissue Sampling in Patients With Cancer of the Upper Gastrointestinal TractNo drug interventionsNot AvailableNot Availablecompleted
NCT03208621
Evaluation of PET and Laparoscopy in STagIng Advanced Gastric CancerNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00537121
Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal Cancertreatment1completed
NCT04864821
Clinical Study of CD276 Targeted Autologous Chimeric Antigen Receptor T Cell Infusion in Patients With CD276 Positive Advanced Solid TumorNo drug interventionstreatment0unknown_status
NCT04351321
The Safety of Totally Laparoscopic Versus Laparoscopy-Assisted Total Gastrectomy.No drug interventionstreatmentNot Availableunknown_status
NCT01444521
Genotype-drive Study of Irinotecan-Cisplatin Combination for Advanced Gastric Cancertreatment2completed
NCT05447221
Automatic Evaluation of the Severity of Gastric Intestinal Metaplasia With Pathology Artificial Intelligence Diagnosis SystemNo drug interventionsNot AvailableNot Availablerecruiting
NCT04006821
PD-1 Antibody + Apatinib Mesylate in 2+ Line Serum AFP-elevated Gastric Adenocarcinomatreatment2unknown_status
NCT05618821
Clinical Outcomes of Indocyanine Green Tracer Using in Laparoscopic Gastrectomy With Lymph Node Dissection for Remnant Gastric Cancertreatment2recruiting
NCT04396821
A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumorstreatment1 / 2recruiting
NCT01963702
A Phase II Trial of Exploring the Predictive Factors of TX and XELOX Regimen in the First Line Treatment of MGCtreatment2unknown_status
NCT06466902
Evaluation of Intra-operative Photographs for the Assessment of a Proper Lymphadenectomy in Minimally-invasive Gastrectomies for Gastric Cancer (PhotoNodes)No drug interventionsNot AvailableNot Availablerecruiting
NCT01625702
Clinical Significance of Circulating Tumor Cells (CTCs) in Blood of Patients With Advanced/Metastatic Gastric CancerNo drug interventionsbasic_scienceNot Availablecompleted
NCT05442502
Safety and Efficacy of OGT Method Versus the Traditional Overlap MethodNo drug interventionsNot AvailableNot Availablecompleted
NCT05519202
Exploratory Clinical Study of Penpulimab Combined With SOX in the Perioperative Treatment of Gastric Cancertreatment2unknown_status
NCT00394602
Chemoradiation-Induced Nausea and Emesis: Quality of LifeNo drug interventionsNot AvailableNot Availableterminated
NCT05186402
Predictive Factors of Morbidity and Mortality and Overall Survival of Patients With Gastric Cancer : a Case SeriesNo drug interventionsNot AvailableNot Availablecompleted
NCT04368702
CONFIRM: Magnetic Resonance Guided Radiation TherapyNo drug interventionstreatmentNot Availablerecruiting
NCT05771584
Therapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Gastric Cancertreatment2recruiting
NCT00210184
Evaluation of Efficacy and Safety of FOLFIRI Association Treatment in Patients 70 Years of Age and Older With Gastric Cancertreatment2completed
NCT02638584
Effects of Ilaprazole on Ulcer Healing Rate and Prevention of Gastrointestinal Bleeding in the Patients Undergone ESD.treatment4completed
NCT05572684
A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid Tumorstreatment1 / 2recruiting
NCT05238584
Total Versus Partial Omentectomy in the Treatment of Gastric CancerNo drug interventionstreatmentNot Availableunknown_status
NCT04071184
Study of Alofanib in Patients With Metastatic Gastric CancerNo drug interventionstreatment1unknown_status
NCT03427684
Study of Hypo-fractionated Neoadjuvant Radiotherapy for Locally Advanced Gastric CancerNo drug interventionstreatment1 / 2unknown_status
NCT03894384
The Value of TFF3 in Diagnosis of Gastric CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT02706184
E. Coli Nissle in Oncologyprevention3completed
NCT02005484
A Study of Herceptin (Trastuzumab) in Patients With Metastatic or Advanced Gastric Cancer With Disease Progressiontreatment2terminated
NCT02713984
A Clinical Research of CAR T Cells Targeting HER2 Positive CancerNo drug interventionstreatment1 / 2withdrawn
NCT06282484
A Study on the Relationship Between Gastric Xanthoma and Gastric Cancer and Precancerous LesionsNo drug interventionsNot AvailableNot Availablecompleted
NCT00260884
Phase III Study OF the Gastric Surgery on Advanced Stage Gastric CancerNo drug interventionstreatment3completed
NCT06031779
Application of Serum Bile Acid Profile in the Diagnosis of Gastric CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT05411679
EP0057 in Combination With Olaparib in Relapsed Advanced Gastric Cancer and Small Cell Lung Cancertreatment2withdrawn
NCT06281379
Complete Mesogastric Excision With D2 Lympadenectomy for Gastric Cancer:No drug interventionstreatmentNot Availablecompleted
NCT06300879
A Prospective Study on Esophagogastrostomy by an Innovative Surgical TechniqueNo drug interventionstreatmentNot Availablerecruiting
NCT03486379
Folfiri as Third Line of TreatmentNo drug interventionsNot AvailableNot Availablecompleted
NCT03179579
Efficacy of HIPEC Combined With Systemic Chemotherapy and CRS on Peritoneal Metastases From Gastric CancerNo drug interventionstreatment3unknown_status
NCT06047379
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasistreatment1 / 2recruiting
NCT03648879
Confocal Endoscopic Microscopy for Detection of Early Stage Gastric Cancer in Subjects With Hereditary Diffuse Gastric Cancer SyndromeNo drug interventionsdiagnostic2completed
NCT04501887
The Efficacy of Precision Treatment for Gastric Cancer Guided by Molecular ProfilingNo drug interventionsNot AvailableNot Availableunknown_status
NCT06055387
Frailty Assessment and Intervention in Elderly Patients With Gastric Cancer Receiving Gastrectomy and Adjuvant ChemotherapyNo drug interventionssupportive_careNot Availablerecruiting
NCT05043987
Dose Escalation and Expansion Study of CPO102, an Anti-claudin 18.2 ADC in Patients With Advanced CancersNo drug interventionstreatment1withdrawn
NCT00376987
Zinc Supplements in Lowering Cadmium Levels in SmokersNo drug interventionsprevention2completed
NCT05648487
HIPEC Combined With Sintilimab for Gastric Cancer With Peritoneal Metastasistreatment2not_yet_recruiting
NCT02572687
A Study of Ramucirumab (LY3009806) Plus MEDI4736 in Participants With Advanced Gastrointestinal or Thoracic Malignanciestreatment1completed
NCT04410887
Neoadjuvant Chemotherapy With PISOXO for Locally-invaded-gastric Cancer (LIGC)No drug interventionstreatment1 / 2unknown_status
NCT01212887
Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancertreatment1terminated
NCT05427487
Study of Intratumoral IVX037 in Patients With Advanced or Metastatic Solid Tumourstreatment1recruiting
NCT00072787
Phase 1/2 Study of S-1 and Cisplatin in Advanced Gastric Cancertreatment1 / 2completed
NCT01672333
Response Rate and Side Effects of Preoperative Chemotherapy (TOX Regimen) in Patients With Locally Advanced Operable Gastric AdenocarcinomaNo drug interventionstreatment2completed
NCT01924533
Efficacy and Safety Study of Olaparib in Combination With Paclitaxel to Treat Advanced Gastric Cancer.treatment3completed
NCT05955833
89Zr-DFO*-Trastuzumab PET in Patients With Gastric or Breast Cancer - a Pilot StudyNo drug interventionsdiagnostic1recruiting
NCT04181333
Safety and Efficacy of Trastuzumab BSNot AvailableNot Availableactive_not_recruiting
NCT00533533
A Phase I/II Trial of Docetaxel and Oxaliplatin in Patients With Advanced Gastric Cancertreatment1 / 2completed
NCT04209933
Helicobacter Pylori Eradication With Different Bismuth Quadruple Therapiestreatment4completed
NCT01715233
Phase II Study Using CHFR Methylation Status in Patients With Metastatic Esophageal, Gastroesophageal, Gastric Cancer.treatment2completed
NCT06346054
Molecular Assessment for Gastro-Esophageal CancerNo drug interventionsdiagnosticNot Availablerecruiting
NCT05898854
[68Ga]Ga-FAPI PET/CT in Gastric and Gastroesophageal Junctional CancerNo drug interventionsdiagnostic2recruiting
NCT05144854
A Study to Evaluate the Efficacy and Safety of ONO-4538 in Combination With Ipilimumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer)treatment3active_not_recruiting
NCT06196554
Gastric Cancer Organoids in the Screening of Neoadjuvant DrugsNot AvailableNot Availablerecruiting
NCT02067754
Circulating Free DNA Analysis in Gastrointestinal Cancer, Genitourinary Cancer, Rare CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT04791254
Anorexia iN Cancer Patients: ANCHORNo drug interventionsNot AvailableNot Availablerecruiting
NCT04787354
Optimal Duration of Oxaliplatin in Adjuvant XELOX for Gastric Cancer Patients (EXODOX)treatment3recruiting
NCT00718354
Overall Survival of Inoperable Gastric/GastroOesophageal Cancer Subjects on Treating With LMWH + Chemotherapy(CT) vs Standard CTsupportive_care3completed
NCT01679054
Cost-minimization Analysis of Gastric Cancer Treatments in Hong KongNo drug interventionsNot AvailableNot Availablecompleted
NCT00452751
Comparison of Laparoscopic Versus Open Gastrectomy for Gastric Cancer: A Prospective Randomized TrialNo drug interventionstreatment3unknown_status
NCT03724851
Vactosertib in Combination With Pembrolizumab in Metastatic Colorectal or Gastric Cancertreatment1 / 2active_not_recruiting
NCT04227951
Gastrectomy With or Without Drainage (ADiGe)?No drug interventionstreatmentNot Availablecompleted
NCT02748551
A Comparison Laparoscopic With Open Gastric Cancer Surgery for Locally Advanced Gastric CancerNo drug interventionstreatment3unknown_status
NCT04198051
The Clinical Study of Adjuvant Chemotherapy on Intestinal and Urethral Flora in Patients With Gastric and Colon CancerNo drug interventionsotherNot Availableunknown_status
NCT04191551
The GAstric Precancerous Conditions StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT04034251
Intraperitoneal and Intravenous Paclitaxel Chemotherapy With Oral Capecitabine for Gastric Adenocarcinoma With Peritoneal Carcinomatosistreatment2active_not_recruiting
NCT01747551
FOLFOX +/- Ziv-Aflibercept for Esophageal and Gastric Cancertreatment2completed
NCT02033551
A Study Evaluating Veliparib as a Single Agent or in Combination With Chemotherapy in Subjects With Solid Tumorstreatment1completed
NCT01342653
Clinical Trial at Neoadjuvant Peritoneal and Systemic Chemotherapy Plus HIPEC in Gastric CarcinomatosisNo drug interventionstreatment2suspended
NCT05029453
Apatinib Combined With Chemotherapy Versus Chemotherapy in Second-line Gastric Cancer Receiving Prior Anti-PD-1 Therapytreatment4unknown_status
NCT05253053
To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumorstreatment1 / 2recruiting
NCT02090153
Study of S-1 Plus LV for Advanced Gastric Cancertreatment2completed
NCT02325453
Robotic, Laparoscopic and Open Surgery for Gastric Cancer Compared on Surgical, Clinical and Oncological OutcomesNo drug interventionsNot AvailableNot Availableunknown_status
NCT01824953
Long-term Follow-up Prognosis of Atrophic Gastritis After 3 YearsNo drug interventionsNot AvailableNot Availablecompleted
NCT04989153
Nasal Endoscopic Screening and Risk Assessment for Early Gastric CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT05985577
Mechanism of Gastric Signet Ring Cell Carcinoma Based on MicroproteomicsNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT01945177
RCT: WLE vs. NBI in Upper Gastrointestinal EndoscopyNo drug interventionsdiagnosticNot Availablecompleted
NCT06101277
Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)No drug interventionstreatmentNot Availablerecruiting
NCT03788447
Effect of Pneumoperitoneum on Remifentanil Requirements in the Surgical Pleth Index-guided AnalgesiaNo drug interventionspreventionNot Availablecompleted
NCT05956847
The Role of Extracellular DNA (ecDNA) in the Occurrence and Development of GastricNo drug interventionsNot AvailableNot Availablerecruiting
NCT01558947
Peri-operative Chemotherapy With ECX or XP in the Treatment of Advanced Gastric CancerNo drug interventionstreatment2unknown_status
NCT00582647
Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal TractNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT02150447
The Use of Proton Pump Inhibitor on the Prevention of Gastric Cancer Bleedingprevention3terminated
NCT06341647
Phase 1 Clinical Trial to Evaluate the Safety and Anti-Tumor Activity of AB-201treatment1not_yet_recruiting
NCT04686747
COVID - 19 and Advanced Gastro-intestinal Cancer TreatmentNo drug interventionsNot AvailableNot Availablecompleted
NCT02372747
Comparison of Delta-Shaped and Billroth II After TLDGNo drug interventionssupportive_careNot Availablecompleted
NCT03046745
Gastric Cancer Registry for Epidemiology and Molecular Risk FactorNo drug interventionsNot AvailableNot Availableunknown_status
NCT00591045
Study of Oxaliplatin, Calcium Folinate, and 5-Fluorouracil as Neoadjuvant Chemotherapy for Resectable Advanced Gastric CancerNo drug interventionstreatment2unknown_status
NCT05739045
Nivolumab Combined With SOX Used in the Perioperative Treatmenttreatment2recruiting
NCT03049345
Gastric Cancer Sentinel Lymph Node MappingdiagnosticNot Availableunknown_status
NCT03829345
A Translational Study of Single Agent Olaparib in the Treatment of Advanced Oesophagogastric Cancertreatment2unknown_status
NCT03556345
A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer Subjects With the Overexpression of HER2No drug interventionstreatment2completed
NCT01152645
Study of ARQ 197 Monotherapytreatment2completed
NCT03349398
Uncut Roux-en-Y vs Roux-en-YNo drug interventionstreatmentNot Availableunknown_status
NCT00398398
Study of XELOX With Cetuximab in Advanced Gastric Cancertreatment2completed
NCT05144698
RAPA-201 Therapy of Solid Tumorstreatment1 / 2recruiting
NCT03210298
International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)No drug interventionsNot AvailableNot Availableunknown_status
NCT01157598
Efficacy of Bispectral Index Monitoring for Midazolam and Meperidine Induced Sedation During Endoscopic Submucosal DissectionNo drug interventionssupportive_care3unknown_status
NCT02640898
Docetaxel-based Chemoradiotherapy Plus Periradiation Chemotherapy Compared With INT 0116 Adjuvant Arm in Gastric CancerNo drug interventionstreatmentNot Availableunknown_status
NCT01491698
Impact of Roux-En-Y Pouch Reconstruction Compared With Conventional Roux-En-Y Reconstruction on Health-Related Quality of Life in Patients Undergoing Total Gastrectomy for AdenocarcinomaNo drug interventionstreatment3completed
NCT00183898
Study of Oxaliplatin and Xeloda and Cetuximab as First Line Treatment for Metastatic or Unresectable Gastric or Gastroesophageal Junction Cancertreatment2unknown_status
NCT06098898
Safety and Efficacy of NK510 to Treat Gastric Cancertreatment0enrolling_by_invitation
NCT05415098
Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or LymphomasNo drug interventionstreatment1recruiting
NCT06293898
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumorstreatment1recruiting
NCT00003298
Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Gastric Cancertreatment2completed
NCT05363605
A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumourstreatment1 / 2terminated
NCT02139605
"Phase III Randomized Trial Comparing D2 vs D3 Lymphadenectomy With Gastric Cancer Following Neoadjuvant ChemotherapyNo drug interventionstreatmentNot Availablerecruiting
NCT00601705
Epirubicin, Oxaliplatin and Fluorouracil (EOF) in Cancer of the Esophagus, Gastroesophageal Junction, or Stomachtreatment2completed
NCT06432205
The Effect of MDT Plus SDM on Survival Benefit of Advanced Gastric CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT05678205
A Clinical Trial of the Safety and Anti-Tumor Activity of AB-201 in Subjects With Advanced HER2+ Solid Tumorstreatment1 / 2not_yet_recruiting
NCT06202105
Comparison of Laparoscopic and Open Total Gastrectomy for Locally Advanced Gastric CancerNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT06346197
Combination of Immune Checkpoint in Locally Advanced or Metastatic MSI/dMMR Esogastric Adenocarcinomastreatment3not_yet_recruiting
NCT06275997
GAIN Project: Gastric Cancer and Artificial IntelligenceNo drug interventionspreventionNot Availablenot_yet_recruiting
NCT03756597
PAN-study: Pan-Cancer Early Detection Study (PAN)No drug interventionsNot AvailableNot Availablecompleted
NCT04205097
Deep vs Moderate Neuromuscular Blocks on Remifentanil for Laparoscopic GastrectomypreventionNot Availablecompleted
NCT00952497
A Study of Telatinib in Combination With Chemotherapy in Subjects With Advanced Gastric Cancertreatment2completed
NCT00002783
Combination Chemotherapy Before and After Surgery in Treating Patients With Stomach Cancertreatment2completed
NCT00155883
Bi-Weekly Docetaxel Plus 24-Hour Infusion of High-Dose 5-Fluorouracil / Leucovorin (HDFL) for Inoperable Advanced or Metastatic Gastric Cancertreatment2terminated
NCT03708783
Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for AGCNo drug interventionstreatmentNot Availableunknown_status
NCT04714983
DNX-2440 for Resectable Colorectal Liver MetastasisNo drug interventionstreatment1suspended
NCT00553683
Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancertreatment1 / 2unknown_status
NCT04400383
Clinical Trial to Evaluate AB011 Injection in Patients With CLDN18.2-positive Advanced Solid TumorsNo drug interventionstreatment1completed
NCT01779583
Circulating Exosomes As Potential Prognostic And Predictive Biomarkers In Advanced Gastric Cancer Patients ("EXO-PPP Study")No drug interventionsNot AvailableNot Availableunknown_status
NCT06073483
Exploratory Study of Toumai Endoscopic Surgery System for Remote GastrectomyNo drug interventionstreatmentNot Availablerecruiting
NCT03104283
Apatinib for the Elderly Advanced Gastric Cancertreatment2completed
NCT00848783
Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Floxuridine, Followed by Capecitabine for Stomach and Gastro-esophageal Junction (GEJ) Cancerstreatment2terminated
NCT04878783
Radiomics and Molecular Expression Predictive Model for Esophago-Gastric Junction and Gastric Cancer TRGNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00020761
Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus or Stomachtreatment2completed
NCT03680261
Enriched-CRT 2017: Advanced Gastric Cancer With LN+ and LVI+, Chemotherapy vs. ChemoradiotherapyNo drug interventionstreatment3unknown_status
NCT03825861
Neoadjuvant FOLFIRINOX in the Treatment of Locally Advanced Gastric CancerNo drug interventionstreatment2recruiting
NCT03941561
S-1 for 9 Months Versus 1 Year for Stage II Gastric Cancer (SMAC)treatment3recruiting
NCT03283761
FOLFOX-A in the Treatment of Metastatic or Advanced Unresectable Gastric, Gastro-Esophageal Junction Adenocarcinomatreatment2completed
NCT01761461
Phase III Randomized Trial of Adjuvant Chemotherapy With S-1 vs S-1/Oxaliplatin ± Radiotherapy for Completely Resected Gastric Adenocarcinoma : The ARTIST II Trialtreatment3unknown_status
NCT04288661
Perianastomotic Drain After Gastrectomy (DRAG)No drug interventionsdiagnosticNot Availableunknown_status
NCT03627728
Study Maintenance Regorafenib vs Placebo, no Progression Patients After I Line Chemotherapy Metastatic Gastric Cancertreatment2unknown_status
NCT06227728
Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer.No drug interventionsNot AvailableNot Availablerecruiting
NCT01172028
Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumorstreatment1completed
NCT04481828
Comparison With Open and Totally Laparoscopic Gastrectomy for Gastric CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT03418428
Intestinal Microbiome After GastrectomyNo drug interventionsNot AvailableNot Availablecompleted
NCT03707028
A Study to Evaluate Safety, Tolerability, and Efficacy Profile of Rivoceranib With Paclitaxel in Advanced Gastric or Gastroesophageal Junction Cancertreatment1 / 2terminated
NCT01851928
Validation of a Nutrition Screening ToolNo drug interventionsNot AvailableNot Availablecompleted
NCT01927328
Iron Replacement in Oesophagogastric Neoplasiatreatment4unknown_status
NCT04591028
A Study to Evaluate Indocyanine Green Lymphangiography to Improve Lymphadenectomy in Gastric Cancer Patientsdiagnostic4withdrawn
NCT02110628
Roux-en-Y vs. Roux-en-Y+ Pouch for D2 Total GastrectomyNo drug interventionstreatment3unknown_status
NCT03606928
mFLOT Chemotherapy as First-line Treatment in GCtreatment1 / 2completed
NCT06253611
First-line EXL01 With Nivolumab and FOLFOX for PD-L1 CPS ≥5 Metastatic Gastric Cancertreatment2recruiting
NCT00477711
A Study of Cetuximab(Erbitux) With Cisplatin and Capecitabine(Xeloda)as 1st Line Treatment in the Advanced Gastric Cancertreatment2completed
NCT05489211
Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)treatment2recruiting
NCT02490111
Clinical Trials for the Prevention of Gallstone Formation After Gastrectomy in Patient With Gastric CancerNo drug interventionsprevention3completed
NCT00182611
S-1 and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage III Stomach Cancertreatment3completed
NCT02549911
HIPEC, Intravenous Chemotherapy and Surgery for the Treatment of Advanced GC With Peritoneal MetastasisNo drug interventionstreatment2unknown_status
NCT03042611
A Study to Evaluate Rivoceranib Plus Best Supportive Care Compared to Placebo Plus Best Supportive Care in Participants With Gastric Cancertreatment3completed
NCT00515411
Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinomatreatment2completed
NCT04886193
FLOT Combined With PD-1 in the First-line Treatment of Patients With Advanced Gastric Cancer and Peritoneal MetastasistreatmentNot Availableunknown_status
NCT03636893
Dragon III: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric CancerNo drug interventionstreatment2completed
NCT01283893
Standardization of D2 Lymphadenectomy and Surgical Quality Control: KLASS-02-QCNo drug interventionsNot AvailableNot Availableunknown_status
NCT05439993
Tepotinib Plus Paclitaxel in MET Amplified or MET Exon 14 Alterated Gastric and GEJ Carcinomatreatment1 / 2recruiting
NCT00544193
Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancertreatment1completed
NCT03642093
HOPE - A Study to Evaluate the Effect of a Prehabilitation Program on GI Cancer Patients Planning to Undergo SurgeryNo drug interventionstreatment4unknown_status
NCT00464893
Phase II Study With Catumaxomab in Patients With Gastric Cancer After Neoadjuvant CTx and Curative Resectiontreatment2completed
NCT00831571
Prospective Analysis of Hypersensitivity Reactions to OxaliplatinNo drug interventionsNot AvailableNot Availablecompleted
NCT06485271
A Real-world Study of Camrelizumab Alone or in Combination With Apatinib/Chemotherapy for Advanced Gastric CancerNot AvailableNot Availablerecruiting
NCT06555471
A Single-arm, Phase II Exploratory Study of Sintilimab in Combination With Chemoradiotherapy in Elderly Patients With Locally Advanced Gastric Cancertreatment2recruiting
NCT05891171
Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancerstreatment1recruiting
NCT03500471
Robotic and Laparoscopic Total Gastrectomy With D2 Lymphadenectomy for Locally Advanced Gastric CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT02537171
Apatinib as Maintenance Therapy After First Line Treatment in Locally Advanced or Metastatic Gastric Cancertreatment3unknown_status
NCT02401971
Irinotecan Plus Thalidomide in Second Line Advanced Gastric Cancertreatment4unknown_status
NCT00568971
Study of Weekly DCF to Treat Advanced Gastric Cancertreatment2terminated
NCT03950271
SHR-1210 Combined With Trastuzumab , Oxaliplatin and Capecitabine for Neoadjuvant Therapy of Gastric Adenocarcinoma/Gastroesophageal Junction Adenocarcinomatreatment2active_not_recruiting
NCT03874871
Function Preserving Gastrectomy for T1/2 Gastric Cancer PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT02352571
Safety Study of GC1118 (Recombinant Human Anti-EGFR Antibody) in Patients With Advanced Solid CancerNo drug interventionstreatment1unknown_status
NCT06464978
Stapler Reinforcement Patches Compared to Standard Staplers in GastrojejunostomyNo drug interventionstreatmentNot Availablerecruiting
NCT02052778
A Study of TAS-120 in Patients With Advanced Solid Tumorstreatment1 / 2completed
NCT06437678
Phase II Study of Liposomal Irinotecan for Advanced Refractory Gastric Cancertreatment2not_yet_recruiting
NCT06038578
A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancertreatment2recruiting
NCT04147078
Personalized DC Vaccine for Postoperative CancerNo drug interventionstreatment1recruiting
NCT04834778
A Study of HC-5404-FU to Establish the Maximum Tolerated Dose (MTD)No drug interventionstreatment1completed
NCT05699278
Investigating the Experiences of Individuals With Gastric Cancer Participating in Clinical TrialsNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT00154778
Taxol(Paclitaxel),UFT and Leucovorin in Patients With Advanced Gastric Cancertreatment2completed
NCT04316078
A Novel Patient Engagement Platform Among Patients With Gastrointestinal MalignanciesNo drug interventionshealth_services_researchNot Availablecompleted
NCT05604378
Relationship of EBV-positive Gastric Cancer and Multiple Genes Associated With Gastric CarcinogenesisNo drug interventionsNot AvailableNot Availablecompleted
NCT04443478
Laparoscopic Versus Open Lower Mediastinal Lymphadenectomy for Esophagogastric Junction CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT03430778
Effect of Pneumoperitoneum on the Continuous and Non-invasive Hemoglobin MonitoringNo drug interventionspreventionNot Availablecompleted
NCT03093688
Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid TumorNo drug interventionstreatment1 / 2unknown_status
NCT03686488
TAS 102 in Combination With Ramucirumab in Advanced, Refractory Gastric or Gastroesophageal Junction (GEJ) Adenocarcinomatreatment2completed
NCT01065688
A Trial of Reconstruction After Distal Gastrectomy for Gastric CancerNo drug interventionstreatment3completed
NCT04745988
An Open Label Phase 2 Study to Evaluate the Safety and Efficacy of Lenvatinib With Pembrolizumab or Lenvatinib, Pembrolizumab and FLOT in the Neoadjuvant / Adjuvant Treatment for Patients With Gastric Cancertreatment2recruiting
NCT03421288
Study of Atezolizumab + FLOT vs. FLOT Alone in Patients With GC/GEJ and High Immune Responsivenesstreatment2recruiting
NCT05233007
Upper GI Serial Tumour BiopsiesNo drug interventionsNot AvailableNot Availablesuspended
NCT06185907
In-hospital Outcomes of Older Patients With Gastric Cancer and Their Risk FactorsNo drug interventionsNot AvailableNot Availablecompleted
NCT01401907
Early Palliative Care in Advanced Lung and Gastrointestinal MalignanciesNo drug interventionssupportive_careNot Availablecompleted
NCT06573307
Hematological Dynamic Scores for Predicting Survival and Treatment Response for Advanced Gastric Cancer After Neoadjuvant TherapyNo drug interventionsNot AvailableNot Availablecompleted
NCT03264807
Lymph Node 14v Dissection in Clinical Stage T3N+, T4N+ of Gastric CancerNo drug interventionstreatment3unknown_status
NCT03253107
Predicting Biomarker of Gastric Cancer Chemotherapy ResponseNot AvailableNot Availablerecruiting
NCT04915807
Real-world Data (RWD) of Ramucirumab Plus PaclitaxelNot AvailableNot Availableunknown_status
NCT02461407
Study of Anlotinib in Patients With Gastric Cancer(ALTER0503)treatment2 / 3unknown_status
NCT01517009
A Multicenter Phase II Study of Neoadjuvant Docetaxel, Cisplatin and Capecitabine and Protocolized Surgery in Resectable Gastric Cancertreatment2completed
NCT00074009
Bortezomib in Treating Patients With Unresectable or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinomatreatment2completed
NCT01527409
The Efficacy of Health Partnership Program for Cancer PatientsNo drug interventionssupportive_careNot Availableunknown_status
NCT06405009
Prediction Model of Occult Omental Metastasis in Patients With Gastric CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT00017056
BMS-247550 in Treating Patients With Recurrent Metastatic Stomach Cancer That Has Been Previously Treated With Chemotherapytreatment2completed
NCT00985556
Oxaliplatin and S-1 or Oxaliplatin and Capecitabine in Treating Patients With Recurrent, Metastatic, or Unresectable Gastric Cancertreatment2unknown_status
NCT01341756
Palliative Radiotherapy for Symptomatic Locally Advanced Gastric Cancer: A Phase II TrialNo drug interventionstreatment2unknown_status
NCT03480256
Study to Evaluate SHR6390 Combined With Pyrotinib in Patients With HER2 Positive Gastric Cancertreatment1unknown_status
NCT00486356
Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancertreatment1completed
NCT04235556
Integrated Care Pathway in Oncology (PASSION)No drug interventionsNot AvailableNot Availableunknown_status
NCT02596256
Apatinib Plus Docetaxel Versus Docetaxel as Second-line Treatment in Advanced Gastric Cancer (AHEAD-301)treatment2unknown_status
NCT03740256
Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid TumorsNo drug interventionstreatment1recruiting
NCT01471756
Improving Complete Endoscopic Mucosal Resection (EMR) of Colorectal NeoplasiaNo drug interventionstreatment4completed
NCT02347956
The Safety and Feasibility of Reduced Port Robotic Distal Gastrectomy Using Single-site for Surgical Treatment of Early Gastric CancerNo drug interventionstreatment1 / 2completed
NCT00005956
Biological Therapy in Treating Patients With Advanced CancerNo drug interventionstreatmentNot Availablecompleted
NCT04840056
Prediction of Gastric Cancer in Intestinal Metaplasia and Atrophic GastritisNo drug interventionsNot AvailableNot Availablerecruiting
NCT00677456
Evaluation of Four Reconstructions After Total GastrectomyNo drug interventionsprevention1unknown_status
NCT02120885
An Effect of an Individualized Physical Activity Intervention for Gastric Cancer Patient Undergoing Minimally Invasive Gastrectomy: a Phase III, Prospective Randomized Controlled TrialNo drug interventionssupportive_care3completed
NCT05899985
Magnetic Sentinel Lymph Node Mapping in Upper Gastro-Intestinal Cancer: A Feasibility Clinical InvestigationNo drug interventionstreatmentNot Availablerecruiting
NCT06201585
Exploratory Study of Single-port Robot-assisted GastrectomyNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT05608785
Single-center, Multi-cohort Exploratory Phase Ib/II Clinical Study of First-line Treatment of Unresectable Locally Advanced/Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Based on Different Genotypestreatment1 / 2not_yet_recruiting
NCT00525785
Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and Gastroesophageal Junction (GEJ)treatment2completed
NCT03253185
A Study of SC-007 in Subjects With Advanced CancerNo drug interventionstreatment1terminated
NCT01099085
Trial of XP (Capecitabine/CDDP) Simvastatin in Advanced Gastric Cancer Patientstreatment3completed
NCT04149015
Neoadjuvant POF in the Treatment of Locally Advanced Gastric Cancertreatment2unknown_status
NCT04843215
A Phase III Study Comparing Total and Partial Omentectomy for Patients With Advanced Gastric CancerNo drug interventionstreatmentNot Availablerecruiting
NCT00310115
Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During PregnancyNo drug interventionsNot AvailableNot Availablecompleted
NCT00849615
Prospective Study With FLOT in Patients With Locally Advanced, Limited Metastatic or Extensive Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junctiontreatment2completed
NCT06105515
Laparoscopic and Endoscopic Collaborative Surgery as Rescue-treatment for Advanced Gastric CancerNo drug interventionstreatmentNot Availablerecruiting
NCT01848015
Circulating Tumor Cells (CTCs) in Advanced Gastric CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT00489515
Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or GallbladderNo drug interventionsNot AvailableNot Availablecompleted
NCT05400915
Two-Part, Phase Ib/II, Open Label, Single-Arm, Multi-center Study to Evaluate the Safety and Efficacy of Varlitinib in Combination With Weekly Paclitaxel in EGFR/HER2 Co-expressing Advanced or Metastatic Gastric Cancer Patientstreatment1 / 2completed
NCT02464215
Effect of Laparoscopy-Assisted Distal Gastrectomy for Locally Advanced Gastric CancerNo drug interventionstreatmentNot Availableunknown_status
NCT04308837
A Phase II Trial of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Chemoradiationtreatment2recruiting
NCT02215837
Study of Autologous Tumor Lysate-pulsed D-CIK Combined With Chemotherapy for Gastric CancerNo drug interventionstreatment2unknown_status
NCT04997837
Study of Adjuvant Chemotherapy With or Without PD-1 Inhibitors and Chemoradiotherapy in Resected pN3 Gastric (G) or GEJ Adenocarcinomatreatment3recruiting
NCT06028737
Total Neoadjuvant Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancertreatment2 / 3recruiting
NCT00003137
Irinotecan in Treating Patients With Advanced Cancer of the Stomachtreatment2completed
NCT06123637
Analgesia Nociception Index-guided Anesthesia and Standard AnesthesiaNo drug interventionspreventionNot Availablenot_yet_recruiting
NCT03787537
Nutritional Status and Nutrient Supply in Hospitalised Surgical PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT03575637
Olanzapine Improves the Chemotherapy Tolerance of Advanced Gastric Cancertreatment2unknown_status
NCT00017537
Vaccine Therapy in Treating Patients With Metastatic or Recurrent CancerNo drug interventionstreatment1withdrawn
NCT03342937
KeyLargo: Pembrolizumab + Oxaliplatin + Capecitabine in Gastric Cancertreatment2completed
NCT03958032
Effects of Sarcopenia on Early Postoperative Outcomes in Patients Undergoing Surgical Treatment for Gastric CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00072332
Edotecarin and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumorstreatment1completed
NCT02450032
Study to Determine the Antibody Response to 500µg G17DT in Treatment of Patients With Gastric Cancertreatment2completed
NCT04923932
Savolitinib for Treating Gastric Cancer and Esophagogastric Junction Adenocarcinoma Patientstreatment2recruiting
NCT04219332
Randomized Controlled Trial on Effect of Lymph Node Mapping by Indocyanine Green Via Submucosal or Subserosal Injectiontreatment3active_not_recruiting
NCT05715632
New Adjuvant Treatment of Locally Advanced Resectable Gastric Cancer With Carelizumab and XELOXNo drug interventionstreatmentNot Availablerecruiting
NCT04545632
Docetaxel Ethanol-induced Symptoms; The Incidence and Risk Forecating FactorNo drug interventionsNot AvailableNot Availablecompleted
NCT04999332
Perioperative Leucovorin, Oxaliplatin, Docetaxel and S-1 (LOTS) For Locally Advanced Gastric or Gastroesophageal Junction Cancertreatment2recruiting
NCT01917552
Adjuvant Capecitabine Versus Observation Alone in Curatively Resected Stage IB Gastric Cancer((KCSG ST14-05): CATALYSIStreatment3recruiting
NCT02736552
Compare S-1 for 6 Months to 1 Year as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancer Staged II , IIIA or IIIB.No drug interventionstreatment3withdrawn
NCT05470452
Validating the Safety and Effectiveness of ENDOANGEL Upper Gastrointestinal Endoscope Image Auxiliary Diagnostic SoftwareNo drug interventionsdiagnosticNot Availableunknown_status
NCT01224652
Efficacy Study of Paclitaxel Versus Irinotecan in Patients With Recurrent or Metastatic Gastric Cancer Who Progress Following First-line Therapytreatment3unknown_status
NCT03025152
Efficacy and Safety of Hou Gu Mi Xi in Patients With Spleen Qi Deficiency and Radical Gastrectomy for Gastric CancerNo drug interventionstreatmentNot Availableterminated
NCT03051152
D1 Versus D2 Lymphadenectomy in High Risk Elderly With Gastric AdenocarcinomaNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT06128252
Clinical Study of Taurine Combined With Neoadjuvant Chemo-Immunotherapy for Treatment of Locally Advanced Gastric CancertreatmentNot Availablerecruiting
NCT01961752
The Efficacy of Topical Bupivacaine and Triamcinolone Acetonide Injection in the Relief of Pain After Endoscopic Submucosal Dissection for Gastric Neoplasia: A Randomized Double-blind, Placebo-controlled TrialtreatmentNot Availablecompleted
NCT00681252
Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Gastric CancerNo drug interventionstreatment1 / 2completed
NCT06500052
A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Lower Expression Gastrointestinal Cancer and Other Solid TumorsNo drug interventionstreatment1recruiting
NCT05385900
Immune Combined Targeted and Chemotherapy in Perioperative Treatment of Locally Advanced Gastric CancertreatmentNot Availableunknown_status
NCT03221400
PEN-866 in Patients With Advanced Solid Malignanciestreatment1 / 2unknown_status
NCT06384300
Financial Incentives and Motivational Intervention to Improve Gastric Cancer Screening in ChinaNo drug interventionshealth_services_researchNot Availablenot_yet_recruiting
NCT04136600
EGFR Monoclonal Antibody for Advanced Gastric CancerNo drug interventionstreatment2unknown_status
NCT02078700
Feasibility of an Early Palliative Care Intervention for Metastatic Cancer Patients. A Phase 2 Study.No drug interventionssupportive_care2completed
NCT05266300
Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines.No drug interventionsNot AvailableNot Availablecompleted
NCT06431100
a Single-arm, Single-center, Open Clinical StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT02276300
HER2-Peptide Vaccination of Patients With Solid Tumorstreatment1completed
NCT03382600
Safety and Efficacy of Pembrolizumab (MK-3475) in Combination With TS-1+Cisplatin or TS-1+Oxaliplatin as First Line Chemotherapy in Gastric Cancer (MK-3475-659/KEYNOTE-659)treatment2completed
NCT06102759
Adebrelimab and Fruquintinib Combined With Paclitaxel/Albumin Paclitaxel for Advanced Gastric Cancer After PD-1 Antibody FailedNot AvailableNot Availablerecruiting
NCT04801459
Study on the Peristaltic Direction of GI Anastomosis in Roux-en-Y ReconstructionNo drug interventionstreatmentNot Availableunknown_status
NCT04632459
Pembrolizumab Plus Ramucirumab in Metastatic Gastric Cancertreatment2unknown_status
NCT06383559
Safety and Efficacy of XELOX Combined With Sintilimab and Lenvatinib in Advanced AFP-positive Gastric Cancer Patientstreatment2recruiting
NCT05438459
GAIA-102 Intraperitoneal Administration in Patients With Advanced Gastrointestinal Cancer of Microsatellite Stable With Malignant AscitesNo drug interventionstreatment1 / 2recruiting
NCT01528059
Roux-en-Y Versus Billroth II Reconstruction After Subtotal Gastrectomy in Gastric Cancer Comorbid With Type II DiabetesNo drug interventionstreatment2 / 3unknown_status
NCT05420259
Combined Exercise and Nutritional Intervention in GI Cancer PatientsNo drug interventionsotherNot Availablerecruiting
NCT02283359
Selinexor in Combination With Irinotecan in Adenocarcinoma of Stomach and Distal Esophagustreatment1terminated
NCT01824459
S-1+Oxaliplatin vs.S-1+Cisplatin First-line Treatment of Advanced or Recurrent Non-intestinal Type Gastric Adenocarcinoma Patientstreatment3completed
NCT00335959
S0425 Oxaliplatin, Capecitabine, and RT in Treating Patients W/Stomach Cancer That Can Be Removed By Surgerytreatment2terminated
NCT05113459
Disitamab Vedotin Combined With PD-1 and Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer(RC48-C018)treatment2unknown_status
NCT06250075
Effects of the Use of Probiotics on the Intestinal Microbiota of Patients With Gastric CancerNo drug interventionstreatmentNot Availablecompleted
NCT05722275
Prediction of Peritoneal Metastasis for Gastric Cancer Based on RadiomicsNo drug interventionsNot AvailableNot Availablerecruiting
NCT03015675
IV Ascorbic Acid in Advanced Gastric Cancertreatment3unknown_status
NCT01178775
Development and Validation of Perceived Fatigue Meaning Scale on Walking ProgramNo drug interventionssupportive_careNot Availableunknown_status
NCT01971775
Clinical Study for Energy Based Devices in Open Gastrectomy for Gastric CancerNo drug interventionstreatment3completed
NCT05886075
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid TumorsNo drug interventionstreatment0recruiting
NCT05715775
Learning Curve and Optimization of Robotic GastrectomyNo drug interventionsNot AvailableNot Availablecompleted
NCT06362070
Comparison of Outcomes of Multiple Platforms for Assisted Robotic - GastrectomyNo drug interventionstreatmentNot Availablerecruiting
NCT03061370
Sarcopenia and Visceral Obesity in Esophageal and Gastric CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00150670
Randomized Phase III Study of TS-1 Alone Versus TS-1 Plus CDDP in Advanced Gastric Cancertreatment3completed
NCT00010270
LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal CancerNo drug interventionstreatment1unknown_status
NCT02784470
Study of Gastroduodenal Metallic Stent vs GastrojejunostomyNo drug interventionstreatment3unknown_status
NCT03745170
Efficacy and Safety Evaluation of Sintilimab or Placebo in Combination With XELOX as First Line Treatment in Patients With Gastric Cancertreatment3completed
NCT04613570
SUrveillance of PREMalignant Stomach - Individualized Endoscopic Follow-upNo drug interventionspreventionNot Availablerecruiting
NCT05030870
Capnographic Monitoring in Gastrointestinal Endoscopy for Elderly PatientsNo drug interventionspreventionNot Availablecompleted
NCT01470742
Trial Comparing Capecitabine Plus Oxaliplatin (XELOX) and Capecitabine (X) as First-line Chemotherapy in Elderly Patients With Advanced Gastric Cancertreatment3withdrawn
NCT05633342
Project CADENCE (CAncer Detected Early caN be CurEd)No drug interventionsNot AvailableNot Availablerecruiting
NCT03952442
Nutrition Education Program for Postoperative Patients With Gastric CancerNo drug interventionssupportive_careNot Availableunknown_status
NCT03721042
Demonstrating the Diagnostic Power of an Electronic Nose: Study on Exhaled Air SamplesNo drug interventionsdiagnosticNot Availableterminated
NCT06522542
Gastric Cancer Complicated With BleedingNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT02726399
Phase II Study of Ramucirumab With Chemotherapy in Patients With Metastatic Gastroesophageal Junction and Gastric Cancertreatment2terminated
NCT05871099
Laparoscopic Gastrectomy With D2 Lymphadenectomy Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or NotNo drug interventionsprevention3recruiting
NCT05982899
A Web-based Calculator Predicts Heterogeneous Frailty TrajectoriesNo drug interventionsNot AvailableNot Availablecompleted
NCT05241899
A Phase II Clinical Study of Fruquintinib Combined With RC48 in the Treatment of Previously Treated HER2-positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (G/GEJ) Cancertreatment2not_yet_recruiting
NCT05301699
Development and Validation of a Web-based Nomorgam to Predict Postoperative ComplicationsNo drug interventionsNot AvailableNot Availablecompleted
NCT02704299
The Study of Surgery,Chemotherapy and Autologous T Cells-Based Immunotherapy for Advanced Gastric Cancer.No drug interventionstreatment0unknown_status
NCT00004099
Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancertreatment3terminated
NCT02012699
Integrated Cancer Repository for Cancer ResearchNo drug interventionsNot AvailableNot Availablerecruiting
NCT04943406
Peritoneal Lavage Liquid Biopsy in Patients With Gastric CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT03188406
Gastric Cancer Precursor Lesions (GCPL) StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT06126406
Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes(CAR-T) for CEA Positive Advanced Malignant Solid TumorsNo drug interventionstreatment1recruiting
NCT01582906
A Survivorship Care Plan for Gynaecological Cancer PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT01671449
S-1 and Cisplatin (3 Weekly) Versus S-1 and Oxaliplatin Combination Chemotherapy for Advanced Gastric Cancertreatment3completed
NCT01979549
Adverse Events During Upper Gastrointestinal EndoscopyNo drug interventionsNot AvailableNot Availableunknown_status
NCT01167049
Xeloda Plus Paclitaxel in Gastric Cancer With Liver Metastasistreatment2unknown_status
NCT05203549
Consistency Between Treatment Responses in PDO Models and Clinical Outcomes in Gastric CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT01719549
Dovitinib for Gastric Cancer With FGFR2 Amplification: GASDOVI-1treatment2completed
NCT06075849
Phase I Study to Evaluate Safety and Anti-tumor Activity of PB101, an Anti-angiogenic Immunomodulating AgentNo drug interventionstreatment1recruiting
NCT01956149
Study With Cabazitaxel in Previously Treated Patients With Advanced or Metastatic Gastric Cancertreatment2completed
NCT05975749
Adjuvant Serplulimab and Trastuzuma and Chemotherapy in Her-2+ Gastric Cancertreatment2recruiting
NCT03314649
Peritoneal Lavage for Early Detecting Gene Mutation of Peritoneal Metastasis of Gastric CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT02521649
Dose-ranging Study to Evaluate Antibody Response to G17DT in Patients With Gastric Cancertreatment2completed
NCT00982449
124I-FIAU Imaging in EBV and KSHV Associated CancersNo drug interventionsbasic_scienceNot Availablecompleted
NCT04744649
Neoadjuvant Immunotherapy and Chemotherapy for Locally Advanced Esophagogastric Junction and Gastric Cancer Trialtreatment2recruiting
NCT03478449
The Criteria for Lymph Node Sorting for Pathological Examination in Gastric CancerNo drug interventionsdiagnosticNot Availableunknown_status
NCT02954536
Phase II Trial of Pembrolizumab With Trastuzumab and Chemotherapy in Advanced HER2 Positive Esophagogastric (EG) Cancertreatment2completed
NCT05233436
PF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid Tumorstreatment1terminated
NCT06447636
Perioperative Surufatinib Plus Sintilimab Combined With Chemotherapy in Gastric/Gastroesophageal Junction Adenocarcinomatreatment2not_yet_recruiting
NCT00454636
A Study of Xeloda (Capecitabine) in Combination With Chemotherapy in Patients With Advanced and/or Metastatic Gastric Cancer.treatment2completed
NCT05368636
Combining Tongue and Gastric Cancer Cascade With Artificial IntelligenceNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT00137813
Avastin and Taxotere for Esophagogastric Cancertreatment2completed
NCT03044613
Nivolumab +/- Relatlimab Prior to Chemoradiation With II/III Gastro/Esophageal Cancertreatment1active_not_recruiting
NCT01938313
Early Recovery After Surgery (ERAS) Versus Conventional Protocol After Laparoscopic GastrectomyNo drug interventionstreatment2completed
NCT06405113
FMT+SOX+Sintilimab as First-line Treatment for Advanced Gastric Cancertreatment2not_yet_recruiting
NCT02252913
A Study of Safety and Pharmacokinetics of Volitinib With Docetaxel in Patients With Advanced Gastric CancerNot Available1completed
NCT04908813
Study of HLX22 in Combanition With Trastuzumab and Chemotherapy Versus Placebo in Combination With Trastuzumab and Chemotherapy for Treatment of Locally Advanced or Metastatic Gastric Cancertreatment2active_not_recruiting
NCT04234113
Study of SO-C101 and SO-C101 in Combination With Pembro in Adult Patients With Advanced/Metastatic Solid Tumorstreatment1active_not_recruiting
NCT03092518
Heated Intraperitoneal Chemotherapy and Gastrectomy for Gastric Cancer With Positive Peritoneal Cytologytreatment2completed
NCT02610218
Liquid Biopsy in Monitoring the Therapeutic Efficacy of Targeted Therapy in Advanced/Metastatic Gastric CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT01464918
Safety and Efficacy of Using MASTER to Perform Endoscopic Submucosal Dissection in HumanNo drug interventionstreatmentNot Availableunknown_status
NCT05723718
MalnutritiOn Assessment With biOelectrical impedaNce Analysis in gastRic Cancer patIentS Undergoing Multimodal trEatmentNo drug interventionsNot AvailableNot Availablerecruiting
NCT04600518
Single Patient Classifier (SPC) Prediction for Stage II and III Advanced Gastric CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT02436018
WEI NASAL JET for The Sedation of Outpatient Upper Gastrointestinal EndoscopyNo drug interventionspreventionNot Availableunknown_status
NCT03668418
Xenotransplantation of Primary Cancer Samples in Zebrafish EmbryosNot AvailableNot Availableunknown_status
NCT02338518
Comparison of SEEOX and SOX Regimens in Stage ⅢB/ⅢC Gastric Cancer Patientstreatment3active_not_recruiting
NCT04768218
BLI for the Diagnosis of Precancerous ConditionsNo drug interventionsNot AvailableNot Availablecompleted
NCT05683418
A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With Select Solid TumorsNo drug interventionstreatment1recruiting
NCT05311618
Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumorstreatment1active_not_recruiting
NCT06090318
Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A Losstreatment1 / 2withdrawn
NCT01590719
A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2) Negative Gastroesophageal Cancertreatment2completed
NCT00606619
Effects of Early Oral Feeding After Resection of Gastric CancerNo drug interventionstreatment3completed
NCT06213519
HIPEC Combined With SOX and Sintilimab in the Treatment of Advanced Gastric Cancer With Peritoneal Metastasistreatment2not_yet_recruiting
NCT01924819
Trial of Preoperative Therapy for Gastric and Esophagogastric Junction Adenocarcinomatreatment2 / 3active_not_recruiting
NCT02248519
Laparoscopic Versus Open Gastrectomy for Gastric CancerNo drug interventionstreatmentNot Availableunknown_status
NCT01621919
Concentration of S-1 Metabolites in Tear and Plasma of Patients Receiving TS-1No drug interventionsNot AvailableNot Availableunknown_status
NCT05642819
REVOLUTION Surgery (REVOLUTION Surgery)No drug interventionsNot AvailableNot Availablerecruiting
NCT05693519
GastroIntestinal Cancer in Children and AdolescentsNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT06395519
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid MalignanciesNo drug interventionstreatment1recruiting
NCT05928819
Evaluation of a Computer-aided Diagnosis System (CADx) in the Early Detection of Gastric Cancer in France. Cancer in France.No drug interventionsNot AvailableNot Availablerecruiting
NCT01627119
The Functional and Clinicopathological Roles and Therapeutic Implication of Connective Tissue Growth Factor in Peritoneal Metastasis of Gastric CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT06521541
Whole Course Multi-model Prehabilitation to Improve Clinical Outcome in Patients Undergoing Neoadjuvant Treatment Prior to GastrectomyNo drug interventionstreatmentNot Availablerecruiting
NCT05647941
Neo-adjuvant Chemotherapy Evluation in Gastric Cancer Patients Based on Circulating Exosomal LncRNA-GC1No drug interventionsNot AvailableNot Availablerecruiting
NCT02648841
A Randomized Phase III Study of Adjuvant Chemotherapy With or Without Chemo-radiotherapy in Patients With Local Advanced Gastric Cancer After D2 Resection.No drug interventionstreatment3unknown_status
NCT02209441
Phase I Study of Sorafinib With Folfox4 as First-line Treatment in Advanced/Metastatic Gastric CancerNot AvailableNot Availableavailable
NCT04099641
An Open Label Study of Bavituximab and Pembrolizumab in Advanced Gastric and GEJ Cancer Patientstreatment2completed
NCT05687617
Near-infrared Imaging With Indocyanine Green for Detection of Peritoneal Metastases for Gastric Adenocarcinoma.diagnostic2terminated
NCT06384417
Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning: Phase 2No drug interventionssupportive_careNot Availablerecruiting
NCT04487717
Prospective Assessment of nProfiler® 1 on Prognosis and Chemotherapy Response for Gastric CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT02024217
Neoadjuvant Chemotherapy Plus Chemoradiation in Patients With Potentially Resectable Gastric CarcinomaNo drug interventionstreatment2unknown_status
NCT05369117
Application of Indocyanine Green Labeled Fluorescent Laparoscopy in Proximal Gastric CancerNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT02140034
Extensive Peritoneal Lavage After Curative Gastrectomy for Gastric Cancer: A Randomised Controlled TrialNo drug interventionspreventionNot Availableunknown_status
NCT02485834
FDG-PET Directed Treatment in Improving Response in Patients With Locally Advanced Stomach or Gastroesophageal Junction Cancertreatment2terminated
NCT00023634
S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancertreatment1terminated
NCT04593134
Effectiveness of Exercise Program in Improving Quality of Life in Patients With Gastric Cancer Undergoing GastrectomyNo drug interventionssupportive_careNot Availablerecruiting
NCT03654534
Oral Nutritional Supplements Compared With Standard Diet in Postoperative Gastric Cancer Patients With Adjuvant ChemotherapyNo drug interventionstreatment3unknown_status
NCT06028724
A Study on the Prevalence of Clinically Useful Mutations in Solid Tumor Characterized by Next Generation Sequencing Methods on Liquid Biopsy Analysis (POPCORN)No drug interventionsNot AvailableNot Availablerecruiting
NCT05894824
An Open Label, Single-arm, Multicenter Phase Ib/II Study to Evaluate the Safety and Efficacy of T-Dxd in Combination With Ramucirumab as a 2nd Line in Patients With HER2 Low Gastric or Gastroesophageal Junction (GEJ) Adenocarcinomatreatment1 / 2not_yet_recruiting
NCT04401124
Status of Management of Surgery in Beijing During COVID-19No drug interventionsNot AvailableNot Availableunknown_status
NCT00354224
Capecitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Stomach Cancertreatment2terminated
NCT03032224
Analysis of Body Composition in Relation to Outcome After Surgery in a Cohort of Patients With Esophageal CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT02074124
CT Perfusion Changes in GI Cancer During Adenosine Vasodilation TestNo drug interventionsNot AvailableNot Availablecompleted
NCT03175224
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumorstreatment2recruiting
NCT06421324
Personalised Health Recommendations to the General Population Through an Integrated AI GuidedNo drug interventionspreventionNot Availablenot_yet_recruiting
NCT05252416
(VELA) Study of BLU-222 in Advanced Solid Tumorstreatment1 / 2recruiting
NCT04385316
Clinical Study of Gastric Cancer, Colorectal Cancer and Bladder Cancer Based on Liquid BiopsyNo drug interventionsNot AvailableNot Availableunknown_status
NCT06202716
Cadonilimab Plus CapeOX as First-Line Treatment for Advanced GC/GEJC With High TMEscoretreatment2not_yet_recruiting
NCT04842916
InteGRAtive Analysis of tuMor, Microenvironment, immunitY and Patient Expectation for Personalized Response Prediction in Gastric CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT00733616
Efficacy and Safety Study of Combination Therapy With Docetaxel-oxaliplatin-capecitabine in Patients With Advanced Gastric Adenocarcinoma and Intermediate General Statustreatment2completed
NCT03079596
ERAS (Early Recovery After Surgery) Protocol After Laparoscopic Total Gastrectomy and Proximal GastrectomyNo drug interventionstreatmentNot Availableunknown_status
NCT06551896
Pemigatinib and Immune Checkpoint Inhibitor Treated FGFR1/2/3 Alteration Advanced Solid Tumortreatment2not_yet_recruiting
NCT06157996
Lenvatinib Plus Tislelizumab and CapeOX as First-Line Treatment for Advanced GC/GEJC With Positive PD-L1 and Low TMEscoretreatment2recruiting
NCT04292496
Anastomotic Leak Testing in GastrectomyNo drug interventionspreventionNot Availablecompleted
NCT02852096
Assessing Her2/Neu Expression in Gastric Cancer With Dual or Multiple Tumor Tissue Paraffin BlocksNo drug interventionsdiagnosticNot Availableunknown_status
NCT03485196
The Relationship Between Microsatellite Instability and Efficacy of Fluorouracil Based Adjuvant Chemotherapy in Gastric Cancer After OperationNo drug interventionsNot AvailableNot Availablecompleted
NCT00903396
Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancersupportive_care2terminated
NCT04379596
Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03)treatment2recruiting
NCT04208958
Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancertreatment1 / 2completed
NCT03425058
Molecular Evaluation of Neoadjuvant Chemotherapy for Locally Advanced Gastric CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT05514158
To Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Disitamab Vedotin Combined With RC98 in the Treatment of Subjects With HER2-expressing Locally Advanced or Metastatic Gastric Cancer (Including AEG)treatment1recruiting
NCT04576858
Clinical Utility of Circulating Tumor DNA in Gastro-Esophageal CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT03098758
Molecular Analysis in Peritoneal Washing Citology for Locally Advanced Gastric CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT06578858
Immunonutrition and Psychosocial Factors in the Recovery of Patients After Gastrectomy: a Multidimensional AnalysisNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT04660058
Associations Among Serum and Gastric Juice Bile Acid Profile, Bile Acid-microbiota Cross-talk in Stomach and the Development of Gastric CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT05934058
Genomic and Dietary Aspects in Gastric Cancer RiskNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT00678535
Erbitux in Combination With Xeloda and Cisplatin in Advanced Esophago-gastric Cancertreatment3completed
NCT04232735
Evidence Based Information Provision to Improve Decision Making After Oesophagogastric Cancer Diagnosis (SOURCE)No drug interventionsotherNot Availablerecruiting
NCT06395935
Wecare Study in Gastric Cancer SurvivorsNo drug interventionssupportive_careNot Availablerecruiting
NCT06454435
Conversion Therapy of Sintilimab in Combination With Fruquintinib and Chemotherapy Versus Sintilimab and Chemotherpay in Stage IV Gastric Cancertreatment2not_yet_recruiting
NCT00004235
Docetaxel and Irinotecan in Treating Patients With Advanced Cancer of the Esophagus or Stomachtreatment2completed
NCT05068635
Evaluation of the Efficacy of Distal Gastrectomy for the Treatment of Gastric Cancer (a Case Series)No drug interventionsNot AvailableNot Availablecompleted
NCT02988635
Early Palliative Care on Quality of Life of Advanced Cancer PatientsNo drug interventionssupportive_care3completed
NCT04529135
The Effect of Dexmedetomidine During Opioid Free Anesthesia on Postoperative Recovery After GastrectomytreatmentNot Availablecompleted
NCT04139135
A Clinical Study of HLX10 Combined With Chemotherapy Versus Placebo Combined With Chemotherapy for Neoadjuvant/Adjuvant Treatment of Gastric Cancertreatment3recruiting
NCT04434963
Safety and Feasibility of Reversible Induction StrategyNo drug interventionsNot AvailableNot Availableunknown_status
NCT03835663
The Bacterial Composition of the Stomach in Reflux DiseaseNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00629863
Endoscopic Ultrasound in Diagnosing Cancer in Patients With Localized Stomach Cancer or Esophageal CancerdiagnosticNot Availablecompleted
NCT06472063
Upfront Surgery Versus NeoAdjuvant Chemotherapy Followed by Surgery for Resectable Advanced Gastric Cancer: SNAC StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT06046963
Sintilimab in Combination With S-1/Oxaliplatin With Nab-paclitaxel Intraperitoneal Infusion for Untreated Advanced Gastric Cancer With Malignant Ascitestreatment2recruiting
NCT06550063
HER2 Status in Esophagogastric Adenocarcinoma and Its Associations With Patient's Clinicopathological OutcomesNo drug interventionsNot AvailableNot Availablerecruiting
NCT05494086
Dual-Port Laparoscopic Distal Gastrectomy for Gastric CancerNo drug interventionstreatmentNot Availablerecruiting
NCT01366586
Confocal Laser Endomicroscopy for in Vivo Molecular Imaging of Gastric Cancer by Targeting MG7-AgNo drug interventionsNot AvailableNot Availablecompleted
NCT04652986
Outcomes of Laparoscopic GastrectomyNo drug interventionsNot AvailableNot Availableunknown_status
NCT04088786
Phase I Trial HIPEC With Nal-irinotecantreatment1completed
NCT04526886
Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX ChemotherapyNo drug interventionstreatmentNot Availablecompleted
NCT01774786
A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastroesophageal Junction or Gastric Cancertreatment3completed
NCT01913639
FOLFOX Plus Regorafenib in Patients With Unresectable or Metastatic Esophagogastric Cancertreatment2completed
NCT05344339
Billroth-II Modified Versus Roux-en-Y After Distal Gastrectomy for Gastric CancerNo drug interventionstreatmentNot Availablerecruiting
NCT03976739
Study on the Effect of Bile Reflux on Gastric Cancer and Its Precancerous Lesions: a Cross-sectional Study.No drug interventionsNot AvailableNot Availablecompleted
NCT01787539
The Role of Postoperative Cycles in the Perioperative Chemotherapy for Gastric CancerNo drug interventionstreatment2 / 3unknown_status
NCT03733639
Tisseel® as a Reinforcement of Esophagojejunal Anastomosesprevention4unknown_status
NCT05632939
ASKB589 in Combination With CAPOX and Sintilimab in Patients With Advanced, and Unresectable G/GEJ Cancer.No drug interventionstreatment1 / 2recruiting
NCT04249739
Pembrolizumab + Capecitabine/Oxaliplatin (CapeOx) -HER2 Nagative and Pembrolizumab + Trastuzumab + Cisplatin/Capecitabine HER2 Positivetreatment2active_not_recruiting
NCT04982939
Peri-operative Sintilimab in Combination With SOX in Locally Advanced Gastric Cancertreatment2unknown_status
NCT05219539
Questionnaire Survey of the Advanced Training Program for Laparoscopic Radical GastrectomyNo drug interventionsNot AvailableNot Availablecompleted
NCT04603339
ReStOre@Home: Feasibility Study of a 12-week Multidisciplinary Telehealth Rehabilitation Programme for Survivors of Upper Gastrointestinal (UGI) CancerNo drug interventionstreatmentNot Availablecompleted
NCT02008422
Clinical Study of Endostar Injection Concomitant With SOX Protocols to Treat Advanced Gastric Cancertreatment3unknown_status
NCT05605522
A Study of [225Ac]-FPI-2059 in Adult Participants With Solid TumoursNo drug interventionstreatment1recruiting
NCT03511222
Vorolanib (X-82) Combined With Checkpoint Inhibitors in Patients With Solid Tumorstreatment1terminated
NCT00002722
High-Dose Chemotherapy in Treating Patients With Advanced Stomach Cancertreatment2completed
NCT03694522
A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancertreatment2completed
NCT03539822
Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignanciestreatment1 / 2active_not_recruiting
NCT01614522
A Clinical Trial Evaluating the Effect of ASLAN001 in Patients With Recurrent/Metastatic Gastric Cancer Whose Tumors Are Either HER-2 Amplified or Co-expressing HER-1 and HER-2basic_science2completed
NCT03132922
MAGE-A4ᶜ¹º³²T for Multi-TumorNo drug interventionstreatment1active_not_recruiting
NCT02102022
Ph 1-2 Study ADI-PEG 20 Plus FOLFOX in Subjects With Advanced GI Malignancies Focusing on Hepatocellular Carcinomatreatment1 / 2terminated
NCT04000425
Potential Clinical Utilities of Circulating Tumor DNA in Gastric CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT05453825
A Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid Tumorstreatment2recruiting
NCT03428425
A Study of HIPEC Plus Apatinib and S-1 Conversion Therapy for Gastric Cancer With Positive Exfoliative Cancer Cellstreatment2unknown_status
NCT04367025
Efficacy and Safety of Perioperative Chemotherapy Plus PD-1 Antibody in Gastric Cancertreatment2unknown_status
NCT06093425
Combination of TST001, Nivolumab and Chemotherapy as First-line Therapy in Advanced or Metastatic GC/GEJ Adenocarcinomatreatment3not_yet_recruiting
NCT06227325
Disitamab Vedotin Combined With Sintilimab and XELOX Perioperative Treatment for Resectable Gastric Caner With HER2 Overexpressiontreatment2not_yet_recruiting
NCT05850130
Acupuncture for Oxaliplatin-induced Peripheral Neuropathy in Gastro-intestinal Cancer PatientsNo drug interventionssupportive_careNot Availablerecruiting
NCT05205330
CR6086/AGEN2034 Combination in Stage IV pMMR - MSS CRC, and Other Metastatic GI Cancerstreatment1 / 2recruiting
NCT05253430
D1 vs D2 Lymphadenectomy in Gastric CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00323830
Phase III Randomized Trial of Adjuvant XP Chemotherapy and XP/RT for Resected Gastric Adenocarcinomatreatment3completed
NCT02425930
The Predictive Value of Complement C3 in Patients With Advanced Gastric CancerNot AvailableNot Availablecompleted
NCT04637048
Observational Study on Patients With Hepatobiliary TumorsNo drug interventionsNot AvailableNot Availableunknown_status
NCT02563548
A Study of PEGylated Recombinant Human Hyaluronidase (PEGPH20) With Pembrolizumab in Participants With Selected Hyaluronan High Solid Tumorstreatment1completed
NCT05397548
Use of Circulating Exosomal LncRNA-GC1 to Monitor Gastric CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT01515748
Docetaxel+Oxaliplatin+S-1 (DOS) Regimen as Neoadjuvant Chemotherapy in Advanced Gastric Cancertreatment3completed
NCT00387348
Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancersupportive_care3terminated
NCT02393248
Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101)treatment1 / 2terminated
NCT01910948
Perioperative Application of Omega-3 Polyunsaturated Fatty Acids in Gastric Cancer Patientssupportive_care4unknown_status
NCT04517448
Quality of Life of Patients Over 75 Yars Undergoing Palliative ChemotherapyNo drug interventionsNot AvailableNot Availableunknown_status
NCT05274048
Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patientstreatment1recruiting
NCT06493448
Prospective Observational Cohort StudyNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT05652348
Response Prediction of Hyperthermic Intraperitoneal Chemotherapy in Gastro- Intestinal CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT02644148
Uncut Roux-en-Y Gastrojejunostomy for Early Gastric Cancer PatientsNo drug interventionstreatment2unknown_status
NCT04657848
Preliminary Efficacy Analysis of Cheng's Giraffe Reconstruction After Proximal GastrectomyNo drug interventionstreatmentNot Availableunknown_status
NCT06221748
DV Combined With Cadonilimab in Subjects With HER2-expressing Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on First-line Therapytreatment2 / 3recruiting
NCT03598348
Evaluate the Efficacy of Maintenance Treatment With Capecitabine Plus Apatinib in Advanced Gastric Cancertreatment3unknown_status
NCT03409848
Ipilimumab or FOLFOX in Combination With Nivolumab and Trastuzumab in HER2 Positive EsophagoGastric Adenocarcinomatreatment2completed
NCT03065257
Endoscopic Resection Multicenter RegistryNo drug interventionsNot AvailableNot Availableunknown_status
NCT05687357
Tislelizumab in Combination With Pre-operative CRT Versus SOC for Locally Advanced G/GEJ Adenocarcinomatreatment2recruiting
NCT00054457
Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal Junctiontreatment2completed
NCT02607826
Short-term Starvation vs. Normal Diet Before Chemotherapy of Solid TumorsNo drug interventionssupportive_careNot Availableunknown_status
NCT03398226
Bone Microstructure After Gastrectomy Evaluating by Using HR-pQCTNo drug interventionsNot AvailableNot Availableunknown_status
NCT05396326
A Pilot Study of Neoadjuvant TACiE in Locally Advanced Gastric Cancertreatment1not_yet_recruiting
NCT01718626
Study Comparing Sequential Therapy of S1+Docetaxel Followed by S1 to Concomitant S1+Docetaxel for Advanced Gastric Cancertreatment2unknown_status
NCT04817826
TremelImumab aNd Durvalumab For the Non-operatIve Management (NOM) of MSI-high Resectable GC/GEJC.treatment2recruiting
NCT05965466
The Incidence of Gallstones After GastrectomyNo drug interventionstreatmentNot Availablerecruiting
NCT00735566
Antiangiogenic Factors in Gastric CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT06337266
A Novel Online Calculator to Predict Long-term Survival and Recurrence Risk of Patients With Gastric AdenocarcinomaNo drug interventionsNot AvailableNot Availablecompleted
NCT01650766
Study of S1 Efficacy and Toxicity as Second-line Treatment on Inoperable or Advanced Gastric CancersNo drug interventionsNot AvailableNot Availableunknown_status
NCT04198766
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)treatment1 / 2recruiting
NCT01286766
Neoadjuvant Combination Chemotherapy of DCS (Cisplatin + Docetaxel + S-1) and DCF (Docetaxel + Cisplatin + 5-FU) in Patients With Locally Advanced Gastric Adenocarcinomatreatment2completed
NCT01180166
Combination of Nimotuzumab,Capecitabine and Radiotherapy for Inoperable or Recurrent Gastric Cancertreatment2unknown_status
NCT05498766
Effect and Safety of Huaier Granule Versus SOX Regimen in Gastric Cancer Patientstreatment4not_yet_recruiting
NCT03924466
Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma PatientsNo drug interventionsdiagnostic2recruiting
NCT04600466
Molecular and Epidemiological Risk Factors in the Development of Gastric CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT05751265
Tislelizumab Combined With Chemotherapy in the Cross-line Treatment of First-line Resistant Advanced Gastric Cancertreatment2not_yet_recruiting
NCT06076265
Quantitative Detection of CEA mRNA in the Smog and Tissue Exudate Whole Process Collected During Laparoscopic (Robotic) Radical Gastrectomy in Gastric Cancer PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT05181865
Phase 1/2a Study to Evaluate FL-301 in Patients With Advanced Solid Tumorstreatment1 / 2withdrawn
NCT00075465
Docetaxel and Epirubicin as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma of the Stomachtreatment2unknown_status
NCT04005365
Clinical Study of Propranolol Combined With Neoadjuvant Chemotherapy in Gastric Cancertreatment2unknown_status
NCT03472365
A Study of SHR-1210 in Combination With Capecitabine + Oxaliplatin or Apatinib in Treatment of Advanced Gastric Cancertreatment2completed
NCT05280665
Specialization in Gastric Cancer SurgeryNo drug interventionsNot AvailableNot Availablecompleted
NCT05229874
Effect of CNSI vs. ICG in Lymph Node Tracing During Gastrectomytreatment2active_not_recruiting
NCT05346874
Neoadjuvant TACiE in Locally Advanced Gastric Cancertreatment2not_yet_recruiting
NCT05860374
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid TumorsNo drug interventionstreatment0recruiting
NCT00019474
Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancertreatment2completed
NCT03486574
Research for Associated Genes for Gastric Cancer in Family Member With Affected First-Degree RelativesNo drug interventionsNot AvailableNot Availablecompleted
NCT04040374
Artificial Intelligence Versus Expert Endoscopists for Diagnosis of Gastric CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT02853474
Early Palliative Care in Patients With Metastatic Upper Gastrointestinal Cancers Treated With First-line ChemotherapyNo drug interventionssupportive_care3completed
NCT05215574
Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumorstreatment1recruiting
NCT04958720
Spanish Registry of Esophagogastric CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT04232020
A Retrospective Validations Microsatellite Instability (MSI) Testing v Mismatch Repair (MMR) in Gastric AdenocarcinomaNo drug interventionsNot AvailableNot Availablecompleted
NCT01863420
The Effect of Bone Marrow-sparing Intensity-Modulated Radiotherapy to GI CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT01836120
A Study of Raltitrexed Plus Docetaxel Versus Docetaxel as Second-line Chemotherapy in Subjects With Gastric Cancertreatment2unknown_status
NCT05775120
Epidemiology of Helicobacter Pylori Infection in MoscowNo drug interventionsNot AvailableNot Availablerecruiting
NCT04798820
The Effect of Intensive Dietary Education on Nutritional Status After Gastrectomy(SING)No drug interventionssupportive_careNot Availablerecruiting
NCT06421220
Evaluation of the Efficacy and Safety of Indocyanine Green Tracing in 3D Fluorescent Laparoscopic Lymph Node Dissection for Gastric CancerNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT00514020
Fluorouracil, Oxaliplatin, and Leucovorin in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancertreatment2completed
NCT05438420
Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid Tumorstreatment1 / 2recruiting
NCT03393182
Comparing the Quality of Life Between LADG and TLDG for Gastric Cancer_KLASS07 (CKLASS01)).No drug interventionstreatmentNot Availablecompleted
NCT06033482
The Possible Range of No.12a Lymph Node Dissection of Locally Advanced Gastric CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT06316882
Opportunistic Gastric Cancer ScreeningNo drug interventionsscreeningNot Availablerecruiting
NCT00448682
Combination Chemotherapy as First-Line Therapy in Treating Patients With Stage IV Gastric Cancer That Cannot Be Removed By Surgerytreatment2terminated
NCT05061082
Genomic Evolution of Metastasis in Gastric CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT02009631
A Study to Evaluate the Effects of Veliparib on Heart Rhythms in Patients With Solid Tumorsother1completed
NCT05052931
Nab-paclitaxel Combined With Oxaliplatin and S-1 for Perioperative Treatment of Advanced Gastric Cancertreatment2recruiting
NCT04973631
The Effects of Sex and Age Differences on Gastric Cancer : a Retrospective StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT03576131
GEN1029 (HexaBody®-DR5/DR5) Safety Trial in Patients With Malignant Solid TumorsNo drug interventionstreatment1 / 2terminated
NCT04631731
Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin ToxicityNo drug interventionsdiagnostic1 / 2recruiting
NCT00197431
Pharmacokinetic and Pharmacodynamic Study of S-1 in Patients With Digestive Organ Cancertreatment2unknown_status
NCT05804331
The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT02971631
Gastrectomy, Eating Behaviour and GLP-1No drug interventionsbasic_scienceNot Availablecompleted
NCT05934331
A LM-302 Combined With Toripalimab Phase II Studytreatment2recruiting
NCT06205173
Explored About Temperature Packing Care to Improve the Quality of Life for Chemotherapy Induced Peripheral Neuropathy (CIPN) in Colorectal Cancer and Gastric Cancer PatientNo drug interventionssupportive_careNot Availablecompleted
NCT06310473
Neoadjuvant Cadonilimab Plus Chemotherapy for Locally Advanced Esophagogastric Junction and Gastric Cancer Trialtreatment2not_yet_recruiting
NCT00737373
Oxaliplatin and 5-Fluorouracil With or Without Docetaxel in Elderly Patients (>65 y) With Stomach and Esophagus Cancertreatment2completed
NCT02089373
A Pilot Study on Usefulness of Probe-based Confocal Laser Endomicroscopy Targeted Gastric BiopsyNo drug interventionsdiagnosticNot Availablecompleted
NCT00004873
Combination Chemotherapy in Treating Patients With Advanced Stomach Cancertreatment2completed
NCT04677673
Neoadjuvant Chemotherapy Plus Surgery Versus Surgery First For Elderly Gastric Cancer PatientsNo drug interventionstreatment2 / 3not_yet_recruiting
NCT02458573
Comparison of the Effects of Continuous Epidural Analgesia and Continuous Intravenous Analgesia on Postoperative Bowel Movement in Patients Undergoing Laparoscopic GastrectomyNo drug interventionsother4completed
NCT01123473
Epirubicin Hydrochloride, Cisplatin, and Fluorouracil or Capecitabine With or Without Lapatinib Ditosylate as First-Line Therapy in Treating Patients With Stomach Cancer or Gastroesophageal Junction Cancertreatment2terminated
NCT02496273
Phase I Trial of CEA Specific AAV-DC-CTL Treatment in Stage IV Gastric CancerNo drug interventionstreatment1active_not_recruiting
NCT04069273
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinomatreatment2recruiting
NCT01748773
A Study of the Combination of Oxaliplatin, Capecitabine, and Trastuzumab With Chemoradiotherapy in the Adjuvant Setting in Operated Participants With Human Epidermal Growth Factor Receptor-2 Positive (HER2+) Gastric or Gastroesophageal Junction Cancertreatment2completed
NCT01921673
Dovitinib Plus Docetaxel in Gastric Cancertreatment1 / 2completed
NCT02674373
Prognostic and Predictive Impact of Circulating Tumor DNA in Gastric Cancer TreatmentNo drug interventionsNot AvailableNot Availableunknown_status
NCT01795027
Compare S-1 Plus Oxaliplatin to S-1 as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancertreatment3unknown_status
NCT00172627
Association and Mechanism Between Cyclooxygenase-2 and Interleukin-6 in Gastric CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT01678027
Gastric Cancer Prevention in the Family Members by Helicobacter Pylori Eradicationprevention3active_not_recruiting
NCT06342427
Stomach Cancer Exosome-based DetectionNo drug interventionsNot AvailableNot Availablecompleted
NCT01876927
Pre-Operative Or Peri-Operative Dox Regimen In Patients With Locally Advanced Resectable Gastric CancerNo drug interventionstreatment2completed
NCT00003427
Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancertreatment1completed
NCT03492827
Evaluation of the Preventive Effect of Chlorhexidine Acetate Gargle for Upper Gastrointestinal Tract Infection After ESDpreventionNot Availableunknown_status
NCT00639327
Second Line Chemotherapy for S-1 Refractory Advanced Gastric Cancertreatment2 / 3completed
NCT02776527
A Clinical Trial of Maintenance Treatment of Apatinib in Advanced Gastric Cancer Patients Have Completed Postoprative Adjuvant Chemotherapytreatment4unknown_status
NCT02356276
Efficacy of HIPEC in the Treatment of Locally Advanced Gastric Cancer After radIcal Gastrectomy With D2No drug interventionstreatment3unknown_status
NCT02647476
Postoperative Enteral Immunonutrition in Gastric CancerNo drug interventionstreatment3completed
NCT02274376
Non-Interventional Study of Xeloda (Capecitabine) in Patients With Gastric CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT05573776
A Pilot Study of the Effect of High Protein Supplement and Exercise Therapy on Preservation of Skeletal Muscle Mass and Quality of Life in Patients With Gastric Cancer and Pancreatic Cancer Treated With ChemotherapyNo drug interventionssupportive_careNot Availablecompleted
NCT03957460
Accuracy of Continuous and Non-invasive Hemoglobin MonitoringNo drug interventionsNot AvailableNot Availablecompleted
NCT03960060
A Study of CCT301-59 CAR T Therapy in Adult Subjects With Recurrent or Refractory Solid TumorsNo drug interventionstreatment1unknown_status
NCT04178460
A Study of Niraparib Combined With MGD013 in Patients With Advanced or Metastatic Solid Tumor Who Failed Prior Treatmenttreatment1terminated
NCT04184960
AG & IM in CA Stomach ProtocolNo drug interventionsNot AvailableNot Availablerecruiting
NCT00011960
Chemotherapy and Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Stomach Who Have Undergone Surgerytreatment2completed
NCT05192460
Safety and Efficacy of Personalized Neoantigen Vaccine in Advanced Gastric Cancer, Esophageal Cancer and Liver CancerNo drug interventionstreatmentNot Availablerecruiting
NCT06281860
Treatment Pleural Carcinosis of Pressurized IntraThoracic Hyperthermic Aerosol Cisplatin AdministrationNo drug interventionstreatment1recruiting
NCT04976660
TT-4 as a Single Agent in Subjects With Advanced Selected Solid TumorsNo drug interventionstreatment1 / 2unknown_status
NCT06239194
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid TumorsNo drug interventionstreatment1 / 2recruiting
NCT05498194
Computational Prediction and Experimental Validation of Gastric Cancer Associated NeoantigensNo drug interventionsNot AvailableNot Availableunknown_status
NCT00675194
Efficacy of Irinotecan and Capecitabine Versus(vs) Cisplatin and Capecitabine in Patients With Esophago-Gastric Cancertreatment2completed
NCT05318794
Neoadjuvant Systemic and Peritoneal Chemotherapy for Advanced Gastric Cancertreatment2not_yet_recruiting
NCT05606094
Real-World Observational Study to Describe Treatment Patterns in Patients With HER2-Positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer in East AsiaNo drug interventionsNot AvailableNot Availablecompleted
NCT01260194
A Study of Herceptin (Trastuzumab) in Combination With Standard Chemotherapy in Patients With HER Positive Metastatic Gastric Cancertreatment4terminated
NCT06531291
Surufatinib Combined With Serplulimab and Standard Chemotherapy as First-line Treatment in Advanced Solid Tumors With Neuroendocrine Differentiationtreatment2not_yet_recruiting
NCT05483491
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancertreatment1recruiting
NCT06325891
Microbiota in Gastric Cancer by Gastric Mucosal BrushingNo drug interventionsNot AvailableNot Availablerecruiting
NCT06385691
Study Evaluating the Efficacy of the myDIET Software Tool in the Nutritional Management of Patients With Localized and Resectable Gastric or Esogastric Junction Cancer.No drug interventionsprevention2recruiting
NCT01147991
Vaccine Therapy in Treating Patients With Epstein-Barr Virus-Related Cancertreatment1completed
NCT03250091
Surveillance of Patients With Precancerous Lesions of the StomachNo drug interventionsNot AvailableNot Availablerecruiting
NCT04800991
NuGa (Nutrition for Gastric Cancer Patients)No drug interventionssupportive_careNot Availablecompleted
NCT04724291
MAGNET (Magnetically Controlled Capsule for Assessment of Gastric Mucosa in Symptomatic Patients)No drug interventionsdiagnosticNot Availablecompleted
NCT03196791
Compare the Oncological Benefit of Deep Neuromuscular Block in Gastric Cancer Obesity Patienttreatment3completed
NCT04782791
Nivolumab, S-1 Combined With Oxaliplatin Versus Nivolumab as Neoadjuvant Therapy in Advanced Gastric Cancertreatment2unknown_status
NCT02078362
ADCC Against Gastric Cancer CellsNo drug interventionsNot AvailableNot Availableunknown_status
NCT03939962
Camrelizumab Combined With FOLFOX Neoadjuvant Therapy for Resectable Gastric and Gastroesophageal Junctional Adenocarcinomatreatment2unknown_status
NCT06477562
Surveillance Endoscopy After Proximal Gastriectomy With Double Tract Reconstruction.No drug interventionsNot AvailableNot Availablecompleted
NCT04105062
LS301 Uptake in Tumors of Patients Undergoing Liver, Pancreas, or Gastric SurgeryNo drug interventionsdiagnostic1 / 2withdrawn
NCT02918162
Perioperative Chemo and Pembrolizumab in Gastric Cancertreatment2completed
NCT02442362
TOF Versus SOX in Metastatic Gastric Cancertreatment2 / 3completed
NCT00215462
Vinorelbine in Unresectable or Metastatic Esophageal and Gastric Adenocarcinomatreatment2completed
NCT05275062
Clinical Trial to Evaluate the Safety and Efficacy of IM92 CAR-T Cells Therapy in Patients With Advanced Gastric or Pancreatic AdenocarcinomaNo drug interventionstreatment0unknown_status
NCT04160962
A Real World Study of Laparoscopic Preservation of the Pylorus GastrectomyNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT04640480
Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumorstreatment1not_yet_recruiting
NCT05800080
An Exploratory Study of Immunotherapy Combined With Anlotinib and Chemotherapy in Perioperative Treatment of LAGCtreatmentNot Availablenot_yet_recruiting
NCT05360680
A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic CancersNo drug interventionstreatment1active_not_recruiting
NCT03257280
Trial on Impact on the Hospital Stay, of an Early Oral Nutrition Protocol Applied to Patients After Total Gastrectomy. (DOPGT_2015)No drug interventionsotherNot Availableunknown_status
NCT05281380
VITAMin Insufficiency in Esophagogastric NeoplasmsNo drug interventionstreatmentNot Availablerecruiting
NCT05657080
Cytosponge for Gastric Intestinal MetaplasiaNo drug interventionsNot AvailableNot Availablerecruiting
NCT05702229
Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinomatreatment2recruiting
NCT02318329
Open-Label, Dose-Finding Study Evaluating Safety and PK of FPA144 in Patients With Advanced Solid Tumorstreatment1completed
NCT03528629
A Study of IMAB362 in Japanese Subjects With Locally Advanced or Metastatic Gastric or Gastro-esophageal Junction (GEJ) AdenocarcinomatreatmentNot Availablecompleted
NCT02348229
Effect of Enhanced Recovery After Surgery (ERAS) on C-reactive and Visceral ProteinsNo drug interventionstreatmentNot Availablecompleted
NCT05518929
Hypoxia During Gastroenterological Endoscope Procedures Sedated With Ciprofol In Overweight Or Obesity Patientstreatment4completed
NCT03121729
Enhanced Recovery After Surgery Program for Gastric Cancer: a Multi-center StudyNo drug interventionstreatmentNot Availableunknown_status
NCT02518529
Study to Assess Tolerability and Safety and Antibody Response to G17DT in Gastric Cancer Patientstreatment2completed
NCT06115629
Surveillance After Resection of Oesophageal aNd Gastric Cancer (SARONG-II) TrialNo drug interventionsdiagnostic3not_yet_recruiting
NCT06487429
Short Course Radiotherapy With Sequential Disitamab Vedotin Combined With S-1 and Sintilimab as Whole Course Neoadjuvant Therapy for HER2 Expressed Locally Progressive Gastric Cancertreatment2recruiting
NCT00568529
Combination of Capecitabine and Oxaliplatin in Patients With Relapsed or Refractory Gastric Cancertreatment2suspended
NCT00252889
Doxil Topotecan Doublet Cancer Studytreatment1completed
NCT01468389
Taxanes or Platinum in Combination With Capecitabine Followed by Capecitabine Alone as First Line Treatment for Patients With Advanced Adenocarcinoma of Stomach or Esophagogastric Junctiontreatment3unknown_status
NCT01498289
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancertreatment2completed
NCT00130689
Use of Cetuximab for Unresectable or Metastatic Esophageal and Gastric Cancertreatment2completed
NCT05698992
Rehabilitation and Recovery for Persons With Esophageal or Gastric CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT04678492
Helicobacter Rescue Therapy With High-dose Esomeprazole and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapytreatment4completed
NCT03609892
Helicobacter Rescue Therapy With Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazolidone Quadruple Therapytreatment4completed
NCT04500392
High-flow Nasal Cannula Oxygenation Decrease Hypoxia in Sedated Gastrointestinal Endoscopes in ObesityNo drug interventionspreventionNot Availablerecruiting
NCT00215644
Matuzumab Treatment With Epirubicin, Cisplatin and Capecitabine (ECX) in Esophago-Gastric Cancertreatment2completed
NCT05579444
Systems Biology of Gastrointestinal and Related DiseasesNo drug interventionsNot AvailableNot Availableterminated
NCT01516944
Perioperative Chemotherapy for Potentially Resectable Gastric Cancertreatment2 / 3completed
NCT02584244
Feasibility of the LUM Imaging System for Detection of Gastrointestinal CancersNo drug interventionsdiagnostic1 / 2recruiting
NCT03277144
Incidence of Duodenal Stump Fistula After Gastrectomy for Gastric Cancer. A Randomized Controlled TrialNo drug interventionspreventionNot Availableunknown_status
NCT05969444
Endoscopic Surveillance on a High-risk Population for Gastric Cancer in Latin America: The ECHOS Cohort Study.No drug interventionsNot AvailableNot Availablecompleted
NCT05431244
Pilot Study of Antiviral Treatment in Combination With Low-dose Gemcitabine in EBV-associated Gastric Cancer (EBVaGC)treatmentNot Availablewithdrawn
NCT03682744
CAR-T Intraperitoneal Infusions for CEA-Expressing Adenocarcinoma Peritoneal Metastases or Malignant Ascites (IPC)No drug interventionstreatment1withdrawn
NCT03784040
Nivolumab, Ipilimumab and OTSGC-A24 Therapeutic Peptide Vaccine in Gastric Cancer - a Combination Immunotherapy Phase Ib Study.treatment1unknown_status
NCT06313567
Metronomic Capecitabine in Stage III Gastric Cancertreatment3recruiting
NCT04498767
Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)No drug interventionstreatmentNot Availablerecruiting
NCT06349967
Nab-paclitaxel Combined With Cadonilimab (AK104) for the Second-line Treatment of Advanced Gastric Cancertreatment2not_yet_recruiting
NCT03076567
Discovery and Validation of Plasma DNA Methylation Biomarker for Detection of Stomach CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00896467
Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial TherapyNo drug interventionsNot AvailableNot Availableterminated
NCT04674267
Resilience and Equity in Aging, Cancer, and Health (REACH)No drug interventionshealth_services_researchNot Availablerecruiting
NCT04106167
Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular ImmunotherapyNo drug interventionsNot AvailableNot Availableterminated
NCT04363801
A Study of DKN-01 in Combination With Tislelizumab ± Chemotherapy in Patients With Gastric or Gastroesophageal Cancertreatment2active_not_recruiting
NCT02632201
Immunotherapy Using Pluripotent Killer-Human Epidermal Growth Factor Receptor-2 (PIK-HER2) Cells for the Treatment of Advanced Gastric Cancer With Liver MetastasisNo drug interventionstreatment1 / 2unknown_status
NCT04223401
Prehabilitation for GastrectomyNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT00596401
The Preventive Effect of Helicobacter Pylori Eradication on the Development of Gastric CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT04384601
Dragon III-Phase 3: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric CancerNo drug interventionstreatment3not_yet_recruiting
NCT06313801
Comparing the Safety and Efficacy of First-line Polychemotherapy and Polychemotherapy in Combination With PIPAC Sessionstreatment2recruiting
NCT06464601
A Real-World Study of Neoadjuvant/Conversion Therapy for Locally Advanced or Metastatic Gastric CancerNot AvailableNot Availablenot_yet_recruiting
NCT02318901
Pembrolizumab and Monoclonal Antibody Therapy in Advanced Cancertreatment1 / 2terminated
NCT05052801
Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpressiontreatment3active_not_recruiting
NCT00534001
Bupropion in Helping Adults Stop Smokingother2completed
NCT05982301
Sintilimab Combined With Modified FLOT Regimen in the Treatment of Metastatic Gastric Cancertreatment2recruiting
NCT05445401
Pre-rehabilitation in Neoadjuvant Patients With Gastric CancerNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT00149201
A Study of 5-FU Versus MTX+5-FU in Gastric Cancer With Peritoneal MetastasisNo drug interventionstreatment3completed
NCT02901301
Pembrolizumab, Trastuzumab, HER2 Positive Gastric Cancertreatment1 / 2unknown_status
NCT04047004
Adjuvant PIPAC in Gastric Cancer Patientsother1completed
NCT00512304
Adjuvant Treatment of Gastric Cancer With Chemotherapy and Chemoradiotherapy (TRACE)No drug interventionstreatment2completed
NCT04871204
Octreotide Treatment to Improve Nutritional Recovery After Surgery for Patients With Esophageal or Gastric Cancertreatment2recruiting
NCT01041404
ToGA Study - A Study of Herceptin (Trastuzumab) in Combination With Chemotherapy Compared With Chemotherapy Alone in Patients With HER2-Positive Advanced Gastric Cancertreatment3completed
NCT04555304
Phase 2 Study of KH903 in Patients With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma As Second-Line Therapytreatment2unknown_status
NCT00004604
Biological Therapy in Treating Patients With Metastatic CancerNo drug interventionstreatment1completed
NCT01824004
Postoperative Chemoradiotherapy With S-1 in Gastric CancerNo drug interventionstreatment2completed
NCT01213004
Evaluation of Respiratory Motion-Corrected Cone-Beam CT in Radiation Treatment of Thoracic and Abdominal CancersNo drug interventionsdiagnosticNot Availablecompleted
NCT06275204
H. Pylori Screen-and-treat Study in a Population of Young AdultsNot AvailableNot Availablerecruiting
NCT00397904
Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and Cisplatintreatment2completed
NCT01486472
S-1-induced Lacrimal Drainage ObstructionNo drug interventionsNot AvailableNot Availableunknown_status
NCT05823272
ONS in Gastric Cancer After Total GastrectomyNo drug interventionstreatmentNot Availablerecruiting
NCT01227772
Study of OTSGC-A24 Vaccine in Advanced Gastric CancerNo drug interventionstreatment1 / 2unknown_status
NCT04077372
Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal CancersNo drug interventionssupportive_careNot Availableterminated
NCT01234272
Comparison of the Analgesic Effect Between Intrathecal Morphine and IV-fentanyl Patient Controlled Analgesia (ITM-IVPCA) and Epidural PCA (PCEA) in Patients Undergoing Gastrectomy -Randomized Allocation Study-treatment4completed
NCT05563272
89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumorsdiagnostic2recruiting
NCT06102772
Adebrelimab and Fruquintinib Combined With Paclitaxel/Albumin Paclitaxel for Advanced Gastric CancerNot AvailableNot Availablerecruiting
NCT03878472
Neoadjuvant Immunotherapy for Resectable Gastric Cancertreatment2recruiting
NCT04902872
Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid TumorsNo drug interventionstreatment1 / 2active_not_recruiting
NCT00183872
Study of Irinotecan and Docetaxel in Patients With Metastatic or Unresectable Gastric or Gastroesophageal Junction Adenocarcinomatreatment2completed
NCT05287672
Retrospective Study of Effect of Adjuvant Chemoradiation of Gastric Carcinoma on Local Control and SurvivalNo drug interventionsNot AvailableNot Availableunknown_status
NCT04649372
EndoVE endosCopic Treatment for Oesophageal and Gastric canceRNo drug interventionstreatmentNot Availablecompleted
NCT00313872
Phase III Trial of DP Followed by FOLFIRI or the Reverse Sequence in Unresectable Gastric Cancertreatment3completed
NCT00595972
Epirubicin Cisplatin and Fluorouracil (FU) Combined With Endostar in Patients With Advanced or Metastatic Gastric Cancertreatment2completed
NCT00195572
Study Evaluating Isovorin in Advanced/Recurrent Gastric Cancertreatment3completed
NCT00415168
Pemetrexed Plus Cisplatin as First-Line Treatment in Stage IV or Recurrence of Gastric Cancertreatment2completed
NCT02764268
Apatinib Dose Titration in Advanced or Metastatic Gastric CancertreatmentNot Availablecompleted
NCT05742568
Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal Microecologytreatment4recruiting
NCT04490668
Human Albumin and Anastomotic Leakage After Gastric Cancer SurgeryNot AvailableNot Availablecompleted
NCT06094868
Clinical Study of Fruquintinib Combined With Sintilimab and XELOX Regimen in the Treatment of Advanced Cancertreatment2not_yet_recruiting
NCT02578368
Chemotherapy Alone vs. Chemotherapy + Surgical Resection in Patients With Limited-metastatic Adenocarcinoma of the Stomach or Esophagogastric Junctiontreatment3active_not_recruiting
NCT00343668
S-1 and Irinotecan Combination Chemotherapy for Advanced Gastric Cancertreatment2unknown_status
NCT02510469
Apatinib as Maintenance Therapy After Adjuvant Chemotherapy in Progressive Gastric Cancer With Positive Exfoliative Cancer Cellstreatment2 / 3unknown_status
NCT05789069
A Study of HFB200603 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumorstreatment1recruiting
NCT05029869
Monitoring Minimal Residual Disease in Gastric Cancer by Liquid Biopsy Study DescriptionNo drug interventionsNot AvailableNot Availablerecruiting
NCT04567069
Safety and Efficacy Study for MG-7-DC Vaccine in Gastric Cancer Treatmenttreatment1 / 2unknown_status
NCT04164069
Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumabprevention1active_not_recruiting
NCT06305169
Measuring the Negative Predictive Value and Specificity of Serum Biomarkers in Gastric CancerNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT00790569
Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop SmokingpreventionNot Availablecompleted
NCT01466569
An A/B Dose Escalation Study of AbGn-7 Alone and With FOLFOX7 Treatment in Patients With Advanced Solid TumorsNo drug interventionstreatment1completed
NCT02711969
A Study of Apatinib Mesylate (YN968D1) 1,000mg in Gastric Cancer Patient Failed to Standard Treatmenttreatment1completed
NCT05638269
A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in ChinaNo drug interventionsNot AvailableNot Availablerecruiting
NCT01662869
A Study of Onartuzumab in Combination With mFOLFOX6 in Participants With Metastatic HER2-Negative and MET-Positive Gastroesophageal Cancertreatment3completed
NCT01905969
Predictive Biomarkers in Stage II/III Gastric Cancer for Adjuvant ChemotherapyNo drug interventionsNot AvailableNot Availableunknown_status
NCT00447746
A Comparison Between D1 and D2 Lymphadenectomy in Gastric Cancer : A Prospective Randomized Controlled TrialNo drug interventionstreatmentNot Availableunknown_status
NCT03007446
The Study of Conversion Surgery for Apatinib in Combination With SOX for Patients With Unresectable Gastric Cancertreatment2unknown_status
NCT04740346
Survival Rates and Quality of Life According to Follow-up Period After Gastrectomy for Gastric Cancer (STOFOLUP)No drug interventionsdiagnosticNot Availablerecruiting
NCT00598546
Quality of Life Among Long-Term Survivors of Resected Gastric CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT01457846
Efficacy and Safety of AZD4547 Versus Paclitaxel in Patients With Advanced Gastric or Gastro-oesophageal Cancertreatment2terminated
NCT00003046
Interleukin-12 in Treating Patients With Cancer in the Abdomentreatment1completed
NCT06046846
Prehabilitation Via a Mobile Application in Oesophago-gastric CancerNo drug interventionsotherNot Availablenot_yet_recruiting
NCT02682446
The Efficacy of Serum Pepsinogen for Prediction of Metachronous Gastric NeoplasmNo drug interventionsNot AvailableNot Availablecompleted
NCT05184946
Clinical Study of Camrelizumab Combined With SOX in the Adjuvant Treatment of Advanced Gastric Adenocarcinoma or Gastric Esophageal Junction Adenocarcinomatreatment2recruiting
NCT05541146
Intraperitoneal Chemotherapy in Gastric Cancer With Peritoneal Carcinomatosistreatment2recruiting
NCT04835246
Evaluating Diagnostic Performance of Spectra IMDx System for Detection of Gastric Cancer and Precancerous LesionsNo drug interventionsdiagnosticNot Availableunknown_status
NCT00017212
DX-8951f in Treating Patients With Metastatic Stomach Cancertreatment2completed
NCT05465512
Using Radiomics to Predict Neoadjuvant Chemotherapy EfficacyNo drug interventionsNot AvailableNot Availablecompleted
NCT03958812
Diagnostic Power Comparison Between VOCs and CTCsNo drug interventionsNot AvailableNot Availableunknown_status
NCT02233712
Open-label, Dose-finding Study to Determine Antibody Response to G17DT Treatment in Patients With Gastric Cancer.treatment2completed
NCT02041312
Serum Cholesterol and Gastric NeoplasmNo drug interventionsNot AvailableNot Availableunknown_status
NCT03778710
Effect of Lymph Node Ratio in Gastric Cancer to Determine Recurrence Rate After Curative ResectionNo drug interventionsNot AvailableNot Availablecompleted
NCT03399110
XELOX for 4 Months Versus 6 Months in Gastric Cancer (LOMAC)prevention3active_not_recruiting
NCT05668910
Gastric Cancer Early Detection by Multi-dimensional Analysis of cfDNANo drug interventionsNot AvailableNot Availablerecruiting
NCT03865810
Postoperative Outcomes Within an Enhanced Recovery After Surgery Protocol in Gastric Surgery for CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT05914610
Envollizumab Combined With Fruquintinib and SOX Versus SOX for Conversion Therapy in Advanced Gastric Cancertreatment3not_yet_recruiting
NCT03841110
FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumorstreatment1completed
NCT01980810
First Line Chemotherapy for Advanced Cancertreatment2terminated
NCT05661110
Biomarker Analysis of HIPEC Combined With PD1/PDL1 Inhibitor for Gastric Cancer With Peritoneal MetastasisNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT03900910
Gastric Cancer Prevention for Indigenous PeoplesNo drug interventionstreatmentNot Availableenrolling_by_invitation
NCT05980481
A Study of RC48-ADC Combination Therapies as First-line Treatment in Advanced Metastatic Gastric Cancertreatment2 / 3recruiting
NCT00745381
A Collection of Clinical and Epidemiologic Data Combined With Tissue and Blood From Patients With a Diagnosis of Neuroendocrine TumorsNo drug interventionsNot AvailableNot Availablecompleted
NCT04798781
Safety and Efficacy of Telatinib in Combination With Keytruda in Subjects With Advanced Stomach and Gastroesophageal Junction Cancers or Hepatocellular Carcinomatreatment2active_not_recruiting
NCT00580281
Effect of Imatinib on Bone Metabolism in Patients With Chronic Myelogenous Leukemia or Gastrointestinal Stromal TumorsNo drug interventionsdiagnosticNot Availablecompleted
NCT04147481
Effects of Abdominal Nerve Block on Postoperative Recovery in Patients Undergoing Gastrointestinal SurgeryNo drug interventionstreatmentNot Availableunknown_status
NCT00006081
Combination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach Cancertreatment2completed
NCT03978481
Effect of Helicobacter Pylori Eradication After Subtotal Gastrectomy on Survival Rate of Gastric Cancer Patients: Retrospective StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT04947995
Multi-Omics Noninvasive Inspection of TumOr Risk for Gastric CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT06232395
Early Detection and Post-operative Monitoring of Gastric CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT02436395
Povidone-iodine and the Normal Saline Cleaning the Incision for the SSIsNo drug interventionstreatmentNot Availableunknown_status
NCT01033695
Interobserver Agreement of Endoscopic Ultrasonography and Endoscopic Sonoelastography in the Evaluation of Lymph NodesNo drug interventionsNot AvailableNot Availablecompleted
NCT04404595
Claudin18.2 CAR-T (CT041) in Patients With Gastric, Pancreatic Cancer, or Other Specified Digestive Cancerstreatment1 / 2active_not_recruiting
NCT02999295
A Phase 1/2 Study of Ramucirumab Plus Nivolumab in Participants With Gastric or GEJ Cancertreatment1 / 2completed
NCT05872295
IKS014 in Advanced Solid Tumors That Express HER2No drug interventionstreatment1recruiting
NCT00134095
S-1 and Irinotecan in Treating Patients Who Are Undergoing Surgery for Locally Advanced Stomach Cancertreatment2unknown_status
NCT05538195
Safety and Efficacy of CEA-targeted CAR-T for CEA-positive Advanced Malignant Solid TumorsNo drug interventionstreatment1 / 2recruiting
NCT06341595
Concurrent Chemoradiotherapy Combined With Sintilimab as Neoadjuvant Therapy for GC Patients With PALMtreatment2recruiting
NCT01100814
Expression of S100A2 and Trefoil Factor Family Members in Epstein-Barr Virus Related Gastric CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT02292914
Prospective Analysis of Robot-Assisted SurgeryNo drug interventionstreatmentNot Availableunknown_status
NCT02788214
Helicobacter Pylori Genome Project (HpGP)No drug interventionsNot AvailableNot Availableterminated
NCT06365814
ERAS for Gastric Cancer Patients After NACTNo drug interventionsNot AvailableNot Availablecompleted
NCT04118114
Phase II Study of PRL3-ZUMAB in Advanced Solid TumorsNo drug interventionstreatment2recruiting
NCT06525714
Effect of HIPEC After Radical Surgery on Long-term Survival for Locally Advanced Gastric Cancertreatment0not_yet_recruiting
NCT05462314
Intestinal Microbiome, Oral Microbiome, and Whole Blood Transcriptome Analyses in Gastrointestinal MalignanciesNo drug interventionsNot AvailableNot Availablerecruiting
NCT02112214
Helicobacter Pylori Eradication for Gastric Cancer Prevention in the General PopulationNo drug interventionsprevention3active_not_recruiting
NCT01269255
A Trial of Induction Chemotherapy and Chemoradiotherapy With TS-1 and Cisplatin (SP) as First-line Treatment in Patients With High Risk Advanced Gastric CancerNot Available1completed
NCT01444755
The Effect of Neoadjuvant Chemotherapy on Locally Advanced Gastric CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT00287755
Clinical Trial of Chemosensitivity TestNo drug interventionsdiagnostic2completed
NCT00558155
The Impact of Immunostimulating Nutrition on the Outcome of Surgerytreatment4completed
NCT01854255
Intraperitoneal Aerosol Chemotherapy in Gastric Cancertreatment2completed
NCT06490055
Predicting the Efficacy in Advanced Gastric Cancer.Not AvailableNot Availablerecruiting
NCT00941655
Prospective Randomized Trial Comparing Gastrectomy, Metastasectomy Plus Systemic Therapy Versus Systemic Therapy Alone: GYMSSA Trialtreatment3completed
NCT04327050
Magnetic Anchoring Guided Endoscopic Submucosal Dissection for Early Gastric CanerNo drug interventionstreatmentNot Availableunknown_status
NCT03329950
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies